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Definitions 
Hospital in-patient prescription Chart  
The structure, design, and arrangement of the prescription information on the 
prescription chart changes depending on whether it is paper or electronic, also changing 
slightly between different hospitals. For the purposes of this study the paper and 
electronic in-patient, prescription chart is defined below. 
Paper in-patient prescription chart (drug chart or Kardex) 
A paper prescription chart is usually produced in the form of an A4 paper booklet or fold 
out Kardex; historically the drug chart design is reviewed and updated by the pharmacy 
department in-house or in collaboration with other Trusts or health care regions. Wales 
and Australia have a national paper-prescription chart that is used for in-patients. 
However, England does not have a national chart, but has Standards for the Design of 
Hospital In-Patient Prescription Charts (2). 
Electronic in-patient prescription chart (ePrescribing or EPMA) 
An electronic prescription chart is produced by software on a computer. The software can 
be sourced from a commercial IT company, or constructed by specific hospital IT teams. 
Electronic Prescribing and Medicines Administration (EPMA) systems enable 
administration of medicines to be recorded in the electronic system, as well as the 
prescription itself. 
Multidisciplinary Team (MDT) 
A multidisciplinary team (MDT) is made up of different healthcare professions (Doctor, 
Nurse, Pharmacist) with specialised knowledge and skills. The HCPs work together as a 
team to make treatment recommendations that facilitate quality patient care.  
Health Care Professional (HCP) 
A Health Care Professional (HCP) for the purpose of this thesis is defined as a qualified 
nurse, medical doctor, or pharmacist working within the NHS hospital setting. All of these 
HCP groups are the main users of the system and are able to independently prescribe (3), 
clinically review, or administer medicines in hospital practice. Dentists and Optometrists 
were excluded based on their specialist background. 
xi 
Clarity for the purposes of this thesis is a factor that relates to the ease with which the 
correct meaning of a prescription can be interpreted by the HCPs using the prescribing 
system. 
Terminology used in association with the prescription chart 
Type of medicine Definition 
Stat One off dose of medication, administered immediately, usually outside of 
the normal medicines administration round times (4). 
eStat Due to electronic automation a one off dose of medication, administered 
immediately, usually outside of the normal medicines administration 
round times(4). 
Regular A medication administered on a regular basis, in a predictable set routine. 
As required (prn) A medication only administered, when required by the patient. 
 
Clinical Indication The reason why the medication is prescribed 
Order Sets An order set is a collection of clinically related medication orders grouped 
by purpose (5) that can be prescribed all at the same time. 
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Abstract 
The National Health Service (NHS) focuses on quality of care as a priority. With the 
NHS planning to go paperless by 2018, more hospitals in England are making the 
transition from paper to electronic prescribing (ePrescribing) systems. The aim of this 
programme of work was to understand and explore the influence different in-patient 
prescribing systems can have on key NHS healthcare professionals (doctors, nurses and 
pharmacists) working practices in England and quality healthcare.  
The programme of work, a three phase sequential design, used both qualitative 
and quantitative approaches. The first phase involved structured telephone interviews 
with chief pharmacists. Chief pharmacist interviews (n=65) focused upon the type of in-
patient prescribing systems in use within each Trust and gained a management 
perspective of the different prescribing systems. Phases two and three were carried out 
at three acute NHS hospitals in England, at various stages of developing and 
implementing their prescribing systems. Phase two data were collected through 
multidisciplinary team (MDT) focus group discussions. The MDT discussions explored a 
number of areas associated with the prescribing systems in use: these included clinical 
workflow, communication, collaboration, patient safety and the use of a clinical indication 
on the prescription chart. Phase three data were collected using documentation analysis 
of the prescribing system and medical records, taken from patients cared for by the MDTs 
involved in phase two. Information extracted included any documentation made of a 
newly initiated medication, as well as the design of the prescribing system. The clarity and 
accuracy of documentation in the prescribing system and medical notes were compared 
to the GMC standards Good Practice in Prescribing Guidelines.  
Triangulation of data indicated how a change in prescribing system can impact 
upon individuals working practices by changing the design and clarity of the prescription 
chart, enforcing of regulations, accessibility and reliability, communication between key 
HCPs and the patient. These influences can be considered latent conditions in the systems 
that need addressing to prevent quality of patient care being compromised. The use of 
Socio-technical systems (STS) theory considered the interaction between humans and 
technology when using the prescribing systems. Understanding the issues where social 
and technical aspects interact in the prescribing system, emphasised where healthcare 
quality is impacted and therefore facilitated recommendations to improve working 
practices.  
The findings will help healthcare organisations to consider the impact a change in 
prescribing system can have on working practices and the latent failures that need 
consideration within the prescribing systems. The Electronic Prescribing and Medicines 
Administration (EPMA) system design must take into account the visual and physical 
needs of the user and consider how they can be improved to facilitate clinical workflow. 
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“Human beings make mistakes because the systems, tasks, and 
processes they work in are poorly designed” 
    Lucian Leape 
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1 THE IMPACT OF PRESCRIBING SYSTEMS ON HEALTHCARE 
QUALITY 
This thesis considers the impact a prescribing system (paper or electronic), within 
the hospital in-patient setting, can have on health care professionals’ (HCPs’) working 
practices and ultimately the quality of care they can provide to their patients. The 
programme of work compares the effect that prescribing systems can have on quality of 
care across three perspectives, namely those of pharmacy management, the 
multidisciplinary team (MDT) made up of key HCPs (doctors, nurses, and pharmacists) and 
that taken by documentation review. This has enabled exploration of the affects that 
different prescribing systems (paper or electronic) can have and explores how the effects 
are inter-related and influence the quality of patient care. 
Within this chapter, the literature applicable to this programme of work is 
reviewed. This begins with the concept of quality healthcare and its importance to the 
NHS, outlining the need for good communication, guidelines, and policies. The prescribing 
and medicines administration process is then described leading on to the use of paper 
and electronic prescribing (ePrecribing) systems and the problems that have been 
encountered with them. Within this, government policy developments appropriate to 
creating a prescription, such as the use of a clinical indication on the prescription chart, is 
deliberated in relation to the prescribing system. The use of socio-technical systems (STS) 
theory is then explained in relation to the programme of work. STS theory is utilised, to 
understand how the change in prescribing system can impact upon the quality of care 
provided. Clinical workflow research surrounding the prescribing process was reviewed to 
gain a perspective on prescribing systems and clinical workflow in secondary care. The 
chapter explains how clinical workflow encompasses many of the social aspects of the STS 
that are required to improve organisational performance. The chapter concludes with the 
literature search purpose and parameters and a description of the originality of the 
programme of work.  
1.1 Quality Care 
The National Health Service (NHS) policy documents High Quality Care For All (6) 
and Equity and excellence: Liberating the NHS (7) emphasised that the NHS services 
2 
should focus on quality of care as a priority. In the wake of the Mid-Staffordshire enquiry 
further NHS reports were produced A promise to learn - a commitment to act (8) and 
Hard Truths, The Journey to Putting Patients First (9) that shifted emphasis towards 
patient centred care, along with continuing its commitment to quality care, being the 
fundamental foundation of the NHS. Within the UK healthcare environment, the NHS 
defines quality care as “clinically effective, personal and safe”(6) . Safety within the 
context of quality is one of the most significant components; the NHS report (8) defined 
how the origin of error causation needs to be distinct in order to consider human error or 
error arising from system failures. Both have multiple causes, many outside the control of 
the person who makes the mistake (8)(10). 
The Institute of Medicine (IOM), a non-profit, non-governmental USA organisation, 
expanded the components of quality care to include safe, timely, effective, efficient, 
equitable and patient centred (11). For the purposes of this thesis, these components are 
abbreviated to STEEEP; see Table 1-1 below for a description of the conceptual 
components.  
Table 1-1 Quality Components – Safe, Timely, Effective, Efficient, Equitable, Patient 
centred (STEEEP) (3). 
Specific aims for quality improvement in healthcare (11) 
Safe Avoiding injuries to patients from the care that is intended to help them 
Timely 
Reducing waits and sometimes harmful delays for both those who receive and those who 
give care 
Effective 
providing services based on scientific knowledge to all who could benefit and refraining from 
providing services to those not likely to benefit (avoiding underuse and overuse) 
Efficient avoiding waste, in particular waste equipment, supplies, ideas and energy 
Equitable 
Providing care that does not vary in quality because of personal characteristics such as 
gender, ethnicity, geographic location and socio-economic status 
Patient-
centred 
providing care that is respectful of and responsive to individual patient preferences, needs 
and values and ensuring that patient values guide all clinical decisions 
 
The STEEEP components that are particularly relevant to the prescribing and 
administration process and the focus of this study are - Safe (e.g. prescribing safely, 
avoiding prescribing and administration errors, and the introduction of a national drug 
chart), Timely (e.g. clinical workflow around the prescribing and administration process), 
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Effective (e.g. is the in-patient prescription chart designed effectively), Efficient (e.g. 
comparing paper and ePrescribing systems efficiency and communication changes) and 
Patient-centred (patient contact to enable responding to patient needs and values). 
Without defined ways of communicating between patients, HCPs, departments and 
throughout the whole hospital, responsibility for providing quality patient care can be 
diffused and therefore not clearly owned (8). Therefore, it is essential to have clear 
communication and defined responsibilities to provide quality patient care. It is important 
to consider that the action of prescribing does not occur in isolation and that 
communication is vital in order to provide quality care within the hospital setting. Rules, 
standards, regulations and enforcement all have a place in the pursuit of quality (8). 
Prescribing by its very nature has a number of local and national policies, processes, and 
systems that govern and influence it in order to facilitate quality care for the patient. 
Several policy documents provide recommendations for written communication in the 
healthcare setting around the prescribing process. The endorsements include guidance 
produced by the General Medical Council Good Practice In Prescribing And Managing 
Medicines And Devices (12) which provides a standard for documentation of a prescribed 
medication on the prescription and in the medical notes. It defines that written 
communication should be clear, accurate and legible, reporting the relevant clinical 
findings, the decisions made, the information given to patients, and any drugs prescribed 
(12). Records should be made at the same time as the event occurs or as soon as possible 
afterwards (12). Clarity for the purposes of this thesis is a factor which relates to the ease 
with which the correct meaning of a prescription can be interpreted by the HCPs using 
the prescribing system and is linked with the definition of a clinically meaningful 
prescribing error; 
 ‘a prescribing decision or prescription writing process that results in an 
unintentional, significant reduction in the probability of treatment being timely and 
effective or an increase in the risk of harm, when compared with generally accepted 
practice’ (13) 
A prescription should therefore provide a succinct piece of communication that is 
clear, accurate and legible in order to convey the right information timely and effectively 
so that a medication can be given to a patient safely (12)(13) and enables quality patient 
care. The National institute for Health and Care excellence (NICE) also emphasises the 
need for healthcare professionals to communicate information effectively to patients and 
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colleagues (14); this needs to be done in a timely manner. For example, the time 
difference between when a prescribing decision is made and documented in the notes, 
and then actually prescribed is how clinical workflow can affect efficiency. This could lead 
to a delay in a patient receiving essential medications, influencing a patient’s outcome.  
1.2 Prescribing and Medicines Administration Process 
The prescribing of medicines is the most common form of therapeutic intervention 
in healthcare (15), thus the quality of the prescription and the prescribing process is 
fundamental for high quality patient care (15). Each patient in the hospital setting is 
assigned a prescription chart (paper or electronic) on admission to the hospital. The 
purpose of the prescription chart is to communicate information about medications, for 
example, what has been given to the patient, as well as a direction on what is to be given 
in the future. When prescribing for in-patients, the details of the medicine are entered on 
to the prescription chart and additional sections prompt the prescriber to include all 
relevant details, making the prescription chart unique to individual in-patients (16). 
Doctors and some nurses and pharmacists are able to independently prescribe (3), are 
the main users of the prescribing system within the hospital, and therefore use the 
system on a regular basis. The individualised prescription chart is used by key HCPs 
(doctors, nurses, and pharmacists) as the basis for medicine review, supply, and 
administration in the hospital. In order to provide quality healthcare for patients, key 
HCPs must work as part of a MDT, reliant on each other to exchange accurate information 
in a timely and efficient manner even when they are in different locations across the 
hospital (17). The interaction that key HCPs have with the prescribing system needs to be 
facilitated by the design and layout of the prescribing system. Once a prescribing system 
is in use within a hospital, whether paper or electronic based, that prescribing system 
must be used; the HCP does not have a choice. The response of HCPs to using the 
prescribing system must be a positive one, in order to achieve optimal performance and 
effective implementation.  
1.3 Paper prescribing 
When the NHS was formed in 1947 hospital prescription charts did not exist, 
instead hospital prescribers wrote the directions to administer a medication in the 
patients notes, a nurse would then write them onto a medicines sheet (18). In 1959, it 
5 
was acknowledged by Fowler that the process of using medicines sheets was no longer fit 
for purpose (19). The reasons for why change was necessary included – the number of 
new medicines being introduced and staff being unable to keep up with new 
developments, pharmacists could not provide medicines information readily, doctors 
could not be expected to memorise details of drugs and dosages, and nurses, with other 
duties can only know new medicines superficially (19). Individual patients were receiving 
more medications at the same time, changes in treatment were becoming more frequent, 
and the number of patients moving through the system was growing (19). The reasons 
given back in 1959 for a change in prescribing system reflect issues that are still present at 
this moment in time, specifically the number of medicines used and their complexity (20). 
In 1965 papers published in the Lancet showed studies undertaken in London (21) and 
Aberdeen (22). They reviewed different types of medication errors, such as omission 
error and transcription error, which resulted in the creation of a prescription chart. 
Consequently, hospital in-patient prescription charts were introduced nationwide, but 
unlike the standard GP prescription sheets, the new hospital prescription charts were not 
standardised (18). The current UK hospital in-patient prescribing systems are based on a 
model established some 60 years ago and have remained largely unchanged until recently 
(20). Traditionally, medicines for hospital in-patients are prescribed on a paper 
prescription chart. These charts have evolved over the years and included “Aberdeen 
sheets” (23), “drug charts”, or “medication Kardex”. Pharmacy departments have 
historically been responsible for the design of paper prescription charts, reviewing the 
charts and updating them over the years. 
Paper prescription charts are low in cost, and do not require hours of training for 
the user to understand how they work. However, the main problem with this system is 
that legibility of handwriting can vary and not all prescription details are completed, 
resulting in inefficient use of HCPs’ time having to contact the prescriber and clarify the 
prescription (24) (25). Previous studies looking at the quality of a paper prescription chart 
have taken into account different indicators of quality such as legibility or the 
completeness of the prescription (25–31) but not always the potential harm the lack of 
quality prescribing may have caused. Another indicator of quality with paper prescriptions 
is the issue of identifying the prescriber, leading to a less than robust audit trail (29).  
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Studies conducted in the UK show that prescribing errors occur in 1.5-14.7% of 
hand written prescriptions for hospital inpatients (1,13,32–37). A systematic review of the 
prevalence and incidence of hand written prescribing errors within hospitals 
internationally noted a median error rate of 7% (37). The EQUIP study involving hospitals 
in England using paper prescription charts, showed that 8.9% of prescriptions written in 
hospitals contained errors (1). Other studies have shown error rates of between 10.7% 
and 14.7% (36)(38). Recommendations in a number of areas were made to improve 
patient safety through minimising prescribing errors when utilising paper prescription 
charts: these included changes to the clinical working environment and that a standard 
drug chart should be introduced throughout the NHS in England to reduce prescribing 
errors (1).  
Currently there is no standardised national paper-based prescription chart in acute 
trusts across England. Acute trusts or regions have developed their own in-patient paper-
based prescription charts, each with varying standards (39–42). A policy move towards 
utilising a standard national prescription chart across England has occurred with the 
publication of Standards for the design of hospital in-patient prescription charts (2). The 
report addresses the design standards that should be met by an optimal prescription 
chart (paper or electronic) with the view that they would be used by hospitals to evaluate 
local charts and inform a national English chart in the future (2).  
The introduction of a standardised paper prescription chart across Australia has 
shown conflicting results. In 2008 a tertiary hospital in Western Australia critically audited 
the design of the national in-patient medication chart (NIMC) against its own prescription 
chart (43). The study concluded that the NIMC was inferior to the prescription chart 
previously used in the tertiary hospital and that some of the new design features within 
the NIMC could lead to adverse outcomes (43).  However in 2009 another study showed a 
significant reduction in the frequency of prescribing errors when using the NIMC, the 
potential risks associated with warfarin management and improved documentation of 
ADRs (adverse drug reaction) (44). When comparing the studies it is not clear if they were 
researching the exact same version of the NIMC. Wales also has a national standardised 
paper prescription chart in place; however, no robust data of its impact has been 
published. Commentary outlining experiences and possible benefits, between 2004-2012, 
of the Welsh national chart has been published (45).  
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1.4 Clinical Indication 
One recommendation of the Standards For The Design Of Hospital In-Patient 
Prescription Charts is the inclusion of a space for clinical indication, both for regular and 
as-required medications (2). The clinical indication of a medication is a design standard on 
hospital in-patient prescriptions in Australia, however reports from The Australian 
Commission on Safety and Quality in Health Care (ASCQHC) show that only 14.5% of 
prescription items had an indication documented (46). Compliance with entering the 
clinical indication on the National Inpatient Medication Chart (NIMC) concluded in 
another study was as low as 8.9% (43). 
Clinical indications for prescribed medication in secondary care are not always clear 
or difficult to locate in patients’ medical notes, thus making monitoring for medication 
appropriateness by HCPs difficult (47). This is particularly important when initiating a 
prescribed medicine within the hospital environment as written communication in notes 
needs to be clear and succinct (12). The lack of written documentation and the quality of 
the documentation regarding prescribing decisions in the medical notes was considered 
to contribute to prescribing errors in a recent study (38). The study highlighted 
communication issues when the patient is transferred between wards or care settings 
leading to confusion amongst HCPs and potentially causing patient harm (38).  It is 
essential to ensure that the information provided on a prescription matches the 
information provided by HCPs in the medical notes. If the information does not match, a 
prescribing or documentation error may have occurred, highlighting potential patient 
safety issues.  
Incorporating the clinical indication of a medicine on to a prescription, for the use of 
antibiotics in the hospital setting, was considered to be a more effective process, than 
previous practice, in reducing the inappropriate prescribing of antibiotic medications, 
allowing verification of formulary, prescribing errors and facilitating audit (47)(48). 
However, it has been good practice for a long time regarding warfarin usage; guidelines 
on oral anticoagulation were produced by the British Committee for Standards in 
Haematology (49). The use of a clinical indication on a prescription makes clinical sense 
and fits with the literature concerning specific clinical situations such as anticoagulants 
and antibiotics. However, the practicalities of incorporating a clinical indication on every 
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prescription and imposing its use have proven difficult, unless key HCPs can see the 
benefits (46). The use of a clinical indication on prescriptions in primary care has been 
supported by the NHS; with its benefits being outlined on a dedicated website (50). 
1.5 Electronic prescribing 
As discussed previously, since 1959, prescribed medications have increased in 
number and complexity, with an inherent potential for greater risk to patients (19)(20). 
With the conception of computer technology, computerisation of prescribing 
(ePrescribing) and associated administration processes is advocated as the next step in 
facilitating  prescribing and a way of reducing prescribing errors (20). The definition used 
by NHS connecting for Health to define ePrescribing is 
The utilisation of electronic systems to facilitate and enhance the communication of 
a prescription or medicine order, aiding the choice, administration, and supply of a 
medicine through knowledge and decision support and provide a robust audit trail 
for the entire medicines use process. 
Patient safety, along with the growing needs for formulary, financial and audit 
control, has led to widespread recommendations for the introduction of ePrescribing 
systems in the UK (20). EPrescribing systems support the efficient management of 
medicines for both patient and hospital as well as being efficient in integrating with other 
hospital systems (20). However, ePrescribing systems are not necessarily about increasing 
the efficiency of individual tasks for HCPs, such as prescribing (51)(52). EPrescribing still 
requires the same data as paper-based prescriptions but more information is now 
required, such as the specific formulation of the medication, but illegibility is no longer an 
issue.  
Over the past twenty-years in secondary care, acute trusts have started to 
implement electronic prescribing and medicines administration (EPMA) systems. At the 
time of writing, NHS acute trusts within England were at very different stages of 
implementing ePrescribing. Research prior to 2011, showing the spread of ePrescribing 
across England in secondary care had used convenience samples to obtain their data 
(53)(54). These studies were survey-based and showed that the hospitals had a high 
interest in ePrescribing, but only a small number had actually implemented ePrescribing. 
A more recent study, conducted in 2011, undertook a detailed review of ePrescribing use 
in terms of its extent of deployment, comprehensiveness with respect to drugs 
9 
prescribed, the decision support functionalities used, and the use of multiple ePrescribing 
systems within the same hospital (55). The study showed that only 13 Trusts used in-
patient ePrescribing across all adult medical and surgical wards (55).  
The role in 2002 of the NHS Connecting for Health (NHS CFH), part of the 
Department of Health Informatics Directorate, was to maintain and develop the NHS 
National IT infrastructure. NHS CFH provided information on ePrescribing system 
evaluation, implementation, clinical safety and decision support (56). Yet, as of 2008, 
there was not one ePrescribing system in use delivered via the national programme (57). 
With 12 ePrescribing systems available in 2008 across England and the choice to 
decentralise decision making, NHS organisations were given more variety of IT systems 
(56). With more localised led decisions regarding ePrescribing, the provision and 
experience of IT clinicians on the ground was likely to vary according to the level of 
support and resources they had locally (58). The opportunity for standardisation of 
ePrescribing and associated interfaces across the country could have been lost at that 
point in 2008. With a change in government in 2010 a new document Liberating the NHS: 
An Information Revolution was published supporting the linking up of systems at a local 
level, rather than a national level (59). 
Prescribing errors with ePrescribing systems have decreased compared to with 
paper prescribing systems. However, there is still a prescribing error rate of between 2% 
and 7.9% being reported with ePrescribing systems (28,32,36). Actual patient harm 
reported in one study occurred 3.9 times per 1000 patient days, caused by ePrescribing 
prescription errors, which was the same as with hand written prescriptions (60,61). 
Another study comparing commercial ePrescribing systems showed a reduction in 
prescribing errors from 6.25 to 2.12 per admission using the Cerner™ ePrescribing system 
and a decline from 3.62 to 1.46 prescribing errors per admission using the iSoft™ 
ePrescribing system (62). However, this drop in error rate was mainly due to procedural 
prescribing errors such as unclear or incomplete orders rather than clinical error rates 
(62). Interestingly system related errors, such as wrong drug selection, accounted for 35% 
of errors after the implementation of ePrescribing (62). 
NHS Connecting for Health guidelines outlined the key safety related features that 
should be present within ePrescribing systems (63). These guidelines recognised that 
although ePrescribing systems have been shown to reduce prescription errors they have 
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introduced new types of error, such as incorrect selection error, where a medicine, other 
than that intended, is mistakenly selected from a list of medicines built into the system  
(63). Incorrect selection (from a drop down menu) is an error unique to ePrescribing 
systems and cannot exist in paper systems as the prescriber does not select from a list, 
but rather writes their choice out. These new selection error types,  for example, wrong 
patient, drug, dose or frequency have been identified in numerous studies (64–70) but 
the extent of the new error types and how they can be robustly identified is still not clear. 
Therefore It is not possible to rely solely on the prescriber and the ‘intelligent’ computer 
to prevent medication errors (50).  
A rapid response report from the NPSA in 2010 recognised that the introduction of 
EPMA introduced new prescribing risks in relation to omitted and delayed medicines and 
magnified existing ones (4). The nature of the new risks is related to both the prescribing 
and administration of Stat prescriptions (once only medicines). EPMA systems 
automatically schedule the time of administration, therefore Stat prescriptions are 
required depending on what time of day the prescription is created (4). The NPSA 
accepted that the risks would become more apparent over time (4). 
EPMA systems can have the capability to create pre-defined order sets, which are 
defined as a collection of clinically related orders grouped by purpose (5). Paper 
prescribing has also included order sets, which have been shown to improve the 
completion rate of medication orders along with reducing prescribing errors (71,72). In 
relation to ePrescribing, order sets enable simultaneous prescribing of a standard list of 
medications used for a specific indication. These order sets have been promoted as a way 
to speed up ePrescribing, ensure a full regime of correctly prescribed drugs, and facilitate 
prescribers (20)(73,74). It has been proposed that it is easier to prescribe one order set 
and then delete unrequired elements than to prescribe each drug individually (20). The 
efficiency of using pre-defined order sets within the ePrescribing system has shown that 
although the number of keystrokes is reduced, usability problems can impair efficiency 
(74). Therefore, the ePrescribing order set can become a “convenience” list if not used in 
the correct manner, facilitating workarounds (which is a method for overcoming a 
problem in a computer system), in order to create a prescription (5). For example, the 
possibility of overprescribing could occur as there is very little information regarding the 
appropriate use of order sets (5). In the document ePrescribing In Hospitals – Challenges 
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And Lessons Learnt, some users were concerned that order sets could be ordered without 
considering whether the individual drugs were safe for the patient concerned; the risk of 
using order sets need to be emphasised in training, and monitored to identify problems 
(20).  
1.6 Clinical Workflow 
The Institute Of Medicine in their report, Preventing Medication Errors (75), 
indicated that software alone is insufficient at preventing and detecting prescribing error, 
within the systems; prescribing systems involve people as well as software, as such 
clinical workflow and human factors must be considered. It is therefore important to 
consider both the social and technical aspects of any system. This report concluded that 
the advancement of a number of technologies, including computerised physician order 
entry (CPOE), are key factors to future improvements in patient safety and quality care 
(76). In a recent review of literature the IOM examined the evidence regarding the impact 
of health Information Technology (IT) on patient safety and concluded that the challenges 
facing safer health care and the safer use of health IT involve people as much as the 
technology (77). One of their key findings stated that the safer implementation and use of 
health IT  begins with viewing it as part of a larger socio-technical system (77). 
Considering the proposed benefits of ePrescribing (20) and the need to implement 
technology to achieve a paperless NHS by 2018 (78), the actual implementation and use 
of a comprehensive ePrescribing system within hospital in-patient areas across England is 
minimal (55), which is also reflected internationally (79). One of the theories for the 
inadequate uptake has been the impact that implementation of ePrescribing can have on 
HCPs’ clinical workflow (17). In reality, HCPs’ and MDTs’ clinical workflow, using a paper 
prescribing system does not match the clinical workflow imposed by an ePrescribing 
system and therefore requires a change in practice (17).  
Clinical workflow encompasses the activities, technologies, environments, people 
and organisations engaged in providing a defined outcome such as a prescription (80). 
Clinical workflow in healthcare is typically distributive, collaborative and interruptive yet 
ePrescribing systems can enforce a linear, sequential and unidirectional model of 
prescribing processes, which do not match actual workflow between professionals 
(17)(81). Socio-technical systems theory views the components of clinical work as a single 
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work system (80). The multi-professional nature of clinical workflow must be considered 
when researching ePrescribing systems (82,83). Previous research has shown that 
ePrescribing systems can encourage prescribers to control other key HCP groups 
workflow, such as nurses and pharmacists, whose work is interrupted or delayed if the 
timely and appropriate execution of prescribers tasks do not occur (17). Requiring 
prescribers and other HCPs to have situation awareness, which is “the understanding of 
the activities of others which provides a context for your own activity” (80), impacts on 
collaboration and communication, part of the social aspect of the STS.  
Prescribing is a critical form of communication between other prescribers, HCPs 
getting the drug, supplying the drug, reviewing clinical progress all within the MDT, so for 
communication to be effective the prescription must be clear and unambiguous to a 
range of HCPs. The consequences of unclear, inaccurate medical documentation are 
particularly serious and have potentially tragic consequences for patients (84). In addition 
to concerns around medication safety, unclear documentation results in wasted 
resources, impaired communication between healthcare professionals, and legal 
complications (85). Understanding the change in communication between a MDT and 
their working practices with involvement from all HCPs would provide insight from a MDT 
perspective to inform and enhance inter-professional training and collaboration in 
achieving quality patient care. 
When reviewing the literature of clinical workflow surrounding prescribing systems, 
it was predominantly qualitative methodologies being utilised. Qualitative methodologies 
included semi-structured interviews (17,65,80,83,86–88), observations (89,90), focus 
groups (86,87,91) and surveys (70,73)(92). A number of systematic reviews and literature 
reviews have studied the impact ePrescribing can have on workflow (82,93–96). However, 
systematic reviews have their limitations, they may consider the impact of ePrescribing 
systems but the importance of aspects influencing the impact could be underestimated 
(97). Systematic review tries to treat eHealth technologies as scientific objects rather than 
social artefacts which are complex in nature (97). 
The literature review of the impact of ePrescribing and CPOE on inpatient clinical 
workflow concluded that more multi-method research is needed to explore ePrescribing’s 
multidimensional and collective impact on clinical workflow (82). After review of the 
clinical workflow literature, it was noted that the perspective of the Multidisciplinary 
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team as a whole had not been considered and was identified as a gap that needed further 
exploration. This gap in the literature led the researcher to consider methodologies that 
gained a group (MDT) consensus and insight into how prescribing systems impacted upon 
the MDTs clinical workflow rather than individual HCPs. 
1.7 Socio-technical systems theory 
The socio-technical concept arose in conjunction with the Tavistock Institute in the 
British coal mining industry in 1949 (98). Within the coal industry, productivity failed to 
increase in step with increased automation, so the National coal board required a 
comparison of mines to understand the changes. This gave rise to the emergence of a 
new paradigm of work, in which the best match would be sought between the 
requirements of the social and technical systems (98). From the beginning, the socio-
technical concept has developed in terms of systems, since it is concerned with 
interdependencies (98). Grounded in both social theory and Information Technology (IT), 
socio-technical approaches to information communication technology evaluation focuses 
on the interrelation between technology and its social environment (99). 
Some studies in the literature used a socio-technical systems theory approach 
which seeks to identify the dynamics between technology and the social, professional and 
cultural environment in which it is used (100). One study reviewing electronic prescribing 
in community pharmacies utilised a socio-technical approach by identifying themes 
relevant to the social subsystem of the STS framework (101). Another paper developed a 
new socio-technical model specifically for studying health information technology (HIT) in 
complex adaptive healthcare systems in which it had eight components, which ultimately 
reinforced the need to review HIT as interdependent and inter-related concepts (102). 
The report Health IT and Patient Safety: Building Safer Systems for Better Care provided 
five  components of any socio-technical system and included the technology, people, 
process, organisation, and external environment as previously discussed (77). Many 
representations of socio-technical systems theory have been utilised within the literature 
(103). Having an understanding of the theories roots and its development over time 
within the literature reinforced that the core principles of the theory do not change. 
However, it has been proposed that the fragmented understanding of socio-technical 
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systems theory has resulted in a continuing focus on the performance of the technical 
system and limited attention to the social system (103).  
 Socio-technical systems theory considers that every healthcare system includes 
people (the social system) such as the employees at all levels (for example, junior, and 
consultant doctors) and the skills, attitudes, values, and needs the employers bring to the 
work environment (for example, multidisciplinary team communication). The tools, 
techniques and knowledge used by the people (for example guidelines, protocols, 
prescription charts), are classed as the technology (the technical aspects of STS) to 
provide quality healthcare for patients (104).  
The complexity of the inter-relationships between people and technology suggests 
that it is not a matter of simply installing new technology to improve performance. For 
example, with the introduction of a new prescribing system comes a change to the 
technology and the way in which people interact with each other on a social level (104), 
making sure all stakeholders are consulted can enable them to embrace the technology 
and not reject it.  
Wears and berg noted that the underlying reason for such failures is not because 
healthcare Information Systems are not developed “right” but because “the right 
systems” are not developed to fit in the socio-technical system of clinical work (105). This 
calls for more process-oriented, user centred studies to be conducted for the socio-
technical design of ePrescribing.  
The prescribing and administration process is information and time-intensive; each 
health care profession collects and documents a set of Patient’s medication related data. 
The medication data produced by different HCPs should be communicated in a timely 
manner and integrated with that of other data, in order to optimise quality and shared 
interaction of socio-technical systems such as clinical workflow, communication and 
collaboration among the MDTs (106). 
Therefore, socio-technical systems theory is used in the thesis to enhance 
understanding of the interface between the social and technical side of the prescribing 
and administration process and its impact on quality. Table 1-2 outlines the social and 
technical aspects of the prescribing process, emphasising the specific areas considered 
within this thesis.  
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Table 1-2 Socio-technical components of the prescribing process for hospital in-patients. 
Technical Social 
Prescribing – Paper and electronic Communication (written and verbal) 
Clinical indication within the 
prescription 
Clinical workflow/ workarounds/ situation 
awareness 
National Drug Chart Collaboration/Teams 
Regulation and Audit Opinions/views/attitudes/needs/Knowledge/skills 
Procedures / guidelines Culture/approach/value 
 
Figure 1-1 depicts the steps involved in creating a prescription and provides an 
overview of the prescribing and medicines administration process using either a paper or 
an ePrescribing system. The model considers and depicts the social and technical aspects 
of collaborative work, that apply throughout specific elements of the prescribing and 
administration workflow process (107).   
The independent prescriber (actor 1) consults the patient and uses the medical 
notes (artefacts) to enable the prescriber to perform the action of prescribing (action), 
within the electronic or paper prescribing system that influences and assists the action of 
prescribing (design characteristics) and the end-product is a prescription (outcome). The 
HCPs (actor 2), consult the patient and use the medical notes (artefacts) to enable the 
HCP to perform the action of clinical and technical review of the prescription (action), 
within the prescribing system that influences and assists the action of clinical prescription 
review (design characteristics) and the end-product is a medicine supplied or a new 
prescription (outcome). The doctor or nurse (actor 3) consult the patient and use the 
medical notes (artefacts) to enable the HCP to choose the correct medication (action), 
within the prescribing system that influences and assists the action of choosing the 
correct medication (design characteristics) and the end product is that the patient 
receives their medication (outcome). 
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Figure 1-1 Schematic diagram of the prescribing and medicines administration process 
(adapted from (107)) 
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1.8 Literature search purpose and parameters 
Journal papers reviewing the use of paper and electronic prescribing systems in 
hospitals were initially reviewed to gain an understanding of the subject area. The 
literature review included both national and international papers, as different prescribing 
systems are utilised worldwide and within different healthcare systems. However, the 
core principles are transferable and relevant to the change in prescribing systems. 
Medline was searched from 01/01/1950 to 01/02/2015, only publications in English were 
included. The initial search included MeSH terms “Medical Order Entry Systems" also 
covers (CPOE and CPOE system) * OR "Prescriptions” OR “Drug prescriptions” * OR "Drug 
Therapy, Computer-Assisted" * OR "Electronic Prescribing". Numerous quantitative 
methodologies were being utilised to review the safety of the prescribing systems 
(1,13,28,32–37), yet the amount of qualitative review was limited. Studies showed the 
importance of workflow issues surrounding prescribing systems and patient safety 
practices (108). One barrier preventing widespread adoption of ePrescribing was the 
potential, detrimental impact on clinical workflow (109). The impact that electronic 
prescribing had on clinical workflow was described as a reason for the slow 
implementation of electronic prescribing internationally, this became the focus of the 
main literature review. 
A review of the clinical workflow literature was undertaken and after thorough 
consideration of the databases included; Medline, CINAHL Plus and Cochrane Library. 
These were included in order to cover the healthcare related journal articles, conference 
proceedings, and summaries. To include journal articles related to psychology, social, 
informatics and cognitive sciences the databases Psych Info, IEE Xplore digital library, and 
Sciences Citation index were also included. MeSH terms and key words to identify 
prescribing systems and clinical workflow published in the English language were used to 
detect relevant journal articles published between 01/01/1990 and 01/02/2015.  
The following key words were used; For Medline MeSH terms included “Medical Order 
Entry Systems" also covers (CPOE and CPOE system) * OR "Prescriptions” OR “Drug 
prescriptions” * OR "Drug Therapy, Computer-Assisted" * OR "Electronic Prescribing" * 
Medication Errors AND "Workflow" * OR "Physician's Practice Patterns" *. CINAHL 
Headings included: "Prescriptions, Drug" OR “Drugs, Prescription" OR “Prescribing 
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Patterns" OR "Medication Prescribing (Iowa NIC)" OR "Medication Systems" OR “Medical 
Orders” OR “Electronic Order Entry" AND "Task Performance and Analysis" OR "Practice 
Patterns" or workflow. Other databases searched Prescribing AND Workflow. 
The clinical workflow research surrounding the medication process was reviewed to 
gain a perspective on prescribing systems and clinical workflow in secondary care. A 
number of published reports relating to clinical workflow were reviewed. These included 
studies conducted both within and outside the UK with most journal papers from the USA 
surrounding CPOE systems. The outcome of the literature review has informed the 
background to this PhD and the methodologies that have been utilised in exploring how 
prescribing systems and clinical workflow aspects have been investigated.  
1.9 Originality 
The research outlined examines both paper-based and electronic-based prescribing 
systems within a hospital environment, in order to explore and compare the different 
systems and the implications these differences can have on MDTs and therefore key HCPs 
working practices and the components of quality healthcare (STEEEP). By applying STS 
theory to the prescribing system, this endeavours to explore how to optimise the 
interface between the social and technical aspects of the prescribing and administration 
process to enhance the quality of patient care. 
This chapter has reviewed the current literature and outlined the frameworks used to 
support the findings in a complex healthcare environment. Chapter 2 describes in detail 
the programme of work. Chapters 3, 4 and 5 outline and discuss the findings of the three 
phases of the study. Chapter 6 brings together the findings from all methods by 
triangulation and finally Chapter 7 presents the conclusions. 
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2 PROGRAMME OF WORK 
Having outlined the background to different prescribing systems in the previous 
chapter, this chapter describes the programme of work by providing its aims and 
objectives and discussing how these are to be addressed. This is followed by an 
overview of the three component phases including a description of the methods 
used and then rationale for the choice of methodology. Within each component, 
ethical approval, participant recruitment, data collection, and analysis are outlined. 
The three hospitals in which phases two and three of the programme of work were 
undertaken are described, along with the rationale for their selection. The chapter 
concludes with the limitations of the methods used within the programme of work. 
Further details of the outcomes of each phase are provided in Chapters 3-5. The 
programme of work is exploratory and requires a system level approach in order to 
understand how all the complexities of the prescribing system interact and work: 
this requires a real world setting and is reflected in the aims and objectives.  
2.1 Aims and Objectives 
The aim of the programme of work was to understand and explore the 
influence that different in-patient prescribing systems can have on healthcare 
quality and how the different prescribing systems impact on NHS healthcare 
professionals (doctors, nurses and pharmacists) working practices in England. The 
objectives of this programme of work were to explore: 
 The type of different in-patient prescribing systems and their design 
features in acute trusts across England. 
 Senior management opinion, on prescribing systems in use within their 
Trusts. 
 The experiences and views of MDT members (doctors, nurses and 
pharmacists) regarding different prescribing systems, in relation to their 
working practices and providing quality healthcare. 
 The role of clinical indication within prescribing systems, and its impact on 
quality healthcare and key healthcare professionals working practices. 
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2.2 Outline of the programme of work 
This programme of work has a sequential three phase design, involving 
qualitative and quantitative (mixed method) approaches. The first phase provides 
an overview of the use of paper and ePrescribing systems in acute hospital trusts 
across England; the second and third phases report on the real world intricacies of 
both paper and ePrescribing systems within three hospital Trusts. The programme 
of work involved the researcher collecting data, independent of the clinical setting, 
and analysing data from the three methods. The data from all three methods were 
then compared and contrasted. This is a valuable approach in providing more 
robust and valid outcomes and is known as method triangulation (110). 
 Each of the three phases utilised a different method as follows:  
 Phase one: Structured telephone interviews with chief pharmacists.  
 Phase two: Focus group discussions with members of MDTs across three 
hospital sites. 
 Phase three: Document analysis of in-patient records under the care of the 
MDTs involved in phase two. 
Data were collected sequentially in the consecutive order shown above. The 
programme of work enabled the early findings to inform future aspects of the work, 
with pilot studies incorporated at the start of each phase, assisting the researcher 
to respond to practical situations that arose. 
The three Hospital Trusts providing the in-vivo prescribing system, involved in 
phases two and three of the programme of work, were at different stages of 
implementing their prescribing systems. These Trusts are described in detail in 
Section 2.3. The programme of work design required phases two and three to take 
place within the same hospitals; this enabled triangulation of the data to take place 
at the end of the study and inform differences between prescribing systems in 
different hospital settings. 
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 Design and philosophical location of the study 2.2.1
The use of qualitative research in the area of Pharmacy Practice is slowly on 
the increase. Within the professional sphere of Pharmacy, its principal research 
approach has been scientific. Scientific methods involve a systematic study of an 
area, to minimise the effects of external factors on the data collected and therefore 
usually involves quantitative methodologies. The primary philosophy on which 
quantitative methods are based is positivism, which assumes that phenomena are 
measurable (111). However, not all aspects of pharmacy practice are measurable, 
especially the opinions of people as in this study. With a transformation in the 
profession of Pharmacy moving toward a more patient focused profession, the 
need for interprevist skills is increasing. Pharmacists as healthcare professionals 
have more interaction with patients and their relatives requiring good 
communication skills. Therefore, the methods being utilised in the field of 
Pharmacy Practice are changing as the philosophical stance slowly brings both a 
positivist and interpretivist viewpoint closer together.  
Conducting qualitative research with a scientific background has provided an 
understanding of both positivist and interpretivist paradigms when approaching 
research. Carrying out research in Pharmacy Practice is not straightforward and 
therefore requires a certain amount of flexibility to designing the research study. 
Combining both quantitative and qualitative styles has led to a multi-strategy 
design in order to provide a more complete understanding of a research problem 
than either approach alone. Qualitative and quantitative approaches should not be 
viewed as rigid, distinct categories; instead, they represent different ends on a 
continuum (112).  
As a Pharmacist, having previously worked within a multidisciplinary team in 
the area of Oncology, a less positivist outlook incorporated with a more 
interpretivist style of questioning has led to a pragmatic worldwide view of research 
in order to provide the best understanding of the research problem (111,112). 
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A number of methods have been used to study clinical workflow in relation to 
prescribing systems and evidence has accrued indicating the efficacy of many 
different methods. Several studies in healthcare have used a single methodology to 
investigate clinical workflow surrounding prescribing systems. For example semi-
structured interviews alone have been used to explore perceptions and attitudes 
towards ePrescribing (83,113), surveys alone have been used to look at prescribing 
systems in use (53–55) or investigate the implementation of ePrescribing and users 
satisfaction (73,92) and unintended consequences (70). 
Focus groups have been used previously in healthcare research to investigate 
HCPs opinions of prescribing systems. For example experiences and perceptions of 
hospital pharmacists using ePrescribing (114), the role of computerized physician 
order entry in facilitating medication errors as discussed by “house staff” (69) and a 
mixture of HCPs and managerial staff concerns regarding implementation of 
ePrescribing and the efficiencies or inefficiencies it may bring (87,91). However, no 
published studies were found in the literature to date, which used MDT based focus 
groups to understand the perceptions of a whole MDT had about prescribing 
systems. 
A systematic literature review published in 2010 investigated the impact 
medication systems’ design aspects had on usability, workflow, and medication 
orders. Of the 19 studies, identified seven were mixed method studies and only 
four involved the use of more than two methods of assessment. Only three utilised 
focus groups as a method, none of which included a MDT perspective. Pre and post-
tests were prominent within the quantitative methods used. Another literature 
review that aimed to gain insight into the impact of CPOE systems on clinical 
workflow reviewed 51 publications. The research designs used were 25 
quantitative, 21 qualitative and 5 used a mixed methods approach. The review 
concluded that more multi-method research is needed to explore ePrescribing’s 
multidimensional and collective impact on clinical workflow (82)  
As the problems in implementing ePrescribing and the impact it can have on 
clinical workflow were likely to be multidimensional, a methodology was required 
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that would enable information to be gathered not only about the prescribing 
systems used but also the opinions of relevant staff. It was therefore decided that, 
in order to obtain as much information as possible about current impacts on clinical 
workflow in relation to prescribing systems, the study should have a mixed 
methodology. An exploratory mixed methods approach was therefore chosen 
comprising telephone interviews with chief pharmacists, focus groups with MDTs 
and a retrospective documentation review. 
Initially the use of case studies was considered as a design of inquiry for the 
research to evaluate how the change in prescribing system impacted upon the HCPs 
working practices (112). The use of case studies would have enabled an in-depth 
analysis of the three hospitals (110) but not the responses of the chief pharmacists 
interviewed. Therefore, the research design utilised in the programme of work is an 
exploratory multiphase mixed methods design that culminated in triangulation of 
the data from all 3 phases (112). Mixed methods, which include a combination of 
both quantitative and qualitative techniques, enable a wider range of data to be 
collected and facilitate triangulation in which findings from one method may be 
supported or confirmed by findings from another method potentially strengthening 
results (111)(115). The case study approach to the research design would not have 
enabled the researcher to carry out triangulation of all three phases, which 
provides further validity enhancement. 
 Data analysis: availability of options 2.2.2
There are several specific analytical techniques used to analyse qualitative 
data and understand how the data was sorted, organised, conceptualised, refined, 
and interpreted (116). Most qualitative analytic techniques involve generating 
emergent themes that evolve from the study of specific pieces of information (117). 
Thematic coding analysis can be used inductively where the codes and themes 
emerge purely from the researcher’s interaction with the data, for example in the 
grounded theory approach. Other qualitative analysis techniques use deductive 
data analysis and a priori themes based on theory or extensive research findings, 
for example Miles and Huberman’s framework analysis (117,118). Several 
24 
taxonomies of qualitative data analysis have been proposed, these include 
categorical strategies, for example constant comparative analysis, contextualising 
strategies, for example phenomenological analysis and qualitative data displays, for 
example sociograms (117). After review of qualitative data analysis techniques such 
as the phenomenological approach of Collaizzi’s procedural steps (119) and Miles 
and Huberman’s framework analysis (118). The constant comparative analysis 
method described by Glaser and Strauss, as having four stages, was utilised to carry 
out data analysis. The core principles of which involve (117) 
1. Comparing incidents applicable to each other - each “incident” is 
compared to a category to which it might (or might not) belong 
2. Integrating categories and their properties – comparing “incidents” to 
tentative versions of rules that will describe the category 
3. Delimiting the theory – reducing the original larger list of categories to 
a parsimonious set of more inclusive, saturated categories 
4. Writing the theory 
Part of the constant comparative analysis process, as outlined above, was to search 
for data, which would disconfirm ideas and theories developed, providing the 
opportunity to refine and modify these ideas. This “negative analysis” is another 
strategy to minimise bias in the study.  
Knowledge of the literature within the field of study can have a role in the analytical 
process, as proposed by Strauss and Corbin (120). This may enhance sensitivity to 
nuances in the data. However, where concepts are identified which also appear in 
the literature, the researcher should examine these to ensure that they are in fact 
emergent from the data (120). This can be done by comparing their properties, 
similarities, and differences (120). The strategy of focussing on emerging concepts 
from the data was adopted, whilst acknowledging the role played by knowledge of 
the literature in informing the analytical process. 
Concerns about the impact of utilising technology when conducting 
qualitative data analysis were deliberated. Proposed advantages include: Having an 
organised single location storage system for all stored material that enables quick 
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and easy access to coded material without using cut and paste techniques (116). 
The capability to handle large volumes of data and force detailed consideration of 
all text in the database on a line-by line basis (116). The software can help the 
development of consistent coding schemes as well as displaying results in many 
ways, it can also analyse differences, similarities and relationships between coded 
elements (116). On the other hand, proficiency in their use takes time and effort 
and can distance researchers from their data. No software package is capable of 
perceiving a link between theory and data or defining an appropriate structure for 
the analysis (121). To undertake analysis requires the researcher’s analytical skills 
rather than basic descriptive and counting exercises (121). The dominance of code 
and retrieve methods to the exclusion of other analytical activities could occur. 
The above concerns were considered when carrying out data analysis of the 
MDT focus groups when using the computer software NVIVO. Having experienced 
qualitative data analysis without using the NVIVO software, the differences 
between the two approaches to analysis were noted by the researcher. This 
provided foresight to the pitfalls of data analysis using computer software. The 
researcher ensured that whilst using NVIVO, the ability to understand the context 
as well as the detail within the text was remembered. 
2.2.2.1 Method of triangulation 
As mentioned in the previous chapter, existing research has sought to 
investigate the impact prescribing systems can have on HCPs working practices by 
taking the opinions of individual HCPs perspectives, rather than a MDT perspective. 
Mixed methods utilised in the research area of clinical workflow and prescribing 
systems have been minimal. This programme of work was designed to explore each 
of the HCPs perspectives as well as the MDT perspective and their interrelatedness, 
in order to take account of a more real-life approach to the impact of prescribing 
systems on quality of care in the NHS.  
Triangulation is a strategy used to enhance validity, by using multiple 
sources of information to enhance the rigour of the research study. Triangulation is 
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a common practice in health research and Pharmacy practice (122). It is a useful 
strategy in overcoming reactivity, researcher bias, and respondent bias. 
There are four types of triangulation proposed by Denzin 1988. These include (110): 
 Data triangulation – The use of more than one method of data collection 
 Observer triangulation – Using more than one observer in the study 
 Methodological triangulation – Combining quantitative and qualitative 
approaches 
 Theory triangulation – Using multiple theories or perspectives 
Within this research design, various forms of data and methodological triangulation 
were utilised in order to incorporate rigour into the programme of work and its 
findings. These forms of triangulation have been established to provide 
complementary perspectives of appropriateness so that a more complete 
understanding of the phenomena can be obtained (123). This understanding 
provides additional evidence about what is known, and not known about the 
subject and includes the barriers and frustrations experienced by MDTs and 
Management when considering the impact of prescribing systems, on working 
practices. Data triangulation involved the data collected from the chief pharmacists, 
MDT’s and patient records. These three different data sources explore the impact 
of prescribing systems from a variety of different viewpoints. This data also varies in 
the level of abstraction, the highest being the patient records, next the chief 
pharmacist interviews, with the MDT’s focus groups supplying the richness of detail. 
Analysis of the data involved inter-relating the varying levels of abstraction but also 
viewing the prescribing system and process from an individual’s level, a member of 
the MDT and part of the larger organisation.  
Since any method can have weaknesses and strengths, method triangulation 
incorporated into the research design, increased reliability by reducing method 
error. Methods in the programme of work were carried out in the consecutive 
order of telephone interviews, focus groups, and document analysis. 
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Finally, socio-technical systems theory integrated the overall findings from data and 
methodological triangulation in the programme of work. Socio-technical systems 
theory provided the backbone and general explanation of the phenomena. 
 Phase 1: Telephone Interviews 2.2.3
This phase involved structured telephone interviews with chief pharmacists 
or senior members of staff, nominated by the chief pharmacist. Liverpool John 
Moores University (LJMU) Research Ethic Committee (REC), on the 9th December 
2011 (approval no.11/PBS/014 see Appendix 9.1.1) gave ethics approval. 
2.2.3.1 Aims and objectives 
The aim of the telephone interviews was to ascertain the extent of different 
in-patient prescribing systems and their design features used within secondary care 
by eliciting the views of acute trust chief pharmacists, across England. 
The objectives were to explore  
 The type of prescribing systems in place in acute trusts across England 
and how long these have been in place 
 The nature and functionalities within the prescribing systems 
 The relationship between the prescribing systems and prescribing 
quality 
 Chief Pharmacists’ views on the use of clinical indication on the 
prescription chart as per the published standards. 
2.2.3.2 Rationale  
The rationale for telephone interviews with acute trust chief pharmacists 
across England was to gain a senior management opinion about what is happening 
and what might be happening regarding prescribing systems across the country. By 
acquiring chief pharmacist’s experiences and their appreciation of the prescribing 
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systems, rather than frontline staff opinions, a senior systems level viewpoint was 
obtained.  
Previous research regarding this area of interest had utilised convenience 
sample surveys, obtained during ePrescribing conferences to gain an understanding 
of prescribing systems in use (54). Self-administered questionnaire based surveys 
can typically have a low response rate (124), however, a recent study designed on a 
large scale, utilised a self-administered postal questionnaire and gained a 61% 
response rate through use of extensive follow up and resources, in relation to 
prescribing systems (55).   
A self-administered postal questionnaire was initially considered; however, 
when comparing response rates between a postal questionnaire and a telephone 
interview, the telephone interview typically gets a better response rate (124). The 
need to engage the Trusts with further research was also a secondary objective of 
phase one, using Telephone Interviews provided a personal contact to build a 
rapport with potential research hospitals. The Trusts that provided the real world 
setting for phases two and three were recruited from the hospitals that 
participated in the telephone interviews. The use of telephone interviews allowed 
more in-depth responses to be gained than would otherwise be expected from 
similar open questions in a self-administered questionnaire (124). The high level of 
knowledge of the interviewees offered the researcher an opportunity to explore 
issues in depth. By using telephone interviews, the researcher could quickly contact 
a large number of potential participants and interview them without having to 
travel all over the country, therefore saving time and money.  
2.2.3.3 Participants 
Participants in phase one were chief pharmacists or senior members of staff, 
nominated by the chief pharmacist, with the required knowledge at each acute 
trust about the in-patient prescribing system within the data collection period. 
Chief pharmacists working in specialist Trusts such as Children’s, Women’s, 
Oncology, Cardio-thoracic, Neuroscience, and reconstructive surgery were excluded 
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due to the specialist nature of the information required on prescription charts, that 
would raise difficulties when comparing and contrasting data obtained.    
2.2.3.4 Recruitment 
From the National Health Service (NHS) (125) database at the time of data 
collection (accessed through the respective web portal), there were 146 non-
specialist acute trusts within England, consisted of 29 small acute organisations, 49 
medium acute organisations, 42 large acute organisations and 26 acute teaching 
organisations.  
A letter (a copy is provided in Appendix 9.1.2) was sent to all chief 
pharmacists across England, whose pharmacy department contact details were 
obtained from the NHS Choices website (125) to ensure that they were aware of 
the study before contact via telephone. This letter outlined the background to the 
study, enclosed the participant information leaflet (a copy is provided in Appendix 
9.1.3) and indicated that the researcher would be in contact in a few days.  
Telephone contact was made after a standard time frame of three working 
days to ensure enough time for delivery had passed. Telephone interviews were 
conducted between Monday 9th January 2012 and Friday 17th February 2012.  
The researcher contacted each chief pharmacist to confirm that they had 
received the letter about the study and if they would be interested in taking part. If 
the potential participants had not received the letter or they had misplaced it, with 
permission, the researcher sent on an e-mail version of the letter and participant 
information sheet. The researcher followed up with at least two phone calls to try 
to recruit participants. Messages were left regarding the research if it was possible 
to leave an answer machine message. 
2.2.3.5 Data Collection 
Informed consent incorporated in the telephone interview schedule (a copy is 
provided in Appendix 9.1.4) was obtained by explaining the research to the 
potential participants, if they were happy to continue, the researcher verbalised 
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each of the statements on the consent form and sought agreement from 
participants. The telephone interviews were recorded using a digital audio recorder, 
a separate file being used for each interview. The semi-structured interviews 
included closed questions as well as asking open questions to encourage 
conversation. Using open questions allowed the participant to develop their 
response.  
Participants’ answers to the closed questions were recorded using a tick box 
format that was incorporated within the interview schedule. The researcher 
transcribed open question data obtained from the interview. The interview was to 
be no longer than 15 minutes with a semi-structured format in order to minimise 
inconvenience to the participant.  
A pilot study was undertaken to ensure that the recruitment procedure and 
the structured telephone interview questions were clear and appropriate.  
2.2.3.6 Data Analysis 
Analysis began as soon as the interviews took place. During the interviews, 
the researcher noted any points that had not previously occurred. The interviews 
were transferred and saved from the digital audio recorder to a computer after the 
end of each interview. A unique recording number was allocated to each recording, 
which became the identification number for each participant and corresponding 
transcription. The quantitative data were transferred from the interview schedule 
completed for each interview and put into an Excel® document for analysis. The 
interviews were then transcribed using Microsoft Word 2007. Any personal 
information was removed at the transcription stage. Data in the excel documents 
and transcriptions were double-checked for quality assurance purposes prior to any 
analysis-taking place. 
The interviews were analysed using content analysis and thematic analysis. 
Content analysis was conducted on all the interviews; this enabled the researcher 
to look at the diversity of data, consider data saturation, and assisted the 
researcher in becoming more familiar with the data. A stratified purposive sample 
31 
of interviews was selected; more details on the sampling criteria are included in the 
qualitative results (Section 3.3.2.). Thematic analysis was carried out with the 
purposive sample of the data collected, from the structured telephone interviews. 
One of the study supervisors, with experience of qualitative data analysis, 
independently verified key themes to ensure that the theory framework was 
appropriate and valid. Chapter 3 provides further details and the findings of the 
structured telephone interviews.  
 Phase 2: Focus Group Discussions 2.2.4
This phase considered the views of the multidisciplinary team, which 
consisted of doctors, nurses, and pharmacists, providing quality of care services, 
and the affect that different prescribing systems can have on their working 
practices. The staff perspective, gives an understanding of their concerns, along 
with helping to identify potential solutions to these. Participants were recruited 
because of their professional role within the multidisciplinary team and their use of 
the prescribing system.  
Research involving the staff of social care providers, is excluded from the 
normal remit of the National Research Ethics Service (NRES) under the harmonised 
edition of Governance Arrangements for Research Ethics Committees (GAfREC) 
(126). Therefore, ethical approval was sought from and granted by Liverpool John 
Moores University (Appendix 9.2.1). Approval from each of the Trust’s research and 
development (R&D) departments was also obtained in line with NHS organisation 
policies for research involving NHS staff and premises. 
A pilot study was undertaken, to ensure that the recruitment procedures 
and focus group schedule were robust and ran smoothly without missing any 
important points relevant to the research. The pilot study did not highlight any 
specific issues with the focus group recruitment or schedule and as such was 
included in the data analysis. 
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2.2.4.1 Aims and Objectives  
The aims and objectives of phase two was to explore how different 
prescribing systems have an impact on the working practices of key Health Care 
Professionals (doctors, nurses, and pharmacists) within their multidisciplinary 
teams. 
 
 
The objectives were  
1. To explore key healthcare professionals’ opinions of different prescribing 
systems and the influence prescribing systems have on their working 
practices. 
2. To determine the impact of different prescribing systems on patient safety, 
as perceived by key healthcare professionals. 
3. To explore key healthcare professionals’ opinions of including a clinical 
indication on an in-patient prescription. 
2.2.4.2 Rationale 
It was considered important to get the MDT members views as a team and 
not in isolation from each other because the topic inherently influences the 
complete multidisciplinary team. Moreover, as discussed in Chapter 1, the 
prescribing systems are not used in isolation by any one HCP within the MDT; HCPs 
interact with the prescribing system individually and the prescribing system forms 
the hub of their communication around medicines use. As such, the inputs and 
outputs from the prescribing system will be influenced by the desire to 
communicate a point to another user when conveying information and to 
understand the intention and meaning of others when interpreting information. 
When the way in which the prescription chart is used by different HCPs is 
considered, all with certain priorities, different aspects of the prescribing system 
and prescription chart may benefit some HCPs and not others. Previous research as 
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outlined in Chapter 1 considered the unintended consequences of new prescribing 
systems on an individual basis rather than from a team perspective. By using a 
focus group approach, the method used can mimic, to a point, the work 
environment of the MDT and consider their interactions within a team setting as 
well as gaining a frontline perspective.  
Other group methods that were considered for this phase included group 
debate, group interviews, Delphi groups and nominal groups all of which can 
provide diverse views on a topic. However, these group methods seek to reach a 
consensus (127). In addition, the aim of the phase was to explore the MDT’s 
experiences and in-depth information about the quality issues with the prescribing 
system. Using focus groups provided in-depth information from the team on a 
specific topic, which consists of open-ended group discussions, guided by the 
facilitator or researcher.  
Focus groups give an opportunity for the team/group to discuss in-depth 
their team experiences and give the researcher an opportunity to see the group 
dynamics across the team. The rationale for using focus groups is that they enable 
rapid identification of different people’s views relating to a specific area of interest, 
without specifically attempting to find a consensus (127). In order to gain a good 
understanding of MDT’s perspectives on the research topic, focus groups provided 
the methodological rationale for the situation (127). The use of open-ended 
questions within a focus group facilitated participants, as in the real world, to 
consider other participants’ thoughts and comments and can therefore stimulate 
and form their own opinion in response to others (127). Having different HCPs from 
the same multidisciplinary team within a group provides different professional 
backgrounds, viewpoints, and experiences which can stimulate and enrich the 
discussion. This can also inspire other group members to look at the topic in a 
different light.  
Bearing in mind a heterogeneous group may risk power imbalances and that 
a dominant participant could destroy the group process it was important to recruit 
participants from the same multidisciplinary team in order to have a common 
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background (127). Group communication was facilitated by having the same 
multidisciplinary team within a focus group, and then ideas could be exchanged 
more readily. The amount and range of data that can be gained from a team of 
people at the same time in focus groups compared to other methodologies 
provided further rationale. Conflicts and concerns are more likely to be discussed 
within a homogenous group as participants have a greater sense of safety.  
The size of the focus groups is important as it can affect the discussion. Group 
size is usually four to eight people (128), allowing all of the participants to be part of 
the discussion and share their thoughts, whilst large enough to obtain diverse 
opinions on the topic. Smaller groups let participants share more ideas but can 
result in a reduced pool of ideas (129). Smaller sizes are therefore more suitable 
where all respondents participate fully, for example health care professionals or 
experts in the field.  
The main barriers to conducting a successful focus group tend to be 
organisational and practical difficulties: identifying enough participants that can be 
available at the same time and in the same location (128). Therefore, both face-to- 
face interviews and focus groups were deliberated and included within the ethics 
application made to each Trust because of the concern regarding recruitment. 
However enough HCPs agreed to take part and managed to attend the focus group 
sessions that took place within each Trust, consequently face-to-face interviews 
were not conducted. 
2.2.4.3 Participants 
Participants (members of MDTs) were recruited from three acute trust sites 
(known as hospital A, B and C) selected from those who participated in phase one. 
Details of hospital selection and further information about each hospital are 
provided later in Section 2.3. Healthcare professionals [HCP] (registered doctor, 
pharmacist or nurse) using the prescribing system on a regular basis (paper or 
electronic) in use within each hospital were recruited. Where the hospital had a 
newly implemented ePrescribing system the HCP must have previously used a 
paper-based system in order to be able to compare systems.  
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2.2.4.4 Recruitment 
The researcher contacted the chief pharmacist (Trust Gatekeeper) of each 
Trust via email (a copy is provided in Appendix 9.2.2), to obtain their consent (a 
copy is provided in Appendices 9.2.3 and 9.2.4) for the researcher to contact clinical 
ward pharmacists within the hospitals. Once the chief pharmacist had agreed to 
take part in the study, approval from the hospitals research and development 
(R&D) department was obtained. Once R&D approval had been given, the chief 
pharmacist introduced the researcher to the clinical ward pharmacists (ward 
gatekeepers). The researcher discussed the study, and any concerns the ward 
gatekeeper had about the study. Once their consent (a copy is provided in 
Appendices 9.2.5 and 9.2.6) was obtained, the study was advertised locally.  
The researcher was present at the hospital to help clinical ward pharmacists 
distribute the recruitment packs on their wards and provide additional information 
to perspective participants. The clinical ward pharmacists within each hospital 
recruited HCPs that work together as a multidisciplinary team within the same ward 
area. The recruitment pack included an invitation letter (a copy is provided in 
Appendix 9.2.7), Participant Information Sheet (a copy is provided in Appendix 
9.2.8) and an Expression of Interest (a copy is provided in Appendix 9.2.10). Those 
HCPs who were interested in taking part in the study could return a completed 
expression of interest form with their telephone and e-mail contact details to the 
researcher via the ward pharmacist, e-mail, or internal post. The researcher then 
contacted interested participants, by telephone or e-mail, to arrange the focus 
groups. Those whom were willing to take part were asked to complete and sign an 
informed consent form (a copy is provided in Appendix 9.2.9).  
Focus groups were conducted with the main users of the system, (doctors, 
nurses, and pharmacists). Multidisciplinary teams were selected; members of the 
team were then recruited. Medical and surgical MDTs were included from the 
specialities of gastroenterology, nephrology, endocrinology, cardiology, 
orthopaedics, colorectal surgery, and general surgery. 
The following inclusion and exclusion criteria were: 
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Inclusion - Currently working as a healthcare professional [HCP] (registered 
doctor, pharmacist or nurse) using the paper or ePrescribing system in use 
within the Trust on a regular basis (at least once in every shift/day worked). 
Where the Trust has a newly implemented ePrescribing system the HCP must 
have previously used a paper-based system in order to compare the systems.  
Exclusion – Healthcare professionals not currently working in secondary care as 
a registered doctor, pharmacist, or nurse or not using the paper or ePrescribing 
system on a regular basis (at least once in every shift/day worked). 
2.2.4.5 Focus Group schedule and structure 
During the focus groups in Hospitals A and B (Section 2.3), the interaction 
each doctor, nurse, and pharmacist had with the ePrescribing system was discussed 
and how the system could facilitate or hinder their working practice. The focus 
groups that took place in Hospital C, without ePrescribing, were asked what their 
perceptions of ePrescribing were and how they believed it would impact upon their 
work.  
To assist with the focus group process, and to reduce moderator bias, a 
schedule for the focus groups was developed and designed from existing literature, 
the findings from phase one and discussions with the supervisory team (a copy is 
provided in Appendix 9.2.11). The schedule provided an initial structure for the 
focus groups, with open questions to stimulate participant interaction and debate. 
The characteristics of participants in each focus group were obtained from the ward 
gatekeeper, consent form, and introductory questions. Initially, participants were 
asked about their experiences of the prescribing systems they had worked with in 
general. The intention was to make the participants comfortable, and for the 
moderator to discover how participants felt initially about the prescribing system 
within their hospital. Each focus group then explored how ePrescribing had 
impacted (Sites A and B) or could impact (Site C) upon the HCPs’ working practice. 
The key areas of interest came from the literature review and phase one findings, 
keeping the questions very open facilitated discussion around the areas of interest.  
Key areas of interest included: 
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 Communication and collaboration  
 Clinical workflow 
 Patient safety 
 Value and effectiveness of including a clinical indication on an in-patient 
prescription. 
Each focus group then concluded with an open question inviting the 
participants to discuss any information they thought would be useful for the 
moderator to know, providing an opportunity for all participants to discuss any 
further subjects they thought were relevant.   
2.2.4.6 Data Collection 
All the focus groups were conducted at each of the three hospital sites and 
were organised at a mutually convenient date and time in a suitable location, taking 
into account healthcare staff workload and pressures. Written consent was 
obtained from participants prior to the focus group taking place. All the focus 
groups were recorded using two digital voice recorders. 
A pilot focus group discussion was conducted to consider recruitment, assess 
content validity of the schedule and methodology.  
2.2.4.7 Data Analysis 
The discussions in the focus groups were transcribed verbatim, before being 
thematically analysed. All data obtained were anonymised with any names of 
people or organisations removed. Thematic analysis using the constant 
comparative analysis framework (130) was undertaken using the computer 
software NVivo® version 9 in order to explore the views of the healthcare 
professionals and establish and explore any trends, links or key themes highlighted 
by the subjects. One of the study supervisors, with experience of qualitative data 
analysis, independently verified key themes to ensure that the theory framework 
was appropriate and valid. Further details and the findings of the focus groups are 
discussed in Chapter 4. 
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 Phase 3: Documentation review 2.2.5
NHS hospitals produce a lot of medical documentation because everything 
should be documented, especially with regard to the patient and their healthcare 
treatment whilst an in-patient, therefore providing a good source of data for 
research. When HCPs enter medical information in the patient’s medical notes it 
tends to read like a “story”, which has historically transpired. This story sometimes 
provides relevant clinical findings, the decisions made, the information given to the 
patients and any drugs prescribed or other investigation or treatment (12).   
 There is limited information available about the change in clarity and 
accuracy of prescription charts when moving from paper to ePrescribing systems. 
The aim of this phase was to explore how different prescribing systems impact on 
the clarity and accuracy of the prescription chart and medical records, with a focus 
on newly initiated medication. A mixed methods approach using concurrent 
collection of qualitative and quantitative data was used through document review 
(115). 
The National Research Ethics Committee in the North West, Cheshire, and 
part of The Health Research Authority (HRA) was contacted in September 2012 to 
confirm that the proposed research was classed as a service evaluation (Appendix 
9.3.1). In accordance with GAfREC 2012, the project is considered a service 
evaluation; consequently, it did not require review by an NHS research ethics 
committee. Ethical approval was sought and obtained from Liverpool John Moores 
University (LJMU) (Appendix 9.3.2). Research and development approval from all 
three hospitals was required and obtained, further information provided in section 
5.2. 
The same three hospitals in phase two were used for phase three along with 
the same general medical and surgical wards that the Multidisciplinary Teams 
worked on when recruited to take part in the focus groups. The wards were 
included in the study to obtain the patient-related documents connected to the 
MDT’s in phase two. 
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2.2.5.1 Aims and objectives 
The aim of this study was to explore how different prescribing systems affect 
quality components (STEEEP), through HCPs working practices and the clarity and 
accuracy of the prescription chart and medical records, with a focus on newly 
initiated medication. Its objectives were: 
 To compare the clarity and accuracy of the prescription chart, between 
prescribing systems 
 To explore the factors that affect the clarity and accuracy of prescription 
charts in Hospitals A, B and C. 
 To consider the clarity and accuracy of documentation in a patient’s medical 
records, once a prescription is newly initiated, as a risk factor for medication 
errors in the in-patient setting 
 To consider the timeliness of prescribing and documentation, in newly 
initiated medications, as an indicator of clinical work-flow and 
communication 
 To deduce how often patients were informed about their newly initiated 
medications and included in the decision making process 
2.2.5.2 Rationale  
Documentation review is an unobtrusive methodology in that it enables a 
researcher to analyse material retrospectively, such as the prescription chart or the 
medical notes of an in-patient, and is therefore non-reactive in that the document 
is not affected by the fact that the researcher is using it (131). The data are in 
permanent form, which can facilitate re-analysis, allowing reliability checks and 
studies to be replicated. Krippendorff (2004) defines content analysis as “a research 
technique for making replicable and valid inferences from texts to the contexts of 
their use”. His definition stresses the relationship between content and context 
such that it is important to consider that the documents were produced for a 
purpose (131). Carrying out documentation review allows the researcher to probe 
and gain information about the topic being explored and supports or refutes 
findings from other methodologies used. The methodology utilised by the 
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professional colleges (2) did not include any electronic prescription charts for 
review, to inform the standards. It was acknowledged, when reviewing the paper 
prescription charts that they needed to obtain original paper prescription charts, in 
order to directly observe the design features often not appreciated using PDF 
versions, such as variations in colour, boldness of typeface and variation in page 
size (2). Therefore, when carrying out phase three documentation review, the 
researcher viewed the “live” EPMA systems, this was important to appreciate the 
design features of the specific EPMA systems within Hospitals A and B.  
Documentation review permitted the researcher to navigate and review the 
prescription chart and consider its design clarity and accuracy with the support of 
other patient related documents also confirming the accuracy of the information 
gained. In addition, certain Trust-specific policies were reviewed. 
2.2.5.3 Documents 
The documents reviewed at each hospital included patient specific hospital-
based healthcare records; medical notes, nursing notes, pharmacy notes, and 
prescription charts in relation to selected patients over a specified period. In 
addition, general prescribing policies in place nationally and within each of the 
Trusts related to the specific patient cases were taken into account. 
2.2.5.4 Document selection and permission 
The inclusion criteria for document selection were: 
 Patient resident on study ward during the specified 7 day period 
 New medication initiated during in-patient admission period  
 Patients whose length of stay on the specified ward is greater than 24 hours 
Exclusion criterion for continued inclusion: 
 Patients whose length of stay on the specified ward is less than 24 hours 
 No new medication initiated during in-patient admission period  
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2.2.5.5 Data collection 
Each prescription chart along with the medical, nursing, and pharmacy notes 
were reviewed for each patient admitted to the study ward over a 7-day period 
following the inclusion and exclusion criteria above. Each patient who was 
prescribed a newly initiated medication during the course of their stay on the 
specified ward was identified and their healthcare records relating to that 
admission were reviewed retrospectively by the researcher.  
The recording unit: All note entries made for every newly initiated medication that 
was prescribed during a patient’s admission on the study ward. This was done by 
identifying all the new medication prescribed; notes were then reviewed and 
entries copied verbatim if any reference to the newly initiated medication was 
documented. 
 A pilot study was undertaken in the same Trust as phase Two, in order to 
determine which data needed to be extracted from the patient-related healthcare 
documents to ensure that the data collected were appropriate to meet the aim of 
the phase. 
Other hospital documentation related to prescribing and the prescribing 
system, but not related to a specific patient case, was collected during fieldwork to 
deliver context to the study and inform the researcher about the scenarios 
encountered. For example, the use of order sets and the hospital policy in relation 
to their use were explained. The documents enhanced the exploration of patient-
specific data collected and the overall data collection and analysis process.  
2.2.5.6  Data Analysis 
All data obtained were anonymised with names and references to 
organisations removed. Anonymous data were entered into a study database 
before being analysed. A mixed methods’ approach of concurrent mixed data 
analysis (115) was undertaken; the qualitative analysis of written documentation 
expanded on the initial understanding gained from the descriptive quantitative 
analysis. The data were integrated in the interpretation of the overall results.  
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Document analysis followed a systematic approach, reviewing and 
evaluating both handwritten and electronic documents. Documentation review was 
used in order to explore the written documentation made by the healthcare 
professionals and establish and explore any trends, links, or key themes highlighted. 
Navigating the EPMA system used in Hospitals A and B enabled the researcher to 
observe and understand issues emphasised in the previous phases. Documentation 
review provided case study examples and understanding into why events had 
occurred. The exploration of healthcare records and the prescription did not set out 
to look at specific specialities or clinical situations; therefore, the variety of 
specialities reviewed provide context to the study. Further details and the findings 
of the documentation review are discussed in Chapter 5. 
2.3 Hospital sites for phases two and three 
The findings from the telephone interviews indicated that the prescribing 
systems in place in acute trusts were very different across England (further details 
are provided in Chapter 3) and varied in terms of both the type of prescribing 
system used and the size and location of the acute trust hospitals. These informed 
the selection criteria for the three study sites for phases 2 and 3 in order to capture 
some of the diversity of the prescribing systems across England.  
The three hospitals selected for the programme of work, each had a 
different prescribing system in place that had implemented within the last 18 
months, to enable a comparison between the different prescribing systems to be 
made. The three hospitals selected had previously taken part in the telephone 
interviews (phase one) and were amongst those that had agreed to participate in 
further research. The three hospitals are described below and are subsequently 
referred to as Hospitals A, B and C in order to distinguish their prescribing system 
characteristics and variations in relation to the research. 
 Hospital A Prescribing System 2.3.1
Hospital A is a district general hospital in England with 600 beds (125) that 
implemented an EPMA system, which is part of a commercially procured system 
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supplied by Meditech® (Medical Information Technology Incorporated); the system 
originated in the US in 1969 (132). The hospital wanted a single electronic 
management interface for patient-related clinical data; as such, since Meditech® 
was already providing the hospital with the Patient Administration System (PAS 
version 5.6) prior to implementation of the EPMA, it was logical to use the 
Meditech® EPMA software. This allowed the prescribing system to communicate 
with the existing hospital software, making it an integrated system that retrieves 
patient data. The support for making a clinical decision available within the system 
has many functions; the functions were limited initially to drug interactions and 
allergies but also included order sets. Certain types of medications such as infusions 
and taper schedules to decrease or increase the dose and/or frequency of a 
medication (e.g. Insulin regimes) were still prescribed on a paper prescription but 
also entered in the EPMA system as a reminder to check for an accompanying 
paper prescription chart. 
Implementation of the EPMA system started in November 2011, using a 
staggered, yet quick rollout to all in-patient wards over a five-month period. The 
EPMA system is currently used on all adult in-patient wards. The Meditech® EPMA 
system enabled nurses, pharmacists, and doctors to annotate prescriptions and 
facilitated staff to incorporate their own nursing or pharmacy notes. Paper medical 
notes, however, were still the mainstay of written documentation for doctors.  
In Hospital A, the prescribers’ view of the prescription chart appears all in 
the one process screen with active and discontinued medications (highlighted in 
blue) for each patient admission in the same list as shown in Figure 2-1. As each 
prescription item is added an “r” appears next to it in the note column within the 
process orders screen, once checked by a pharmacist to indicate that the 
prescription is clinically approved the “r” is no longer visible. The listing sequence of 
medications as they appear on screen from top to bottom is once only (Stat) 
medication, PRN medication, regular medication and discontinued medication (in 
BLUE), within each category they are in alphabetical order. 
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Figure 2-1 Example of a prescription chart used in Hospital A 
 
The image originally presented here cannot be made freely available via 
LJMU Digital Collections because of copyright. The image was sourced 
from Hospital A, EPMA system. 
 
 
 
In Hospital A, Stat medications have to be prescribed independently of any 
other medication type. At the order type field the prescriber must select one and 
press <return> and then prescribe the Medication, Dose and Route as for Regular 
Medications, the start date and time and stop date and time defaults in. 
Prescription order sets are abbreviated to SETS; they enable simultaneous 
prescribing of a list of standard medications used for a specific indication (via a Look 
Up menu for selection of the correct SET). Medications from the SET can be deleted 
if they are not required or they are duplicate orders.  
 Hospital B Prescribing System  2.3.2
Hospital B is a teaching hospital in England with 750 beds (125) that 
implemented an EPMA system, which is part of a commercially procured system 
supplied by JAC®; the system originated in the UK in 1983 (132). To retrieve patient 
data, JAC communicates with the existing hospital information system (HIS). The 
EPMA system during the study was not used on all in-patient wards. Therefore, the 
prescribing system at Hospital B consisted of a specific paper prescription chart 
adapted for use on the Medical Admissions Unit (MAU) only, with the EPMA system 
being used on the rest of the in-patient wards. This study took place on specific in-
patient wards excluding the MAU and consequently only the EPMA prescribing 
system was reviewed. 
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Clinical decision support within the EPMA system had many functions but 
was limited initially to drug interactions and allergies, as well as order sets. As with 
Hospital A, certain types of medications such as infusions and taper schedules to 
decrease or increase the dose and/or frequency of a medication (e.g. Prednisolone 
reducing dose) were still prescribed on a paper prescription but also entered in the 
EPMA system as a reminder to check for an accompanying paper prescription chart. 
Implementation of the EPMA system started in January 2011, using a 
staggered rollout, taking approximately 18 months. Preference was for patients to 
be discharged from the ePrescribing system: for this reason, feeder wards (e.g. 
MAU) were left until later to enable patients to move from paper to electronic 
wards rather than vice versa as this involved fewer transcriptions to take place. As 
such, the EPMA system was used on in-patient wards but not the MAU. The 
prescribing system in hospital B is a combination of paper prescribing and EPMA 
prescribing.  
The JAC® EPMA system enabled doctors, nurses, and pharmacists to 
annotate prescriptions and facilitated them to incorporate their own nursing, 
pharmacy, and medical notes. Paper medical notes, however, were still the 
mainstay of written documentation.  
In Hospital B, the view of the prescription chart is separated into two 
folders; each folder or “tab” displays the active and discontinued medications for 
each patient admission as seen in Figure 2-2. As each prescription item is added, it 
is displayed with a blue background, once checked by a pharmacist the background 
changes to white. Prescription items are placed in sections, which are separated by 
yellow dividers and come in the order of regular and Stat medications together, 
PRN, TTO & Short Term Leave. 
Figure 2-2 Example of a prescription chart used in Hospital B  
The image originally presented here cannot be made freely available via 
LJMU Digital Collections because of copyright. The image was sourced 
from  Hospital B, EPMA system. 
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In Hospital B the EPMA system performs two functions from one drug selection. 
When the item is prescribed on a regular basis, an associated Stat can be prescribed 
at the same time as seen in Figure 2-3. 
Figure 2-3 Prescription chart screen used in Hospital B showing how an associated 
eStat medication is prescribed 
The image originally presented here cannot be made freely available via 
LJMU Digital Collections because of copyright. The image was sourced 
from  Hospital B, EPMA system. 
 
To do this, the prescriber has to click on the “create associated Stat” order button, 
in addition to the regular order details. This then processes the regular order, and 
retains the drug item to enable the eStat order to be created. When all the fields 
are completed, both orders are added to the prescription in their appropriate 
sections.  
In Hospital B, prescription order sets are called treatment protocols and can 
be used to enable users to prescribe pre-agreed sets of drugs in one transaction. 
There is an option when adding a prescription item to select a treatment protocol; 
in the drug name section, the name of the treatment protocol is entered. If the 
prescriber does not know the name of the protocol they can enter * as the drug 
name to reveal ALL protocols. Although the details of each item have been pre-set 
according to the agreed protocol, any of these fields may be changed. Items can be 
de-selected which are not required, a red cross appears confirming that the item 
will not be prescribed.  
 Hospital C Prescribing System 2.3.3
Hospital C is a district general hospital in England with 480 beds that has a paper 
prescribing system in place on all in-patient wards. A new formatted paper 
prescription was implemented in January 2012 after piloting the paper chart, which 
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is an A4 paper booklet containing 6 pages with the top part removed, so that 
patient details are always visible, see figure 2-4. 
There is no instant clinical decision support available within the system 
compared to ePrescribing systems. Written documentation by HCPs, once the 
paper prescribing system was implemented, did not change. Doctors, nurses, and 
pharmacists could annotate prescriptions by hand; their main written 
documentation did not change with paper medical notes still the main stay of 
written communication.   
 
 
 
Figure 2-4 Example of a prescription chart used in Hospital C 
The image originally presented here cannot be made freely available via 
LJMU Digital Collections because of copyright. The image was sourced 
from  Hospital C, paper prescribing system. 
 
2.3.3.1 Chapter Summary 
This chapter has outlined the programme of work, including aims and 
objectives, and described the rational for the methods used within each of the 
three phases. The reasons for choosing the three Hospital Trusts where the 
research took place in phases two and three is given along with a general overview 
in relation to prescribing systems within the Trusts. The next chapter of the thesis 
gives an account of the telephone interviews conducted in phase one, and the 
subsequent chapters describe phases two and three followed by a final 
triangulation discussion chapter.  
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3 ONE NHS, MANY SYSTEMS: ASCERTAINING THE TYPE OF 
PRESCRIBING SYSTEMS USED IN ACUTE TRUSTS ACROSS 
ENGLAND 
Having described in the previous chapter the methodologies, rationale, data 
collection and analysis for the programme of work, this chapter will focus on phase 
one. The aims and objectives are reiterated to facilitate the findings that are then 
presented and summarised, which informed the next phase of the programme of 
work. 
3.1 Aim and Objectives 
The aim of the telephone interviews was to ascertain the type of different 
in-patient prescribing systems and their design features used within secondary care 
by gaining the views of acute trust chief pharmacists, across England. 
The objectives were to explore  
 The type of prescribing systems in place in acute trusts across England 
and how long these have been in place 
 The nature and functionalities within the prescribing systems 
 The perceived relationship between the prescribing systems and 
prescribing quality 
 Senior Pharmacy Management views on the use of clinical indication 
within the prescription chart design, as per the published standards for 
the design of hospital in-patient charts (2) 
3.2 Method 
During January and February 2012, structured telephone interviews were 
completed with chief pharmacists or their nominated senior staff members. Of the 
146 chief pharmacists that were contacted regarding the telephone interviews, 
sixty-five Acute Hospital Trust chief pharmacists agreed to take part, which resulted 
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in a 45% response rate. Details of the methodology and a description of the method 
have previously been discussed in Section 0.   
The interview questions were developed based on existing literature, 
previous questionnaires, discussions with the supervisory team and the pilot study. 
The pilot study consisted of three telephone interviews with chief pharmacists, one 
Trust was using ePrescribing, and two Trusts were using paper prescribing. The pilot 
study interviews ran smoothly, therefore no significant changes were made to the 
structured telephone interview questions.  
The interview schedule consisted of open and closed questions (Appendix 
9.1.4). The questions asked covered the following areas: the prescribing system, use 
of clinical indication and the reporting system for prescribing errors. The interview 
commenced with the interviewer asking basic questions such as, how many acute 
hospitals were in the acute trust and what prescribing system was in place, to 
enable the participant to feel comfortable with the interviewer. Probing questions 
were included if the participant gave short, one word answers to allow a 
conversation to build. 
A stratified purposive sample (133) was obtained from the sixty-five 
interviews, for qualitative thematic data analysis, in which acute trust size and 
Cluster Strategic Health authority (SHA) region were the strata (134), see Table 3-1. 
One interview for each of the 16 “cells” for paper prescribing were analysed where 
possible along with the 12 interviews conducted about ePrescribing. Three 
additional interviews were also selected, as they were particularly information rich, 
this incorporated extreme case sampling (124). Table 3-1 presents the interviews 
obtained from each stratum for purposive sampling. Qualitative data analysis of the 
12 interviews with chief pharmacists whose Trust used ePrescribing, and 18 from 
those who used paper prescribing took place.  
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Table 3-1 Number of interviews obtained from each stratum for purposive 
sampling. 
Size of Acute 
Trust 
SHA Cluster 
North 
SHA Cluster 
Midlands 
SHA Cluster 
South 
SHA Cluster   
London 
Small 4  8 (1)       3 (1) 1 
Medium       10 (2) 8 (1) 3 1 
Large       7 (1) 4 (1) 3 0 
Teaching       5 (2) 3 (1) 3       2 (2) 
 * Numbers in red represent interviews conducted about ePrescribing 
The interview data were collated and pulled into a Word Document under 
each question and section of the interview bringing together the answers from each 
interview to be analysed. The initial stage of analysis was to break down each of the 
interviews to identify codes; the researcher went through each document 
identifying codes and referring back each time to previous codes to ensure a new 
code was required or the data were linked, this is referred to as constant 
comparison analysis (130). Similar codes were identified within the Word document 
by highlighting specific sections with the same colour for each code represented. 
These codes were then written on a post-it note and placed onto an A3 sheet of 
paper for all purposively sampled interviews. The researcher was then able to see 
all the codes produced from the data. Grouping of the initial codes then occurred 
by moving around the post-it notes, as required, into a smaller number of themes. 
The next stage of the analysis involved giving each of the themes a sub-theme and 
major theme to enable comparisons to be made again between the different 
interviews and to check if the themes worked in relation to the entire data set. The 
sub-themes were then compared to discover trends and differences, which were 
included in the findings report. One of the study supervisors, with experience of 
qualitative data analysis, independently verified key themes to ensure that the 
theory framework was appropriate and valid. 
The transcribed interviews revealed a number of key insights, which are 
described below. Quotations were used to support the sub-themes and major 
themes, which were established. The quotes were left in the language of the 
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participant to show how the interviewees expressed themselves. The size of the 
Trust is provided in brackets to preserve the participants’ anonymity and 
confidentiality. The chief pharmacists and nominated senior members had no 
concerns regarding discussing prescribing systems and related issues within their 
hospitals, a number were very enthusiastic about the topic. The perceived 
relationship of the prescribing systems and quality of prescribing were identified. 
3.3 Results  
A pilot study was undertaken, to ensure that the recruitment procedures 
and interview questions were robust and ran smoothly without missing any 
important points relevant to the research. The pilot study did not highlight any 
specific issues with recruitment or the interview questions and as such, the 
interviews were included in the data analysis. 
Eight participants took the initiative to arrange interview times before the 
researcher had made telephone contact, five participants used e-mail, and three 
telephoned the researcher to arrange times. 
Follow up e-mails were sent out, 53 in total, 18 of which were sent to the 
personal assistants of the chief pharmacists. Sixteen of the follow up e-mails led to 
interviews being conducted. Eight chief pharmacists officially declined to take part 
in the study due to time constraints and two were willing to take part but 
unfortunately were not able to complete in the data collection period.  
  Sixty-five interviews were conducted in total; the average time recording 
interviews was 16.5 minutes (min 8 min, max 35min SD 5.25min). This time 
included the initial greetings with personal assistants and participants, verbal 
consent and future contact details. The interview process continued until as much 
quantitative data as possible had been collected.   
 In-patient Prescribing Systems used in each Hospital Trust 3.3.1
The findings from the analysis of quantitative data indicated that the sixty-
five chief pharmacists interviewed, 18% (n=12/65) stated that their Trust had 
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ePrescribing in place or were actively implementing an ePrescribing system for use 
on in-patient wards. The main EPMA system in place or being implemented was 
JAC® (n=5) followed by MEDITECH® (n=3), iSOFT® (n=2), PICS® (n = 1) and one in-
house created system. Of the Trusts that had a paper drug chart in place, 64% (n= 
34/53) planned to implement or change to ePrescribing in the future.  
Four Trusts had recently implemented ePrescribing within the last two 
years. Three of the Trusts had implemented the ePrescribing system provided by 
JAC® and one had implemented the ePrescribing system provided by Meditech®. Of 
these Trusts, two were purposively selected for phases two and three based on 
location in England, prescribing system in place (JAC® and Meditech®) and length of 
time (less than two years) the system has been in place. These hospitals enabled an 
insight into the changes that occur when switching from paper to ePrescribing. 
Eighty-two per cent (n=53/65) had a paper drug chart in place. When asked 
about how recently the paper chart had been updated within each Trust, 77% 
(n=41) had reviewed and updated the paper chart within the previous 2 years. Eight 
Trusts had reviewed or were in the process of reviewing the paper drug chart due 
to the recent publication of the Royal Colleges publication Standards For The Design 
Of Hospital In-Patient Prescription Charts (2). Trusts were also asked if they had 
considered the publication, only nine trusts (14%) had not considered the 
publication, 3 of which were Trusts with ePrescribing. 
3.3.1.1 Electronic In-patient Prescribing systems 
Of the 12 Trusts that had ePrescribing in place, four had ePrescribing on all 
of their adult in-patient wards, and the remaining eight Trusts had a mixture of 
paper and ePrescribing systems in use. The interviewees that had ePrescribing in 
place were asked about the use of supplementary paper prescription charts. All the 
Trusts with ePrescribing had supplementary paper charts in place to some extent, 
except for one. The number of supplementary paper prescription charts and type of 
charts still used in conjunction with ePrescribing are shown in Figure 3-1. 
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Figure 3-1 Drugs prescribed on a supplementary paper prescription chart in 
conjunction with the ePrescribing system in the 12 Trusts. 
 
Staffs from the twelve Trusts with ePrescribing in place were asked about 
the functionalities of the systems and if they felt, they were effective at improving 
prescribing quality. The main functionality incorporated into the systems was the 
use of discharge summaries or patient transfers, one of the main drivers for NHS 
connecting for health. The functionalities are presented in Figure 3-2. 
Figure 3-2 Electronic prescription chart functionalities provided by the 
ePrescribing software in the 12 Trusts. 
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3.3.1.2 Hospital Trusts inclusion of a clinical indication on the in-patient 
prescription 
Part of the interview focused on the use of clinical indication for a 
prescribed medication on the paper chart or ePrescribing system, as well as the 
notes, as a communication tool. One Trust claimed that they didn’t know about the 
use of a clinical indication on the prescription, so only 64 Trusts answered the 
question. 72% (46/64) of Trusts required a clinical indication to be included on the 
in-patient prescription for antibiotics (includes all medications) and 39% (n=25/64) 
for warfarin (includes all medications). Incidentally the antibiotic stewardship 
national policy was noted as the driver for the introduction of a clinical indication to 
be documented on the prescription in (31/49) 63% of cases. Twenty-three percent 
(n=15/64) of Trusts did not require an indication for any medications on their 
prescription charts, see Figure 3-3 below.  
Figure 3-3 Hospital Trusts that require a clinical indication on the prescription for 
a specific medication 
 
The drugs included in the other category in Figure 3-3 above are; unlicensed 
medications, Payment by Results excluded medications, National Institute for 
Clinical Excellence (NICE) drugs, proton pump inhibitors, Low Molecular Weight 
Heparins , Anticoagulants, Chemotherapeutic agents and immunoglobulins. 
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Of the 76% (49/64) Trusts that required a clinical indication for a medicine 
on the in-patient prescription chart, 59% (n= 29/49) stated that the clinical 
indication was completed all the time or most of the time on the prescription. The 
remainder stated sometimes, with only one trust stating rarely. 
 Qualitative Results 3.3.2
The emergent themes included: 
 Regulation - control, feedback, govern, direction and management.  
 Clinical workflow - time/efficiency/communication 
 Patient safety - knowledge /education /compliance /accuracy 
The themes are described in relation to the components of quality (STEEEP), as 
shown earlier in Table 1-1. Where illustrative quotations from chief pharmacists 
have been extracted verbatim from the transcripts, the size of hospital to which 
these quotes are attributable are noted in brackets alongside as follows: (Medium)  
3.3.2.1 Regulation: Effective and Equitable 
In the theme of regulation a number of participants, (n=8/12) indicated that 
the ePrescribing systems had enabled control and timely feedback that was not 
previously possible with the previous paper-based system. 
“It’s picked up a lot of things we didn’t know before, like how many missed 
doses there are, which you can tell straight away”. (Medium) 
At one hospital, the ePrescribing system had enabled live data on quality to be 
reported to frontline staff via a quality dashboard; however, this has led to more 
pressures on staff. It was noted that the extent of the regulation was affecting 
personnel in a negative way showing a social impact upon the workforce. 
“We have some extremely comprehensive quality dash boards…There is also a 
lot of pressure internally now both on the nurses and the medics because of 
course the reporting capability within the system means there is nowhere to 
hide”. (Teaching) 
EPrescribing was considered to enforce policies and controls through mandatory 
fields. Interestingly, policies that were put in place prior to implementation of 
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ePrescribing were questioned once enforced, showing that the policy had not 
previously been acknowledged or followed when a paper prescribing system was in 
place. 
“So it was a good illustration of how a well-designed system beats a policy or 
instruction any time”. (Medium) 
Specific policies were noted as a driver for the introduction of a clinical indication 
on the prescription, the main driver was the policy regarding  antibiotic stewardship 
(47).  
“It’s part of the governance around the prescribing of antibiotics and it was 
something, which became quite a normal thing for...Um…hospitals to adopt 
as good practice”. (Teaching) 
The use of an ePrescribing system in conjunction with a clinical indication was seen 
as supporting control and feedback on the prescribing process; one interviewee 
believed that ePrescribing systems would improve control and feedback compared 
to a paper based drug chart. 
“The more information you have got the more you can be sure the prescribing 
is correct and being used for the right indications. When you are based on a 
paper based system, it’s very hard to formulary control isn’t it. Whereas when 
we are moving with electronic prescribing formulary control will become a lot 
better and a lot greater. It’s a check [clinical indication] that everyone is 
aware of what they are doing really isn’t it”. (Large) 
After Implementation of ePrescribing, in one Trust, the completion rate of a clinical 
indication on the prescription had become inferior compared to the paper 
prescribing system. Showing that ePrescribing did not always facilitate greater 
control over prescribing. 
“It [clinical indication] always was for antibiotics when we had a paper system 
but it’s quite difficult to impose that with our EP system because you have to 
put it in as a note so that’s not compulsory… So it’s a disadvantage really”. 
(Medium) 
By having the clinical indication on the prescription, it was seen as facilitating audit 
for financial reasons, providing information to facilitate claims in relation to 
Payment by Results (PBR) excluded medications. 
“Requiring [Primary Care Trust PCT] more and more information from us 
around PBR excluded and cancer therapy so we do by the end of this financial 
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year need to be providing the PCT with the clinical indication for PBR excluded 
meds”. (Large) 
Governance issues and patient confidentiality were noted as a limitation to the use 
of incorporating a clinical indication on the prescription. Management felt that 
patient confidentiality could be compromised, if a clinical indication were provided 
on the prescription chart and family members or friends were to view the paper 
prescription chart. 
“So my personal view is if we get around the issues to do with err concerns 
over patient confidentiality then it would be a nice standard to have”. (Large) 
From a quality initiative perspective, it was emphasised that if the amount of work 
that had gone into preparing for ePrescribing had been applied before the 
introduction of a paper drug chart, then maybe that would also have enabled 
stakeholder buy-in and good quality prescribing on a paper drug chart. 
We did a huge amount of work (with ePrescribing)…getting the clinicians to 
agree on what needs to go on, in what way and what’s the protocols…you 
kind of get people together to talk about these things and having to 
compromise. In itself that is quite a good quality initiative, if you had only 
done that for paper well, it’s very hard to get people to comply then isn’t it. 
(Teaching) 
3.3.2.2 Clinical Workflow; Time, Efficiency and Patient Centred  
The theme of clinical workflow with the sub theme of time and efficiency 
covered both lack of time and more time surrounding the prescribing system and 
quality of prescribing. As discussed above, the feedback within the ePrescribing 
system had reduced time taken to audit situations but could also increase the time 
taken to enter all required prescription fields. This is where both aspects of the 
socio-technical system interface around prescribing. 
The beauty of it (ePrescribing) is you can make it do so many things, so we 
could actually make it half an hour to prescribe a single drug if we wanted to. 
So it becomes a balance between workflow, audit information, and safety 
info. So it’s about balance along the line, it probably doesn’t have a bearing on 
for one drug it’s when it becomes routine. (Large) 
Recently a national shortage of a drug occurred; one of the interviewees explained 
how ePrescribing had benefited them regarding time and efficiency in terms of 
implementing a switch to another product which was available. 
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Had we been on paper (prescribing) that would have been a very time 
consuming bit of logistics to sort that switch out. It was done within half a 
day…there are just some things where you know it just makes everything so 
much easier. (Medium) 
On the other hand, it was noted that ePrescribing was perceived to be more time 
consuming in other situations and inhibited patient contact. 
It’s definitely more time consuming and people don’t speak to patients as 
much because they can work remotely, those are the two negatives really. 
(Teaching) 
The terms helpful and useful were used on a number (n=23/65) of occasions 
regarding the use of a clinical indication on the prescription suggesting that its use 
may be beneficial in assisting HCPs’ communication and clinical workflow around 
the prescribing process along with providing information to patients. It was also 
noted that the clinical indication was rarely documented in the patients’ notes.  
Very pro [about clinical indication], because not only does it help with…I think 
it helps prescribers, certainly helps pharmacists when checking the 
prescriptions and also it assists with the information that we are now 
supposed to be sharing with patients. (Small) 
Just having it up their upfront would make life rather simpler; the notes very 
often don’t have that indication any way. (Medium) 
The use of an ePrescribing system can result in new ‘workarounds’ – ways that 
people discover to get the job done faster or easier, compared to the paper 
prescribing system. People will, in effect; configure the ePrescribing system to meet 
their particular clinical workflow needs (20). These were mentioned in the 
interviews. 
You develop or you find out about a lot of workarounds that people put in 
place [ePrescribing]. (Teaching) 
The communication between members of MDTs is essential to ensure that quality 
patient care is achieved in a timely manner and in an efficient way. Communication 
regarding the time it takes to try to find the clinical indication in the medical notes 
was highlighted along with having the clinical indication available when a patient is 
transferred between wards within the hospital or other transfer situations. 
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Clearly, on a medical ward, I think that info is...um... Absolutely pertinent 
when we are transferring patients between different wards, hospitals, primary 
care, secondary care, GPs. (Large) 
One of the chief pharmacists acknowledged that different professions work in 
different ways and stated - We need to think about how the medics would work 
which is very different to the way we work. (Teaching) 
3.3.2.3 Patient Safety; Safe and Effective 
A number of interviewees (n=8/12) mentioned that new error types had been 
encountered within the ePrescribing system such as wrong selection of patient, 
drug and strength. It was explained how human error was predictable in some 
cases, due to the design and layout of the ePrescribing system. Prescribing error 
had therefore been minimised by changing the design of the system, however 
human error was not completely removed.  
People kept picking the enteric-coated (aspirin) so when we put aspirin 
dispersible at the top of the list followed by enteric coated that sort of reduced 
that error almost completely. (It’s) Funny people do tend to pick the thing at 
the top of the list because it’s what they are expecting to see so it changes the 
nature of selection errors but it doesn’t mean it removes them completely. 
(Teaching) 
The use of a clinical indication within a paper prescribing system and an 
ePrescribing system was thought to have facilitated the clarity of the prescription, 
allowing clinical appropriateness of medications to be established. From a patient 
safety viewpoint, it was thought to confirm that the prescription was correct. 
To be clear, it gives [clinical indication] you a lot more understanding that the 
drug has been prescribed is correct, that the dose is correct and also that the 
actual treatment length is right. (Small) 
However, concerns about accuracy of the clinical indication, compliance in 
completing the clinical indication, and whether the clinical indication would 
improve patient safety were debated. Views regarding the extent of medications 
that should have a clinical indication documented on the prescription varied, they 
included all medications, newly initiated medications, to a select few. The rationale 
given for not expecting a clinical indication on all medications concerned junior 
doctors’ abilities to find the clinical indication of a patient’s medication on 
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admission. Several comments were made regarding medications prescribed on 
admission being more of a transcribing process than a prescribing process and 
therefore prescribers would not know the indication of each medication.  
I think that for certain things it’s a good idea [about clinical indication] but I 
think for particularly some of the regular meds, I would be concerned that 
actually the junior doctors wouldn’t know and would therefore guess. Then 
you have actually got inaccurate information, so erm…because they won’t 
know when they write that drug up on admission what the clinical indication 
for everything is. (Medium) 
Another reason was about what information would actually be given if the clinical 
indication was made compulsory on the prescription and therefore remarked about 
a clinical indication only being beneficial in certain situations. The practicalities of 
providing a clinical indication for every medication and ensuring it was completed 
were not realistic unless some electronic support was provided. 
I think for many medicines it [clinical indication] would improve safe use of 
medicines, in reality it is not practical without some electronic support. 
(Teaching) 
One chief pharmacist with paper prescribing in place acknowledged that they had 
gone as far as possible in designing a safe and effective drug chart. Other 
interviewees felt prescribing had become of inferior quality over time due to 
doctors’ training; one gave a perceived insight into the training of doctors and the 
culture of medical training. 
It’s all about the diagnosis and the treatment is a poor second…I’m not saying 
it’s not a consideration but the therapeutics is second to the diagnosis. 
(Medium) 
The three themes of regulation, clinical workflow, and patient safety were 
interconnected, with one quote specifically connecting all three.  
The beauty of it [ePrescribing] is you can make it do so many things, so we 
could actually make it half an hour to prescribe a single drug if we wanted to. 
So it becomes a balance between workflow, audit information, and safety 
info. So it’s about balance along the line, it probably doesn’t have a bearing on 
for one drug it’s when it becomes routine. (Medium) 
Figure 3-4 below depicts the quality components in relation to the design of the 
prescribing system (paper or electronic, with or without a clinical indication) and 
the findings from phase one. All of the themes identified, to different extents, the 
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influence a change in prescribing system can have on regulation, clinical workflow, 
and patient safety in relation to the prescribing and medicines administration 
process.  
Figure 3-4 Quality components (STEEEP) in relation to prescribing systems 
identified 
 
3.4 Discussion 
The exploration of the type of prescribing systems in place in acute trusts 
across England showed that out of the 65 interviews five different ePrescribing 
systems (JAC® followed by MEDITECH®, iSOFT®, PICS® and one in-house system) 
were in place in twelve Trusts. The rest of the Trusts had a paper drug chart on 
which to prescribe in-patient medications. Of the twelve Trusts with ePrescribing in 
place, each system had different functionalities and supplementary paper 
prescription charts in use. 
The use of a clinical indication on the prescription chart for antibiotics and 
warfarin differed across the Trusts with 23% (n=15/64) of Trusts not requiring an 
indication for any medications on their prescription charts. This highlighted the lack 
of equivalent usage of an indication on the prescription chart across England, and 
that the Royal Colleges’ standards (2) could only advise regarding the inclusion of 
an indication on the prescription chart.  
The main themes, that emerged from the qualitative data, after thematic 
analysis included regulation, clinical workflow, and patient safety. Socio-technical 
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systems theory was then explored as a conceptual framework to view the emergent 
themes and their relevance to prescribing quality (assessed using STEEEP 
framework).  
Regulation – is put in place to ensure effective care can be carried out to an 
equitable standard. In order for regulation to be effective the guidelines, policies, 
and procedures need to be followed otherwise, there is no point in having them in 
place. EPrescribing was seen to be both effective and ineffective when enforcing 
policies within the in-patient prescribing system, for example using a clinical 
indication on the prescription chart. It was perceived from the results that by 
having mandatory fields in place, the prescriber is forced to complete all the 
required fields; this created an effective way compared to the paper prescribing 
systems to enforce policies and guidelines, yet it could lead to incorrect entry of 
information. This became apparent when a chief pharmacist explained how HCPs 
had only become aware of some policies when they were made compulsory 
through the ePrescribing system. Respondents in trusts with ePrescribing reported 
workarounds being evident in the working practices of their staff, whereby staff 
bypass the mandatory fields to streamline their working practices, which may lead 
to inaccurate information being supplied.  
National policies, such as the antibiotic stewardship, are required to enable 
an equitable NHS and therefore are important to ensure quality care across 
England. The antibiotic stewardship national policy was noted as the driver for the 
introduction of a clinical indication to be documented on the prescription in many 
cases. Another national recommendation regarding The Standards for the Design of 
Hospital Inpatient Prescription Charts were also referred to with 85% (55/65) having 
considered the standards. The completion rate of clinical indication, on antibiotic 
prescriptions, with the introduction of ePrescribing, had declined in one Trust 
compared to when the same Trust used a paper prescribing system. This was 
because the clinical indication entry was not a mandatory field within the 
ePrescribing system, showing that without a mandatory field greater control was 
not always achievable with ePrescribing. Financial incentives were also cited as a 
reason for incorporating the clinical indication on the prescription in order to be 
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able to claim back money from the Primary Care Trusts for payment by results 
excluded medications.  
The growing need for formulary control driven by financial incentives and 
audit, has led to widespread recommendations for the introduction of ePrescribing 
systems in the UK (20). Coding analysis, (n=8/12) indicated that the ePrescribing 
systems had enabled timely audit and feedback that was not previously possible 
with paper prescribing systems. 
Clinical workflow that is not impeded in any way should achieve an efficient 
and timely outcome for patients and healthcare professionals. It was noted that the 
extent of the regulation through the ePrescribing system had enabled quality 
healthcare to be audited in a more timely fashion compared to paper prescribing 
systems, sometimes having “live” quality data available. However, this was stated 
to have put healthcare workers under pressure, showing how the technology can 
have a social impact upon the workforce. The technical aspects of ePrescribing and 
having a clinical indication on the prescription were reported to impact on the 
shared parts of clinical workflow in a positive and negative manner. The influence 
on timeliness and efficiency that regulation had imposed to improve patient safety 
had increased time taken to prescribe each individual drug resulting in 
inefficiencies, at the point of prescribing, to frontline HCPs’ clinical workflow. 
However, pharmacy management felt they could now audit and impose regulation, 
using mandatory fields, in a more efficient manner using ePrescribing.  
The change in patient contact was also considered when moving from a paper 
based prescribing system to an electronic system. It was perceived that ePrescribing 
had changed working practice by aiding frontline staff to work remotely to the 
patient, resulting in less patient contact.  
The use of a clinical indication on the prescription was considered “helpful or 
useful” in assisting the prescribing, prescription review and administration process. 
The clinical indication was perceived to be rarely documented in the notes as 
mentioned by a number of chief pharmacists “the notes very often don’t have that 
indication any way” and reinforced by previous research (38)(135). Further review 
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regarding the use of a clinical indication on the prescription, and whether it 
influences the efficiency of HCPs clinical workflow is required. 
Patient safety focuses on safeguarding patients in an effective manner. With 
the change from paper to ePrescribing systems come new types of prescribing error 
(65–70). Illegibility is no longer an issue with ePrescribing systems however; 
incorrect selection could be classed as a comparable new error, such as wrong 
selection of patient, drug, strength, or frequency. This was discussed in the 
interviews; the order in which the drugs appeared on the drop-down menu for 
selection had a bearing on whether the correct drug was selected or not. It was 
noted that HCPs tend to pick the drug at the top of the list because it is what they 
were expecting to see. This shows a social interaction with the computer because 
the order, in which drug names appeared, was perceived to influence the new error 
type. The prominence of the new error types requires further investigation so that 
HCPs’ can be made aware of the pitfalls that come regarding ePrescribing, 
particularly those relating to patient safety. 
 The value and effectiveness of a clinical indication space, incorporated in the 
design of paper and ePrescribing systems, on all medications requires further 
investigation, especially from a patient safety perspective. There was debate as to 
which medication should have a documented clinical indication on the prescription. 
The medications that were thought to warrant a clinical indication on the 
prescription were not differentiated by therapeutic area or diagnosis, but by the 
ability of frontline staff to provide an accurate clinical indication, without impeding 
their clinical workflow. The examples given were for all medications, newly initiated 
medications or a select few. The reasons for the debate involved concerns about 
accuracy, compliance, and patient safety. Several comments were made regarding 
medications prescribed on admission being more of a transcribing process than a 
prescribing process and therefore prescribers would not know the indication of 
each medication. The areas highlighted during these interviews, such as new error 
types with ePrescribing and the increased efficiency regarding audit, concur with 
those from other research studies (20)(136). The discussions reinforced the fact 
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that a balance is required between the social and technical aspects of the system in 
order to achieve optimal performance. 
Limitations 
It was noted that this time of year was probably not an ideal data collection 
period as a number of participants were still on annual leave after the Christmas 
Break. Due to the time frames of the study, data collection had to go ahead. This 
led to the data collection period extending over 6 weeks to accommodate 
participants’ busy schedules on return from annual leave. Another difficulty in 
contacting chief pharmacists arose when it materialised that several chief 
pharmacists were retiring or moving positions due to imminent Trust mergers and 
changes in the NHS.  
It was acknowledged that the number of chief pharmacists, from the London 
region, interviewed in the data collection period was low compared to other 
regions in England. The purposive sample, based on Trust location and size 
provided an even spread of interviews, therefore limiting, to some extent the bias 
introduced by region. 
3.5 Chapter Summary 
Within this chapter, phase one data revealed that the majority of in-patient 
prescribing systems in hospital are paper systems. The number of different 
prescribing systems in use within secondary care, at that time, across England 
highlighted the diversity of prescribing systems, and that a national paper or 
ePrescribing system across the NHS was unlikely to occur in the near future. 
However, an initial step to standardising the design of prescription charts had been 
made, as the standards for the design of hospital in-patient charts had been 
consulted by 85% of the chief pharmacists interviewed. EPrescribing systems had 
been implemented with supplementary drug charts for a variety of medications. 
Functionalities within the EPMA system differed between trusts, making it difficult 
to compare in the future, let alone standardise their design and use. Qualitative 
data indicated that the regulation required to provide effective and equitable 
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patient care was to different extents perceived, in some cases, to be enforced with 
an ePrescribing system. However, this can then impact accuracy and clinical 
workflow, leading to workarounds that can be harmful and are not officially 
documented in policies or procedures. Patient contact was perceived to have 
diminished with the introduction of ePrescribing possibly leading to a change in 
patient centred care. The use of a clinical indication on the prescription could 
improve communication between HCPs and patients regarding prescribed 
medications. Several of the themes reinforced the need to seek other opinions of 
frontline HCPs about the different prescribing systems in order to understand more 
in-depth how the social and technical areas of prescribing systems have changed 
and how they impact on quality of care.  
This chapter has provided the Trust chief pharmacist and managerial 
perspective regarding both electronic and paper prescribing systems. The next 
chapter focuses on the MDT member’s viewpoints about how the ePrescribing 
system can or could influence their working practices. Phase two utilises a focus 
group methodology of teams drawn from three of the sites at which the chief 
pharmacists worked. 
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4 THE IMPACT OF PRESCRIBING SYSTEMS ON HEALTH CARE 
PROFESSIONALS’ WORKING PRACTICES 
Chapter 3 described how different in-patient prescribing systems are used in 
acute trusts throughout England and how the prescribing systems are perceived 
from a pharmacy management perspective. This chapter will focus on how those 
prescribing systems impact on doctors, nurses, and pharmacists working practices 
as part of a multidisciplinary team. As well as the aims and objectives, detailed 
descriptions of the focus group characteristics along with the findings are 
presented. 
4.1 Aim and Objectives 
The aim of this phase was to explore how different prescribing systems have 
an impact on the working practices of key health care professionals (doctors, 
nurses, and pharmacists) within their multidisciplinary teams. 
This phase has three objectives: 
1. To explore key healthcare professionals’ opinions of different prescribing 
systems and the positive and negative impacts prescribing systems have on 
their working practices. 
2. To determine the impact of different prescribing systems on patient safety, 
as perceived by key healthcare professionals. 
3. To explore the role of clinical indication within the design of prescribing 
systems, and it’s perceived impact on key healthcare professionals working 
practices. 
4.2 Method 
As described previously in Chapter 2, this phase is a qualitative study of paper 
prescribing systems and EPMA systems in use in 2012/2013. The selection criteria 
for the three study sites (Hospitals A, B and C) captured the diversity of the 
prescribing systems across England. The selection of the three hospital sites for 
phase two was previously explained in Section 2.3. 
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4.3 Results 
Eleven focus groups were conducted, each with five to nine participants 
between September 2012 and May 2013 in the three hospitals. A total of 73 
participants: 28 doctors, 25 nurses, and 20 pharmacists took part in the focus 
groups. The characteristics of the multidisciplinary teams and their medical or 
surgical background are outlined below in Table 4-1 to provide context to their 
subsequent comments. The findings are then presented in distinct sections to 
consider, under emergent themes, the impact that prescribing systems have on the 
working practices of HCPs within the multidisciplinary team. The impact can be 
considered moving forward to provide ways in which EPMA technology can be used 
effectively and to its full potential. Transcriptions were double-checked for quality 
assurance purposes prior to any analysis-taking place. Where illustrative quotations 
have been extracted verbatim from the transcripts, the focus group hospital and 
focus group number to which these quotes are attributable are noted in brackets 
alongside as follows: A3 (Hospital A, focus group 3) at the beginning of each quote 
the professional role is provided e.g. Nurse. The illustrative quotations were also 
double-checked for quality assurance purposes. 
 Characteristics of Multidisciplinary team focus groups 4.3.1
The size of the focus groups varied between five and nine HCPs and the 
overall gender mix was 49 (67%) female to 24 (33%) male. 28 (38%) doctors, 25 
(34%) nurses, and 20 (28%) pharmacists represented the different HCPs. Table 4-1 
provides the characteristics of the MDT based focus groups in more detail below. 
The focus group meetings lasted between 37 and 76 minutes giving an 
average overall time of 59 minutes. Focus groups were conducted with seven MDTs 
from a medical speciality and four MDTs from a surgical speciality. There was a 
different prescribing system in place in each of the three hospitals, an EPMA system 
in Hospital A, a hybrid paper and EPMA system in Hospital B, and a paper system in 
Hospital C (See Section 2.3). 
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Table 4-1 Characteristics of the MDT based focus groups 
Focus Group 
No. 
Length of Focus 
Group in min. 
No. of 
Participants 
Doctor  Nurse Pharmacist 
Hospital A 
1 (Medical) 59 5 (2Male) 3 1 1 
2 (Surgical) 48 7 (1Male) 3 2 2 
3 (Medical) 59 9 (4Male) 4 3 2 
4 (Surgical) 76 8 (2Male) 3 3 2 
5 (Medical) 57 8 (4Male) 3 3 2 
Total 5 Average 60 Total 37 Total 16 Total 12 Total 9 
Hospital B 
1 (Surgical) 72 7 (4Male) 3 2 2 
2 (Medical) 56 5 (0Male) 1 3 1 
3 (Medical) 56 6 (1Male) 2 2 2 
Total 3 Average 61 Total 18 Total 6 Total 7 Total 5 
Hospital C 
1 (medical) 70 5 (1Male) 1 2 2 
2 (medical) 59 6 (4Male) 2 2 2 
3 (Surgical) 37 7 (1Male) 3 2 2 
Total 3 Average 55 Total 18 Total 6 Total 6 Total 6 
 
Thematic analysis identified how interaction with the prescribing system, 
within the hospital, influenced the MDT members’ working practices; all three 
professional groups considered this, both positively and negatively.  
The three emergent themes that were identified are: 
1) Interface; is about the interaction between the HCP and the prescribing system 
and it includes the sub-themes 
 Logistics        
 Clarity of the prescription 
 Operating the system 
 Using the system 
2) Change in working practices; is about the multidisciplinary team member’s 
change in role due to a change in prescribing system and it includes the sub-
themes 
 Key health care professionals roles 
 Situational awareness 
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 Communication 
 Patient contact 
3) External Influences; is about the decisions made outside the MDT that can 
influence the prescribing and medicines administration system and it includes 
the sub-themes 
 The NHS as an organisation 
 Hospital management 
 Accountability 
The three themes were mapped to STS to explore if the model provided any insight 
on the interrelated nature of the emergent themes. One of the study supervisors, 
with experience of qualitative data analysis, independently verified key themes to 
ensure that the theory framework was appropriate and valid. The themes interact 
and depend on one another, to show how EPMA is used and impacts on all areas of 
the complex healthcare system that is the NHS. 
4.4 Interface  
The interaction HCPs had with the prescribing system in order to create a 
prescription, review a prescription, administer a medication or gain general 
information about the patient emerged as a theme from the data. The prescribing 
system should facilitate HCPs’ working practices and so this theme shows how the 
interface between the HCP and the prescribing system works. 
When HCPs interact with the prescribing system, they can influence the 
system by ensuring it provides the correct or incorrect information, at that moment 
in time, which can lead to different actions in the future. The introduction of 
computer technology to prescribing was seen by participants as a way of 
standardising practice and ultimately eliminating user variability, as one doctor said, 
“Because that [EPMA] eliminates then the variability of how good the doctor is”. 
Other HCPs felt that by being able to read the prescription they could be sure that 
they were giving the correct medication. 
Nurse: I think reading the prescription would be greatly improved, and being 
sure that you are giving what should be given. 
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Standardising practice and human error were discussed throughout all the focus 
groups. Discussions were insightful, with MDT members concluding that they still 
needed to be mindful that technology can only minimise, not remove human 
variability. The is also discussed within legibility, see Section 4.4.2.1 
Nurse: So I can counter yes, it is easier to read the writing but you've also got 
the other side is if it’s, if it’s prescribed wrong it’s that little bit harder to see it. 
B3 
 Logistics 4.4.1
The sub-theme of logistics looks at and describes the alteration in physical 
locality of the prescription and HCP once the prescribing system changes, therefore 
affecting key HCPs’ physical workflow and interface with the system. Logistics, 
which includes being forced to do things in different places, can introduce new 
issues. This is picked up in the socio technical systems theory, which recognises how 
the change of location alters the dynamics and interaction with the system and can 
have knock on effects that may affect quality patient care.  
4.4.1.1 Lost Prescriptions 
The change in logistics and re-structure that can take place when moving 
from paper prescribing to EPMA ensured to a point that the prescription could no 
longer be “lost”, therefore saving time and effort in finding the prescription. This 
was discussed in all of the focus groups. 
Nurse: You don’t have to actually run up and down the ward looking for the 
medicine chart and who had them last. It’s all there ready B3 
The extent of paper in-patient prescriptions going missing has not been quantified 
in previous research studies, however qualitative studies have cited it as an issue 
with paper prescribing (86). Missing paper prescriptions were discussed as an issue 
in each focus group, to different extents. The NHS connecting for Health Report (20) 
acknowledged the issue of missing in-patient paper prescriptions, stating that 
EPMA would remove the problem of missing charts.  
 The HCPs who use the hybrid EPMA-paper system described how they still 
had the problem of “lost” charts and logistical difficulties because the Medical 
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Admissions Unit uses paper charts and described how this has repercussions on 
efficiency and time throughout the rest of the hospital wards. 
Doctor: …because we have paper charts that are still used in the emergency 
form [on the medical admissions ward] there's a lot of extra work in 
transcribing to EPMA and then that drug chart may go missing so yeah it’s a 
good thing that we don't, the paper charts don’t go missing a lot now that 
we’re on EPMA, but they still can. B2 
However, a possible reason for why the paper chart tended to be “lost” was 
discussed in a focus group that had paper prescribing in place. The group stated 
that the paper chart was used as a physical prompt to remind some key HCPs to 
communicate with each other or carry out a specific task. Having the paper chart in 
a specific place encouraged members of the MDT to review or discuss specific 
things that were needed to carry out quality patient care. This then raised concern 
about losing that physical prompt when an electronic system was used. 
Nurse: Yes we leave them (paper drug chart) out for the doctor, you know, if 
when they need to rely on our, they need their warfarin prescribing then it will 
be left out or if they're waiting for something to come up or if something’s 
been prescribed at three o’clock for the afternoon, you know. Pharmacist: And 
also if I'm working on the wards I might have two or three waiting to go to the 
doctors and speak to them about all three at once …C2 (same focus group) 
The HCPs nevertheless believed the time and frustration saved by not having to 
track down a prescription was a huge advantage. They reinforced their frustrations 
of not having the paper prescription chart available, which caused delays and 
inefficiency when trying to locate it. Having to-rewrite the prescription, if it could 
not be located, also led to patient safety concerns.  
Doctor: you don’t lose the drug charts [with EPMA}, which can be an absolute 
[with paper-prescriptions]. Which can be…really compromise patient care if 
somebody has been titrated on a dose and nobody can quite remember what 
it was? Pharmacist: Yes big-time…And the medical notes don’t document the 
medication changes or whatever so…A1 
However, the need for a reliable and accessible EPMA system was stressed, in order 
to avoid the prescription being “lost” on the computer. If the ePrescribing system 
was not accessible, it would be pointless, as this could cause further disruption to 
clinical workflow. 
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Doctor: The thing with paper drug charts is, I’ve said we get pulled to re-write 
them all the time, maybe they’ve finished or they’ve fallen apart or they're lost 
or they’ve been lost somewhere, whereas this one's just going to be available 
on the computer, but then obviously you have to make sure it’s a reliable 
system you're using otherwise it’s just pointless C1 
The HCPs using paper charts deliberated that by having an electronic chart the 
prescription would be reviewed more because it would be more accessible. 
Increased accessibility could help key HCPs working practice, especially if the EPMA 
system facilitated more than one HCP to view the prescription at the same time as 
another HCP. However the ePrescribing system in hospital B did not allow more 
than one HCP to view a patient’s prescription at the same time as another. 
Doctor: So you've got a problem you can only have one person looking at the 
(paper) chart at a time generally and then first thing in the morning doctors 
try and do their round, pharmacists try and do their round, nurses try and do 
their drugs, it can’t be with everybody at the same time…So don't know 
whether you can access electronic systems in many ways but if that’s the sort 
of thing that C3  
The extent and detail of prescription review were considered. A paper prescription 
chart, due to the fact that it can require re-writing, can get a detailed review during 
the re-write. With ePrescribing the practice of re-writing a prescription is no longer 
necessary, yet having constant access to the prescription, some HCPs felt they 
looked at the ePrescribing system all the time, even when it was not necessary. This 
was because HCPs were concerned about missing any changes that may have 
occurred, that they were not necessarily informed about by their fellow HCPs. 
Pharmacist : you can feel like you should be checking them [ePrescribing] 
more because they're there and available erm and because things do appear, 
whereas before if the nurse needed something they’d ring and if I'm not here 
they’ll bleep me to go and get it whereas because it’s done on the computer… 
B2 
The reliability of the EPMA system was highlighted by the ePrescribing focus groups 
when comparing a situation of having a “lost paper drug chart”. Examples were 
given providing first hand insight into the frustrations of hardware difficulties 
affecting medication ward rounds, delaying patients receiving their medications. 
This showed how important it is to have a reliable system, to prevent delays or have 
a prompt response to any hardware difficulties as soon as they occur. 
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Nurse : If a cart [computer] goes down it’s gone down for everybody and 
you're screwed because IT [Information Technology] take at least an hour to 
look at the problem so you know that’s your, all your meds having to wait an 
hour and you're way behind time and it’s some (patients) on antibiotics and 
even though they say you can print it off you've got to go to a cart that's 
working and access a printer that’s working to print off all your meds for all 
those patients which is like another half an hour, hour possibly on top of that, 
so that is a problem B1 
One of the EPMA Trusts did not allow multiple concurrent accesses to the EPMA 
system, which meant that a patient’s record could only be viewed by one HCP at a 
time. This limited access to the prescription even more than if paper prescribing 
were still in place because HCPs found that they could not access a certain patient’s 
prescription at all if somebody had not logged out of the system properly leading to 
confusion about whether another HCP is looking at a patient’s prescription or the 
system was “locked”.  
Doctor: The difficulty with computers is that if someone else is accessing it 
then you can’t look at the [prescription] .Pharmacist: I don’t know if that’s 
happened to you but it happens a lot (laughter) patients can become locked, 
as in the programme didn’t close properly when the person last looked at it 
and it thinks somebody's still looking at it so it won’t let you in. Doctor: Okay I 
always think somebody else is still looking at it (laughter). B3 
Access issues, to the EPMA system in Hospital B and specific patient’s prescriptions 
have caused long delays. The HCP has to ring the Information Technology (IT) 
department and invariably wait in a queuing system to explain the situation. Once 
they speak to IT staff, they have standard responses of “have you waited 20 
minutes?” HCPs have learnt to say yes to this question so they do not have to wait 
20 minutes to access the information and continue with their work, causing a 
“workaround” (where the user, in order to get the task done will not necessarily 
follow the intended sequence that was originally set up). This situation has actually 
added to access difficulties with the EPMA system and caused many delays in HCPs 
working practice. 
Other issues of access to the prescription were discussed in the EPMA focus 
groups, such as lack of computer availability, or not logging out of the system 
before changing location. Not logging out of the system then stops the HCP logging 
onto the system in a different location. This shows how the system and HCP can 
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affect each other to provide the same outcome of not being able to access the 
prescription. All of these situations would require the HCP to change their physical 
location, in order to obtain a solution to the problem and continue to carry out 
their work. 
Doctor 1: It’s an absolute nightmare on call because you are not in the same 
working place…you are on different wards all over the shop so if you forget to 
log out, then all of a sudden I’m powerless Doctor 2: It’s like taking your pen 
away isn’t it! A5 
The repercussions of not having a prescription available were discussed. Patient 
safety and efficiency issues occurred such as delays to all HCPs carrying out their 
work, minimal reviews of the prescription on ward rounds, patients not receiving 
medications on time, and re-writing paper prescriptions without detailed 
documentation in the notes to refer to and therefore not knowing quite what a 
patient was previously taking. 
4.4.1.2 Location of the prescription 
The location of the prescription was altered with a change in prescribing 
system. Generally with paper prescriptions the chart is kept at the end of a patient’s 
bed but with the move to EPMA the computers that are needed to access the 
prescription can be located anywhere, on the ward or off the ward. The typical 
position of the computers, away from the patient, has altered how the HCPs carry 
out their work prompting less natural patient contact and potentially missing 
important information. 
Doctor: You maybe talk about the patients drugs a little bit less with the 
patient, because you don’t have them [medications] all in front of you. So 
whereas before you might of said ohh have you been on this bisoprolol since 
you came in or did we start this you know if you’ve forgotten yourself or if it’s 
a new patient to you, then you maybe don’t ask as many questions to when 
you are at the bedside because you don’t have that [prescription chart] at the 
bedside unless you have brought a computer with you. A1 
In the EPMA trusts, the main desktop computers do not require charging and are 
therefore the most reliable; these are located at the nursing station, away from the 
patient. Other computers are available on wheels, as carts or as laptops and can be 
moved around the wards to the patient bedside. However, these mobile computers 
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need to be charged whilst not in use, and then unplugged to go around the wards. 
However, there is variability in how reliable these mobile computers are because 
the system requires staff to plug them in and re-charge them. The battery life of the 
computers can also be an issue, even if they have been charged long enough. With 
all the different types of computer available, there were still a number of physical 
barriers preventing HCPs from carrying out their work. Such barriers included 
nurses needing the prescription in the clinic room, the physical effort to move the 
computer around, and computer availability. 
Nurse: When you would be getting them [Intravenous medications] ready for 
administration you would have the drug chart there at the side of you. Now 
it’s on a computer that doesn’t fit in the clinical room so it’s outside the door… 
Doctor: Yes it’s a posing case for [hand held device] tablets…A4 
The fact that HCPs felt that they had to make an effort to take the computer on 
wheels to the patient bedside was perceived as a barrier and shows how much of a 
physical hardship it could be, potentially slowing the HCP down;  
Pharmacist: you have to make sure you make more of a conscious effort to 
make yourself go round with the trolley push it round and go and see the 
patients B3 
Concern was raised about the fact that as more medical documentation becomes 
electronic in the hospital setting; the patient contact would lessen because it would 
take a conscious effort to go physically back and forth between the computer and 
patient. 
Doctor: Now you are coming backwards and forwards for everything and as 
they move one…another thing onto electronic, you have less and less reason 
to be at the [patient] bedside and more and more reason to be away from it. 
A5 
The surgeons defined how their ward rounds differed from the medical doctors, 
citing how their patients tended to be spread out across the hospital rather than on 
one ward. The situation does not encourage the use of computers on wheels; things 
are slowed down even more with difficulty in gaining computer access and logistical 
issues. 
Doctor: Well [pause] we don’t, we don’t do a round with a, well certainly my 
[surgical] team, don’t do a round with a computer unless we have got just lots 
of patients on one ward where, otherwise it does tend to slow things down. A4 
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The medical teams, being normally ward-based, were more likely to use the 
computer on wheels, as discussed in the medical speciality focus groups. If the 
computer were at the patient’s bedside, it would change patient contact and 
ultimately patient centred care. It was considered in the focus groups that when 
the HCP and the computer are both at the patient’s bedside, patient-centred care is 
more likely to take place effectively. Either way, a culture of not having the 
computer at the patient’s bedside along with the HCP was perceived to be 
developing in both the EPMA trusts. 
HCPs felt that being able to discuss with the patient their medications provided 
them with information about any potential concerns the patient may have and 
could reveal any patient safety issues. In addition, the patient can be informed 
about their progress on and experiences individualised patient care. By changing 
the type and degree of patient contact, the opportunities to discover potential 
harm and provide quality care can be reduced. Even a slight distance between HCP 
and patient can be enough to hinder communication. 
Pharmacist: Because I used to see every patient every day because that’s 
where I went to go and speak to them and talk to them and quite often it 
would be the patient that would tell me why things had been changed 
(laughs) erm and I don’t get to do that anymore. B2 
Doctor: I mean I know that it’s a problem on written prescribing as well, you 
can still get it wrong, but if you have got a card in front of someone you can 
definitely, you’re more likely to check with them than you are if you are 
prescribing even 20 meters away that they are not allergic to anything and I 
think that it…I don’t know. A1 
Ultimately the solution to having more patient contact, as discussed in the focus 
groups, was to bring the computer system back to the patient bedside. Suggestions 
made included hand held devices. 
Doctor: Bringing the computer close to the patient will always be...any 
solution that brings the computer to the patient is going to be more effective 
than, whether it be a tablet [hand held computer device] or a lap top. A4 
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4.4.1.3 Accessing the prescribing system remotely 
Remote access allows the HCP to view and change the prescription at any 
computer within the hospital or off-site if the EPMA system is installed on the 
computer. When on call during unsociable hours, staffing levels of HCPs are 
minimised and therefore staff have more patients that they are individually 
responsible for. This can lead to doctors covering several different wards creating 
logistical difficulties. Having remote access was seen as a double-edged sword by 
the HCPs because it was perceived to save time and improve efficiency by enabling 
them, especially when on call, to advise or prescribe whilst in a different location to 
the patient. Yet, they were also very cautious about how remote prescribing was 
used, potentially causing patient safety issues and ultimately it could facilitate going 
against GMC advice to have adequate knowledge of the patient’s health and that 
the prescriber is satisfied that the medicine serves the patient’s need (12). 
Doctor: The thing about remote prescribing that it is a big advantage but to 
everyone; nurses, doctors, patients when you are on call, that you can just 
prescribe a pain killer or something when you are on a different ward. A1 
Nurses felt that it had saved them time as they no longer had to go looking for the 
doctor to get a medication started or changed to facilitate patient care. 
Nurse: Yeah it’s great for on call as well if you're on another ward you can 
explain exactly what you need for the patients and it can be done pretty much 
the same, no running round looking for the doctor to go and do it because it 
can be done. B1 
The ability to access the system from home when on call and see everything whilst 
not in the hospital has enabled the pharmacist to follow up on advice they have 
given to the HCP requiring advice. They can check that there were no 
misunderstandings and that the HCP followed the recommended advice. This also 
facilitated the pharmacist’s work, enabling them to stay at home wherever possible, 
rather than attending the hospital in the night. 
Pharmacist: it’s especially convenient when you are on call and you give 
advice over the phone and then you can check up the next …even like at home 
you can check up to see what has been done and uhh…it’s really really 
beneficial on call especially when you are not in the hospital and you can see 
everything. A1 
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 Prescribing remotely raised safety concerns with doctors and pharmacists 
about not seeing the patient before prescribing or advising. All the focus groups 
acknowledged how important patient contact was in order for HCPs to carry out 
their job to the best of their ability and provide compassionate care. One doctor 
described how he prepared for ward rounds, looking through the patient notes and 
considering the next step regarding medication, before seeing the patient. However 
it was explained that the initial plan, prior to seeing the patient can all change once 
the patient has been seen. 
Doctor: You can probably make a very considered decision and think this is the 
right thing [medication] but I can’t tell you how many times I changed my 
mind after looking at the patient. You do your ward round work up and you 
think I’m going to go and see him and I will prescribe this, you look at the 
patient and you think I couldn’t be more wrong and change your mind. You 
need to see them [patient]… A5 
Pharmacists explained how they were the second check on prescribing and 
therefore needed to see the patient in order to carry out this second check 
competently. Concern about the patient becoming “something on the screen” was 
explained. 
Pharmacist: The second check of the prescribing is the pharmacist and they 
should actually be seeing the patient because you pick up so much from just 
seeing the patient, never mind talking to them, erm so I think there is a danger 
that they [patient] become something on the screen and they pass through 
the system and you never see them and you think ‘that’s not my job’ you know 
‘I'm just dealing with the drugs’. C2 
With remote prescribing or clinical review, a patient’s medical notes or other 
medications prescribed on paper are not always available, leading to an incomplete 
patient history when making a clinical decision.  
Doctor: Being able to prescribe remotely is useful sometimes, but you just 
wonder if that brings in another element of risk don’t you? If you are on the 
end of a phone and you don’t have access to notes… A2 
Pharmacist: A lot of them [pharmacists] will do a full drug history and umm 
full care plan from their office rather than on the wards, so they have no 
medical notes A1 
Not having the medical notes at hand could also lead to the clinical decision about 
the patient not being documented in the notes or at least the relevant 
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documentation being delayed. This was also considered by the focus groups that 
had paper prescribing in place as a potential patient safety issue with EPMA.  
Pharmacist: The only thing is though, could you then access when you're 
looking at from a distant place [remote prescribing], so you're therefore then 
not looking at the patient or the notes.C3 
The lack of experience of some junior staff to not question what is being asked of 
them was cited as another concern regarding remote prescribing. Thus making all 
staff aware of the pitfalls of not examining the patient or not accessing the relevant 
medical notes needs to be reinforced by the Trust. Safeguards need to be put in 
place, such as preventing pressure being put on staff to make a clinical decision 
remotely or to prescribe without all the necessary information, along with a culture 
of “patient safety” awareness. 
Doctor: Again about the laziness, possible ways with long range prescribing 
and I think it’s definitely a good point that junior members of staff might be 
more inclined to just write up whatever is asked of them. A1 
Doctor: Sometimes I think that’s a bit of a double edged sword is that you can 
get asked to prescribe things when you are distant to the patient and when 
you are on call, it can be helpful if it’s appropriate, but occasionally there can 
be pressure to do things…because you have that ability you have to guard 
against it. A5 
Pharmacists stated how remote access had enabled them to follow up on 
outstanding queries and that previously this would not have been possible, yet, this 
had led to less patient contact. The concern by one pharmacist that they may be 
isolating themselves from the ward and the MDT team was very poignant. 
However, it was perceived that other pharmacists outside of the MDT team might 
not have the same viewpoint and that the lack of time on the wards was perceived 
to be promoting laziness. A cultural change may be emerging with the arrival of 
EPMA systems that must be considered and highlighted before compassionate 
patient care is compromised. 
Pharmacist: I’m just conscious that I don’t want to lose the patient [contact] 
and the communication with the team because I… I’d much rather be involved 
with my team and discussing decisions, so I like to be on the ward and be 
involved in that. A3 
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The focus groups conducted in Hospital C with a paper prescribing system in place 
discussed how remote access to patients’ prescriptions could be an advantage 
during staff shortages, enabling a pharmacist to review all the medications of each 
patient without having to physically be on the ward or see the patient. However the 
pharmacists still acknowledged that remotely accessing the prescription would take 
them away from the patients and wards but that the way things were changing in 
the NHS, it might be necessary even though patient-centred care was a priority. 
Pharmacist: I think it would help us in a way if we were really short staffed 
because it could, we could get to the point where we've got a lot of people off 
sick, we can’t see every patient every day, and if that were the case it would 
be really good because we could see how patients were being updated, erm 
what the doctor’s changed and we could see that from a distance if we 
needed to. I think that would be a really beneficial thing for us, not that we 
would want to move away from it [patient], move away from the wards, but 
it’s getting to the point soon where …C1 
 Clarity of the prescription 4.4.2
The sub-theme of clarity of the prescription considers and describes how 
the legibility and design of the prescription chart impacts on its clarity, whether it is 
a paper or ePrescribing system and therefore influencing how HCPs interact with 
the system.  
4.4.2.1 Legibility 
The EPMA system was perceived as a great improvement now that the 
prescription was legible. Being able to read the prescription without having to try to 
interpret the prescriber’s handwriting was discussed in all the groups and that 
taking away the inconsistency of prescribers’ handwriting was one of the main 
drivers for patient safety and the EPMA system. However, the uniformity of 
computer text was considered so clear, in some cases, that it could be overlooked. 
Nurse: I think (biggest change) accuracy with the written aspect because there 
are so many doctors with bad handwriting and, you know, the interpretation 
of the prescriptions.” C1 
Pharmacist: I think actually one thing about handwriting as much as it’s not 
always clear there is something distinctive about the shapes whereas it’s all 
typed in block you can sometimes just get reject. B3 
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One nurse felt that by being able to read the EPMA prescription clearly, he/she 
could be sure that the patient would be given the medication they should be given. 
This then raises the question about how much trust the HCPs can place on the 
information provided in the electronic system when the information provided 
within the system is still open to human input error.  
Nurse: I think er reading the [EPMA] prescription would be greatly improved 
erm and being sure that you're giving what should be given C2 
Key HCPs discussed how the prompt they used to have with the prescriber’s 
handwriting, such as hesitation in the writing, has been lost. These were perceived 
as warning signs or safeguards that came with illegible handwriting that regrettably, 
for patient safety, are no longer available with the EPMA systems. It was proposed 
by the HCPs that the errors in ePrescribing are quite convincing and that they were 
not as obvious.  
Pharmacist: With EP the errors are quite convincing as well, they are not as 
obvious because you could…when with handwriting you could kind of spot 
that they really didn’t know what they were doing because it was like illegible 
so you were then going to the notes to try and decipher what was actually 
said on the ward round but with EP because it’s clear and legible in there its 
quite convincing that that is actually an instruction as to what you want. So 
before they used to kind of smack you in the face, the errors and knew it was 
quite obvious, now they are very subtle and it is looking out for them A3 
The ePrescribing system was also seen as possibly facilitating prescribing error, as 
the system could provide prescribers with lists of possible medications that a 
patient could be taking. 
Pharmacist: If there was something written down and they didn’t know what 
it was then that's not given, but if a doctor thinks ‘oh well actually the patient 
said this it’s probably this’ then they can match a drug to it, even if it might be 
the wrong drug they might pick it. Whereas before they would have written 
down this incomprehensible thing and it would never have got given, so there 
has been that as well. B2 
4.4.2.2 Design of the prescription 
HCPs who worked with the EPMA system on a regular basis commented on 
how the layout and view of the prescription in EPMA actually hindered their work 
rather than facilitated it, so it is important to get it right. The design of the paper 
drug chart was considered more favourable for HCPs’ working practice needs. The 
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amount of information provided on each screen was considered too much and 
distracted from the important information. 
Doctor: there’s so much more going on, on that screen, isn’t there, you know 
sometimes the most important information doesn’t jump out at you; you have 
to go looking for it…A1 
The display and order in which medication information is provided in EPMA can 
change within the system, with medications appearing in alphabetical order or in 
BNF category order. This can hinder HCPs ability to recall what medications a 
patient is taking, therefore hindering their capability to memorise medications 
when navigating between different screens.  
Pharmacist: I find it a lot harder to see on EPMA, than it is on a drug chart and 
I find it harder to remember what a patient is on because it all looks the same. 
Also because, depending on whether it comes in the order of the BNF or 
whether you have got it set to drug name where it comes alphabetically, it can 
look different each time. B2 
The paper prescription chart provides medicines information chronologically and so 
facilitated the prescribing story that members of the MDT referred to. 
Pharmacist: The good thing about the drug charts were that you could sort of 
see the little story as things were prescribed and the sort of date order…you 
could see in one place what's been given. B3 
Generally, the willingness of staff to engage with the EPMA system is increased if it 
is easy to use. The user friendliness of the system was important to the HCPs stating 
that a more up to date, snazzy and appealing system would motivate staff to 
interact with the system more. 
Doctor: It’s taken a while to get used to the system, the system is laborious, I 
do like Mac and windows based systems and something that looks like a 
zooped up dos is always a bit of a hard task, especially when the acronyms 
have been designed by the person who did the programming rather than the 
doctor. A4 
HCPs felt that their ability to perceive risks with the medication and get a clear 
picture of what medications a patient was taking had been reduced due to the 
layout and intricacies of the system.  
Doctor: I still like looking at a prescription chart and that’s my big bug bear 
with EP is that I can’t actually easily, see what they [patient] are on and when 
it was discontinued and how long have they been on the antibiotics. I’m not 
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happy with the view of the system…So I still hark back to some of the 
simplicity of looking at a [paper] chart. A3 
General comments were made about the overall system along with more 
specific difficulties that were encountered. These included small screens, navigation 
required between multiple screens, lists that cause difficulty in distinguishing 
medications, the dose a patient should receive, the number of warnings that 
appear and the use of different colours. 
The size of the screen reduced the clarity of the prescription and did not make 
the EPMA system user friendly; this was commented on in all the focus groups with 
EPMA in place. Each EPMA system provided a small display of the electronic 
prescription chart, which never completely filled the computer’s visual display unit 
for the HCPs to view and interact with, in order to get the vital information that 
they needed. This required the HCPs to pay attention, so as not to miss something, 
which can be difficult in the healthcare working environment full of interruptions. 
Doctor: It does give you the feeling that you are trying to run a hospital 
through a letter box…and you have got this massive screen [visual display 
unit] in front of you A5 
The EPMA systems rely on HCPs having to view and remembering to review 
different screens to get the full medication information they require. This was a 
concern that, during busy working periods, the different screens may not always be 
viewed and having to navigate through the screens had slowed the HCPs down. The 
time it takes to review the prescription compared to the paper system is potentially 
inefficient and has implications to patient safety.  
Pharmacist: I find it takes a lot longer than what erm than when I used to do it 
because like I say it’s having to look at many different screens to get the same 
information as looking at one chart. B2 
Pharmacist: I think it slows you down and you’re definitely more conscious of 
(pause) looking at…because it’s…the EP screen that we have, doesn’t tell you 
all the information so you have to go into a different screen to find out the full 
information A3 
Specific examples of detached information in the ePrescribing system were 
recognised as causing safety issues, the MDT members provided in detail some of 
the issues encountered. For example, not knowing if a course of steroid medication 
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was stopped abruptly or tapered, at a glance, could cause clinical issues and harm 
for a patient. 
Pharmacist: You have to go to different screens each time with EPMA, to know 
where to look sometimes and also if things get stopped it’s harder to see, like 
if somebody stops a steroid course suddenly. You would of seen it on the 
[paper] chart it’s been stopped, but you have to remember to go to 
discontinued drugs and that could be something that you don’t always, if 
you're busy, you may not do… every day or time B3 
Different screens within the same software could not be viewed at exactly the same 
time. This had led to key HCPs needing to remember information between different 
screens, resulting in an increased cognitive load, which can be difficult and lead to 
error in times of stress and high work pressures. 
Doctor: When you get that list of medications like you know came in and not 
prescribed you have to (laughs) have to close down that notes window to 
prescribe one medicine and then go back to it. B1 
The medications appear as a list to the doctors and pharmacists in both EPMA 
systems. This had caused difficulty in deciphering and distinguishing each drug, to 
ensure they are appropriate for the patient. For example, Stat doses (one-off doses) 
for patients appear first in the list of medications and are thus not always relevant 
for review (Figure 2-1). This means that the HCP then has to scroll down the page to 
find the regular medications which are in the same colour and font as all the other 
medications.  
Doctor: Drugs are classified as regular orders, prns [as required], Stats, aren’t 
they pretty much and they come in the order probably Stat, prn, regulars I 
think don’t they. It’s difficult to remember that in your head though, so you 
look at the screen and you see morphine, morphine, on the top and zopiclone 
plus a lot of morphine and it takes a few minutes, every time I look at the 
screen to realise that there the ones that have just been given last week and 
it’s not relevant anymore. A5 
Pharmacist: That is interesting because that is one of the problems that I have 
noticed a lot, is that the first screen you get is rubbish, then you have to go 
through all that to get to what you actually want to see. A5 
HCPS explained that in Hospital A, it was difficult to scroll through the medications 
and get to the specific medication that they wanted to view. The EPMA system did 
not permit them to page up or down the screen, instead they had to scroll through 
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each individual medication. This had led to delays in clinical workflow, causing 
inefficiencies for HCPs.  
Doctor: So you are trying to scroll through it [medication list] all and you can’t 
just page up or page down. Pharmacist: Oh yes it won’t let you do page up or 
page down… Doctor: So you can’t jump down a whole screen and yes and tap 
all the way through and then you miss one and it goes off and you try and go 
back up and it freezes … 
Medications that have been administered, but not officially discontinued on the 
EPMA system can still appear, leading to delays and possible mistakes in 
administering the right medications. 
Nurse: the admin chart, but then you can have drugs that have been 
prescribed for three weeks that have been stopped and finished and you might 
take twenty minutes to find the medication that you want.B3 
Pharmacists have taken on the responsibility of trying to tidy up the Stat doses to 
help reduce the number of medications that need scrolling through, before a 
medication review takes place. This has added to pharmacists’ workload, in order to 
improve the efficiency of other colleagues working practices. 
Pharmacist 1: We keep on top of that [discontinuing Stat prescriptions], but on 
all the other wards, surgical for instance, they do a lot of stat doses; you can’t 
always keep on top of every patient every day. Because that’s a waste of time, 
and then you get them being given again and then that’s an incorrect 
administration. Pharmacist 2: and I’ve made, (exacerbation) I’ve gone thinking 
I am tidying up the prescription and ended up stopping stuff that hasn’t been 
given.A5 
The dosing information of drug strength and the total dose a patient should receive 
caused “confusion” when viewed by doctors and nurses; they recognised that this 
could lead to potential prescribing and administration errors.  
Nurse: The EPMA system here compared to my old one, you have like the dose 
that it will come in but then like the patients’ dose and I found it really difficult 
not getting them confused. B2 
The dosing information within the two EPMA systems in hospitals A and B is not 
displayed the same way as on a paper prescription or compared to some other 
EPMA systems. It was perceived that the dose in the EPMA system was set out in 
that way to facilitate pharmacists, rather than other HCPs.  
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Doctor: its apparent what drugs they are on but it’s quite difficult to look at it 
and just see how much of one drug they are taking… it’s not how I think about 
drugs, it’s not how its laid out, its laid out how a pharmacist thinks about 
drugs to me (all laugh loudly) A5 
The numerous warning signs that come up in both the EPMA systems have led 
to HCPs overlooking the important warnings, leading to what is termed “warning 
fatigue”, especially as the amount of reported warnings could sometimes go “off 
the page”. This was discussed within the focus groups, how imperative it was that 
important warnings needed to be more refined. 
Pharmacist: Basically It’s the same box comes up for allergy and duplicates 
which I don’t think is a good idea I don’t think because it should be a different 
box for allergies. Doctor: It needs to be a big red box which you can’t ignore. 
A1 
The different EPMA systems presented the same vital information; by utilising 
different colours in one of the systems, it had alerted the HCPs more. However, the 
frustration of many HCPs was that there did not seem to be any rationale for many 
of the warnings, which had led to the overall practice of ignoring them.  
Doctor: With the very small window that’s the point there are so many 
interactions that come up that you have to scroll down to some that are off 
the page and I think it’s the red ones come to the top no matter what which is, 
you know, a good feature of the programme but it’s to the point that you 
don’t look at them because so many come up that you know are actually the 
intended benefit of the medication. B1 
The use of different colours visually facilitated the HCPs view of the prescription, as 
discussed earlier with warnings. Although, alternative colours such as “green” led to 
difficulty in reading the information, and had been relayed back to the EPMA team. 
However, feedback that the HCPs had received was that the system was too old to 
change the green colour. This had reinforced the HCPs perceptions that if they did 
feedback any design concerns, they could not be acted on anyway. 
Nurse: I know a lot of people have said the same thing; it’s that the green 
background but apparently the programme that’s been written is so old that 
they can’t change it. The language doesn’t exist anymore to change the 
colouring of the background which is probably not great (laughter) B3 
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 Operating the system 4.4.3
Operating the system considers the training and experience required by key 
HCPs to operate the prescribing system to the best of their ability. The training 
provided is imperative to enable the multidisciplinary team to provide quality 
patient care. If the training is not fit for purpose and then HCPs are required to use 
the prescribing system, patient safety issues can become a major concern. 
Operating the system can be difficult for staff who are not comfortable with 
technology and are not necessarily computer literate as well as agency staff who 
have possibly not had the training needed to provide quality patient care. 
4.4.3.1 Training 
All staff need training in order to use the EPMA prescribing system. The paper 
prescription chart was thought, within the focus groups, to be understandable and 
therefore structured training in its use was minimal. The fact that the knowledge of 
how to use the EPMA system has to be provided and maintained was seen as an 
extra time burden but that it was necessary, as it is not something that should be 
guessed in order to operate the system.  
Doctor: It is an extra amount of time and work just to learn it and then it’s a 
laborious system so there is much more work involved in “IT” (Information 
Technology) than paper prescribing. A4 
The system and the information within that system is only as good as the data that 
are put in by the operators. That is why it is essential to provide quality training in 
order to prevent prescribing errors, or the wrong information being communicated 
between HCPs and the patient. All the focus groups mentioned and acknowledged 
how important training was before using any EPMA system. 
Doctor: You can find the information you need on the prescribing system. It’s 
just knowing where to look with it, with the prescription chart you didn’t need 
training for that, you didn’t need to be told and you have to retain that 
information…A3 
The training of staff in order to operate the system effectively varied between 
different professional groups (doctors, nurses, and pharmacists) and Trusts. Each 
Trust had a “compulsory” training course in place, but this was not always 
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perceived to be the case regarding doctors that were more senior. It was felt by 
some focus groups that senior prescribers had not attended the EPMA training 
course and that there should be no exceptions. It is important that senior staff lead 
by example; they are responsible for the development of junior staff and their 
training, which would include prescribing. Senior doctors should be involved in 
using the EPMA prescribing system and encouraging their junior staff. 
Doctor: I think they (consultants) don’t, I don’t know how much training they 
received, I think it was sort of more up to them whether they went. B2 
However, it would not be unreasonable to assume that senior doctors have 
attended the compulsory training for EPMA but that their ability to prescribe is 
impacted by irregular use. 
Doctor: I was half an hour late for a ward round because I had to do 
something first and the consultant was still on the first patient trying to figure 
out how to use the EPMA. B1 
The training of nursing staff also differed between Trusts. Nurses at one Trust 
were always given standard training by the EPMA team, but new nursing staff 
members at another Trust were trained on the job by nursing colleagues when they 
started. This, however, had jeopardised the training quality as there was no time 
allocated to train new nurses, along with potentially passing on bad habits and 
workarounds. 
Nurse: I mean they don’t have training now, the new nurses…we have to teach 
them now, they don’t go. Somehow we are meant to fit it in but we don’t. 
(Uneasy laughs) A2 
Each profession had their own specific training within each Trust in order to 
focus on the part of the EPMA system they would be using the most. MDT members 
highlighted that even though they all use a certain part of the system, it would be 
beneficial to be able to navigate their way around the whole system.  
Doctor: the doctors were never really told from the nurses point of view, 
sometimes if you like there's certain things like nursing staff can’t give like IV 
Morphine and like I'd have to do it myself on the system so we like you kind of 
have to learn on the job how to chart medications and how to transfer 
patients and put things on the ward we were never formally taught that. B1 
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Training on how to use the whole system would enable HCPs to have an awareness 
of what their actions can have, on the work of other HCPs. Pharmacists stated how 
they use the EPMA system nearly all the time in their job role, yet their training 
seemed to focus specifically on a combination of doctor and nurse training. 
Pharmacist: There's not actually a pack. Yeah ‘cos yeah when we went to that 
training with the EPMA team they had the nurses pack and the doctor’s pack 
and it was where’s the pharmacist’s pack? and then it was like ‘you look at the 
yellow screen which is what the doctors use’ so we kind of use that a bit more 
but not completely erm and then it was just a lot of playing around really 
because we kind of we discuss between us in the department don’t we you 
know the different ways we go round things. B1 
The training sessions were described as “painful” and “complicated” and generally 
did not fulfil the needs of the staff so that they could go away and use the system 
with confidence.  
Doctor: It (training) was painful (Laughs)…I think its standard IT training 
where you spend about half an hour learning how to log on and then the 
actual…B3 
Nurse: I think the training made it more complicated…You came out of the 
room thinking ‘oh my good God this is going to be a nightmare’ and then 
when you actually were there and using it this is ten times easier B3 
The format of the training and how beneficial it was for each HCP was discussed, 
highlighting what could be improved in future training sessions in order to provide a 
better understanding of how the system works and acknowledging safety concerns 
with any new system. Opinions raised about new systems would support having a 
national EPMA system, which, as proposed with a paper prescription chart would 
facilitate training and minimise patient safety issues.  
Doctor: When you start in a new place you are probably in greater risk of 
making an error and if you are using a new computer system that’s probably 
particularly true and I don’t know how good the computer training actually…I 
mean it’s alright but I’m not sure it’s that good at identifying the areas where 
your most likely to make a mistake when you first start and I think that all the 
computer training I’ve had has never really said yes this is where you will 
make an absolute mess out of…so watch it A1 
HCPs stated how they had gained experience with the system and that the 
information should really be utilised to inform further training in the future. The 
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need for follow up training sessions after the initial one was reinforced when 
members of the MDT were discussing how they taught themselves. 
Doctor: It (training) was lengthy and it was a bit sort of painful to be honest 
sitting through it and it didn’t...all of the things that were discussed in that 
session were things that I could of figured out for myself, whereas there were 
other little things like dating and dosing and all that stuff that have taken a 
little longer to try and figure out…I think all the issues that um are problems 
you just come up with to figure out for yourself and ask each other A1 
The amount of support each profession had after IT training also varied, doctors, 
nurses, and pharmacists within the same focus group gave different accounts of 
their follow up after training. The nurses had been informed of somebody coming 
around their ward a couple of hours each morning if they had any further questions 
about the EPMA system. The pharmacists mentioned the EPMA pharmacists that 
were contactable if they had any queries about the EPMA system and the doctors 
figured it out amongst themselves.   
Doctor: It’s very different I think when you get trained in a system and then to 
actually go and use it. You almost could of done with follow up, you know 
someone coming round, coming to the ward and asking if everything was OK 
or if you were given an opportunity like that then perhaps more things could 
have been resolved. A2 
A good safety culture needs to be provided by the staff members who provide 
EPMA, explaining what the EPMA system is able and unable to do. The staff 
providing the training must also consider the importance of each individual training 
session in its own right, to ensure sufficient training is given to new staff. This will 
hopefully ensure that substandard training does not happen and does not have a 
knock on effect for future patient care. 
Doctor: Well you feel like the training session was very, very quick and the 
people giving it were very keen on saying let’s try and get this done quickly so 
we can all go home and so they burned through everything and every 
individual step wasn’t too complicated to learn…there was so much of it and 
then we all had to sign a form saying , yes I know how to do this, yes I know 
how to do this and it wasn’t, so then that’s taking the liability out of their 
hands. I’ve said yes I do…and I’m filling this in and I was kind of shell shocked 
afterwards, just thinking do I remember to do all that now…A4 
When probed about who each HCP went to if they were having difficulty using the 
EPMA system, some did not have a definite answer, but the HCPs thought of the 
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pharmacist, rightly or wrongly, as a key person to help them out with the EPMA 
system.  
Doctor: We tend to urm; my experience with our F1s is we tend to ask the 
pharmacists, urm because they know all the features of the EP quite in depth. 
Pharmacist: You perceive us to know! (All laugh). A3 
One of the focus groups in the Trust without EPMA in place acknowledged how 
there should be a central person who is responsible for training and support. It has 
been previously noted that across the NHS, there is a culture of not making a fuss; 
staff grumble to their colleagues about specific issues but do not report them until 
they become critical (20). EPMA-support staff must be identified and their details 
incorporated and clarified throughout the training sessions to ensure HCPs feel they 
have the support going forward once they have completed formal training.  
Nurse: I think from my point of view in that situation I didn’t actually know 
who to go to. Like if you have a problem with EPMA, do you go to pharmacy? 
Do you go to the pharmacist? And I think that’s a little well, from my 
experience that’s a bit of a grey area and no one really knows who to go to if it 
goes wrong like that. A2 
Even after having training on the EPMA system, one doctor did not feel confident to 
use the system and called upon pharmacy to take them through the process. 
However, this shows how important it is to have the support in order to provide 
safe patient care and not to be left having to decipher the system like other HCPs 
were potentially doing.  
Pharmacist: They (anaesthetists) would phone pharmacy and they would 
demand somebody went up there (theatre) to hold their hands to prescribe, 
which you could say is right or wrong but at the end of the day they knew how 
to ask and it was safe, they weren’t just using the system blind. A3 
It was pointed out that poor training was how bad habits and workarounds were 
introduced into the system. Because if a HCP is not taught correctly the first time, 
the correct course of action will not happen and ultimately it is the patient that will 
be affected. 
Nurse: Its getting into the right habit when you first start and if people are in 
training and they don’t get taught to write “drug unavailable edit text, this is 
what you have to do next”, then they will just keep doing drug unavailable 
and it’s your patient that is the one that loses out. A1 
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 However, it came to light in the focus groups that most of the pharmacists, 
except for those on the EPMA team, had been given the same training as the 
prescribers on the EPMA system with a limited amount of specific pharmacist 
training. Therefore pharmacists were advising HCPs in an area that they did not 
necessarily know themselves, and had taught themselves about prescribing on the 
job along with understanding the prescribing system for their own use.  
Doctor: I'd contact the pharmacist if I don’t know, because they seem to know 
more about how to work EPMA than me to be honest. Pharmacist 1: Yeah I 
get a lot of queries about it, I'm happy to help them but actually we don’t get 
any training how to prescribe. Pharmacist 2: A lot of our training is on the job 
and then I feel like sometimes if I don’t play around with it I don’t know like ,I 
don’t know you know I need to play around with it so I can tell people where 
to look and stuff. B1 
4.4.3.2 Agency Staff 
 Agency Staff, both doctors and nurses, were discussed regarding their lack 
of training on the EPMA system. This meant they could not use the system at all, 
leading to many knock-on effects on the working practices of fellow colleagues. 
Resentment toward agency staff was noted in one of the focus groups, as it was felt 
that having agency staff was a bit of a “nuisance” and that it “doubled the work” for 
regular staff. Prescribing on behalf of the locums was also mentioned, which could 
lead to legal and ethical issues, along with faults in the EPMA audit trail. 
Nurse: they can’t use EPMA a lot of agency staff trained nurses so they use 
downtime…Which is a bit of a nuisance especially for the other staff nurses on 
because it’s more or less double the work for them to do. A4 
Doctor: There is always a lot of issues with like locums as well because they 
don’t always have these sign in, so that’s an issue where, you know, they can’t 
do their prescribing jobs, they have to wait for the next person B2 
4.4.3.3 Computer Literacy 
 In one of the focus groups, it was felt that they were “quite an electronic 
literate group” and one specific participant thought that “everybody is these days” 
showing how sometimes it can be taken for granted that staff can use and embrace 
technology without any difficulties.  
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Doctor: I mean, I guess we are quite of sort of an electronic literate group erm 
but you do notice some…Nurse: I think everybody is these days…Doctor: Some 
people will take longer with the computer systems and be a bit thrown by pop 
ups… A3 
Thinking to the future of healthcare and how technology was advancing led to 
acknowledgment of how different generations would embrace the technology.  
Doctor: I have been using paper for 30 years then, that’s the way you set up as 
a default isn’t it…but it’s not just me, there’s other people that have made 
similar comments.…future generations are going to get much more used to 
the computer, electronics… A2 
Without regular use, it was acknowledged that efficiency was affected and that 
EPMA can be difficult to use. 
Pharmacist: I do like EP but I find it difficult at the moment because I’m doing 
a slightly different role, I’m not using EP as a pharmacist regularly, I find it 
quite difficult then when I cover a ward, to use it, because I’m not having that 
regular use. A2 
4.4.3.4 Experience 
 There is a distinct difference between training and experience of using the 
EPMA system that regularly appeared in the EPMA focus groups. HCPs reflected 
that they learnt more once they started using the EPMA system compared to the 
training they received. 
Pharmacist: the best training though is just doing it, at the end of the day. A1 
Nurse: I can’t even remember doing the training now but I think you learn 
more once you start it. B3 
Taking people’s experience of using the system and ensuring it provides further 
advantage in the future is important. It needs to be acknowledged that people with 
experience have a lot of valid information that should be embraced in order to 
inform less experienced staff how to improve patient safety and care. 
Doctor: I just think that sometimes one of the good things if you have got a EP 
system and you have got pharmacists that are used to it, is to maybe be 
compiling a list of commonly made mistakes and commonly made errors so 
that when people start using systems they are already aware of what the 
errors are rather than making them. A1 
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4.4.3.4.1 Workarounds 
  Workarounds are where the user, in order to get the task done will not 
necessarily follow the intended sequence that was originally set up; creating 
different ways of getting the same result that are not always the most efficient or 
safest routes to take. Workarounds navigate the inflexible part of the system and 
provide alternative ways of getting the job done. With experience of using the 
system, workarounds can be created when constraints occur within the EPMA 
system. The workarounds that were not taught in training tend to stay with the 
person or group that created them and as a result are not identified unless 
specifically questioned or witnessed. 
Pharmacist: Suddenly you find out that there is a whole new way of doing 
something that you know you didn’t realise…we didn’t know what it would do 
and people try different keys and try to see what happens if you press this, 
type of thing and very occasionally it produces a good result haha…(all laugh). 
A5 
Continual support by the EPMA team is required to uncover the potential 
workarounds that could be incorporated into training or may need to be 
discouraged due to the effects it could have on the system as a whole. 
Pharmacist: There's always little workaround things you suddenly discover 
and you go oh ‘I didn’t realise you could do that’…It’s like just using a word 
document isn't it? You have to understand … B3 
 Using the system 4.4.4
A lot of detail about different aspects of using the EPMA system such as 
prescribing, discontinuing and selecting medications, inputting allergies, and 
specific medication groups like antibiotics, was discussed first hand, with examples 
providing insight into specific constraints that were present in the system leading to 
workarounds and different repercussions on the HCPs working practice and 
potentially patient care. All of these situations show how using computer 
technology is not completely effective at standardising practice and eliminating 
user variability unless the system is specifically designed otherwise. 
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4.4.4.1 Selection errors 
To create a prescription within the EPMA system, several different selection 
processes have to take place. In order to select the correct patient within one of the 
EPMA systems a “black bar” is used. Thus, selection of the wrong patient within the 
EPMA system can have a knock on effect right at the beginning of a long chain of 
events in order to create a prescription. This has led to the term “selection errors” 
that can occur through human error.  
Pharmacist: The thing with EP or any computerised thing I think is picking 
errors, so you pick the wrong patient because you may not of moved your 
black bar down, you might have been looking at that one but you haven’t 
moved your black bar down to the one you really intend …it’s often when you, 
look at how they have done it, it’s the one above or below the actual intended 
one just from people’s perceptions of looking at a list of things. A4 
The phenomenon of selecting the wrong item within the EPMA system had also 
been observed in other parts of the Meditech system. For example (quote below) in 
Hospital A, microbiology eye swabs are ordered frequently on ICU, but this is not 
because eye swabs are carried out, it is because they are next to the central line-tip 
selection list in the Meditech system. This reinforces the occurrence of human error 
when inputting information into the system and highlights an issue with the audit 
trail and quantifying tests that are actually carried out. 
Doctor 1: Well that’s a regular phenomenon (in the pick list) with Meditech 
based systems anyway, if you look at the number of microbiological eye swabs 
that we do in the ITU, we don’t do any, but we have got loads of results 
coming back because its right next door to central line tip… A4 
In one Trust, medications have to be selected from a list by choosing a number that 
correlates with the required medication, rather than physically typing it into the 
system. One doctor explained that using the system had made his prescribing less 
safe due to selection errors; this was also reinforced by other HCPs.  
Doctor: It’s not safer for me because I prescribe the majority of medications 
so…I don’t write the wrong thing but I can click on the wrong thing and if I’ve 
written the wrong thing it’s because I’m stupid, if I click on the wrong thing it’s 
because I have made a mistake. A5 
In both Trusts using EPMA, the fact that staff do not have to physically type 
out the medication, can lead the HCP to not think through what they are asking the 
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system to do. For example creating a “discharge summary” or another term “To 
Take out (TTO), medications for patients to go home on were previously written out 
by the prescriber. Within the EPMA system, each medication has to be “ticked” to 
incorporate it onto the TTO. The process of going down the “list” of medications 
and ticking the correct ones has led to selection errors that can then cause 
confusion for the patient or harm if the error is not picked up before they leave the 
hospital. 
Doctor: straight down the (TTO) list and people will continue medications that 
they shouldn’t because they’re just clicking through whereas if you have to 
write it out you do at least have to think about what you are writing or at 
least I do. A3 
4.4.4.2 Antibiotic prescribing 
 The prescribing of antibiotics was focused on in all the focus groups at some 
point, probably due to external targets set by the Department of Health (DoH) (47) 
and the funding specifically set aside to improve antibiotic prescribing that had 
made it an important topic of discussion. In order, for regulation to be effective, the 
guidelines, policies, and procedures need to be followed. Due to the DoH 
recommendations regarding antibiotic prescribing (47), existing and new 
prescribing protocols were capable of being enforced by the EPMA system.  
 Protocols had always been in place at one of the hospitals to ensure that 
consultants or registrars were consulted regarding the prescribing of antibiotics and 
length of course each patient should receive. However this added to the time 
constraints and barriers that HCPs now faced using the EPMA system when having 
to prescribe antibiotics. They explained how it wasn’t uncommon that you needed 
to prescribe four times to enter a treatment course for the patient and that every 
time, extra things needed to be completed. 
Doctor: antibiotic prescribing I always say is quite cumbersome because you 
need to put in your, you have to put a “Y” in the box to say that yes you have 
discussed it with a senior, even though my electronic prescription it says SPR, I 
still have to put I have discussed it with myself (everybody laughs) and put my 
own user name in… A3 
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 The reason why an antibiotic has been prescribed is termed the clinical 
indication of the medication. The document Start Smart - Then Focus requires the 
clinical indication for any prescribed antibiotic to be documented in the notes and 
on the prescription, so that all HCPs are aware of why the patient requires the 
antibiotic and also provides an indication of potential course length (47)(48).  
 New designs on a paper prescription have enabled a box to be incorporated 
onto the antibiotic prescriptions in order to facilitate and prompt the prescriber to 
complete the clinical indication information. Hospitals have been able to audit how 
often this information is completed on a paper chart and also by increasing 
awareness of its benefits to the MDT. This information has therefore slowly been 
incorporated into the patient safety culture within the hospitals to different extents 
(Section 3.3.1.2). Once EPMA is installed it was thought that providing a clinical 
indication on an antibiotic prescription would be enforced. This, however, was not 
possible with one of the EPMA systems, underlining the differences in functionality 
between the EPMA systems thus effecting HCPs’ working practice.  
Pharmacist: I think depends if it was forced or if it wasn’t forced but you have 
to put a reason in before you moved on or whether it was optional. If it was 
good practice it probably wouldn't get done (laughs). The things that you get 
done like DVT group they all get done because there's a money incentive 
because there's people on it do you know what I mean when you're so busy 
isn't it there's often an incentive or if the screen forces you to put something 
on that’s probably the way that would … B3 
 Previous work in phase one (Section 3.3.2.1) about the completion rates of 
an antibiotic clinical indication, had been proposed with the same software to have 
become worse rather than better since moving to EPMA. The EPMA system in 
Hospital A did enforce prescribers to complete the clinical indication.  Accuracy of 
the information provided was questioned, as the drop down menu for providing the 
clinical indication was very long and had no logical order; therefore HCPs were not 
necessarily picking the correct one or putting “I don’t know”. 
Doctor: antibiotics, it’s very difficult often to find the indication that you want 
from the drop down menu...and then having to find a thing to say I don’t know 
(all laugh). A3 
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 So the quality of the clinical indication information was then brought into 
question. On reflection, if key HCPs are forced into providing a clinical indication, 
this raises the question would the information provided be correct.  
4.4.4.2.1 Antibiotic course length 
 A three day antibiotic course length can be automatically populated within 
the EPMA system or can be pre-printed for three days of administration on the 
paper chart. These design features of the prescribing systems are in place to 
facilitate antibiotic discontinuation in a timely fashion. Both paper and EPMA 
systems have their difficulties regarding this area, but ultimately it comes down to 
the prescriber putting in the right information in the first place, again showing an 
area of prescribing more susceptible to human error. 
Nurse: Initial treatment’s just three days isn't it and then it needs to continue. 
Pharmacist: But that’s because they weren't being stopped which I suppose 
could be a problem with the electronic ones couldn’t it? Just roll on until well, 
until when actually because (EPMA) drug card will never need re-writing 
(laughs). Doctor: Yeah I think as well the safety will be to sort of as you 
prescribe it prompt you to when you want it stopped otherwise you just carry 
on. Pharmacist: Yeah but the current drug card does that and nobody fills in 
the stop date. C2 
 It was considered in the focus groups, conducted in Hospital C, how EPMA 
might change the discontinuation of antibiotics, possibly leading to the prescription 
never being stopped. The EPMA systems are able to counteract the potential 
problem of antibiotics never being stopped, by utilising automatic stop dates within 
the system. However, the EPMA system may overcompensate, if the stop date is 
inappropriate, leading to patient safety issues.  
Doctor 1: The antibiotic auto stop dates…Doctor 2: That’s a minefield isn’t it, 
especially when it hits the weekend, you’ve got somebody with sepsis day 3, 
they stop the antibiotic, that’s not a good thing at all Doctor 1: No, and you 
simply don’t have time as the SHO providing the service at the weekend to 
review and continue everyone’s antibiotics, at the weekend, it’s not feasible. 
A5 
The EPMA system relies on the prescriber inputting the correct course length into 
the system otherwise it discontinues the antibiotic after three days, unless it is 
altered by the prescriber. Once the antibiotic course comes to an end the antibiotic 
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prescription drops off the screen; this can lead to patients not getting the right 
antibiotic course length highlighting a potential patient safety issue that raised 
concern in the focus groups with the EPMA system in place.  
Doctor: even though you know they (patient) are on antibiotics it drops 
(antibiotic moves to discontinued screen) off like and you don’t sometimes 
realise about it even though you want them (it) to continue (antibiotics)… it’s 
really hard to keep on top of everyone’s stop dates all the time… A2 
Solutions for the patient safety issues around automatic stop dates for antibiotics, 
such as a warning screen that “Flashes up and says you know this is due to stop in 
the next sort of 24, 48 hours and then it kind of alerts you to it” A2 were discussed 
in groups, showing that this was definitely an area of concern shared by junior 
doctors in particular. One doctor provided insight into his rationale for not changing 
the antibiotic course length when prescribing, as he was concerned about the 
patient contracting the infection Clostridium difficile and could be asked to account 
for his actions in prescribing a 2 week course of antibiotics, which was necessary for 
the patient with sepsis. This shows how outside influences and policies can 
influence a HCP carrying out their job to the best of their ability. 
Doctor 2: when you are prescribing you can’t put 14 days of Tazocin can you 
because when they get Cdiff 7 days later you’ve had it. There’s no middle 
ground. A5 
This insight by the doctor did touch on one of the drivers for antibiotic automatic 
stop dates, but as with any policy there is always a fine balance about how far it 
should go and how beneficial it is at facilitating effective patient care and patient 
safety. 
 Pharmacist: I know when we first started with EP we were hoping that 
antibiotic prescribing may eventually cut down C. diff figures, I’m not sure that 
that’s happened … I hope it’s made medics stop and think. A3 
4.4.4.3 Allergy Status 
 Information about a patient’s allergy status is essential to provide effective 
and safe patient care, especially if the prescriber is considering a new medication 
for the patient. On paper charts the allergy status of a patient has to be written on 
the front of the drug card, in hospital C policies are in place that prohibits the nurse 
from administering any medication, unless the allergy status of the patient is 
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documented on the front of the drug chart.  In the EPMA system the allergy status 
has to be entered into the system, which can prove difficult at times.  
Doctor: think the allergy data could be better set out… it’s like you can have 
class or generic but then you have to go, you have to fiddle around quite a lot 
to actually find out what the reaction was. A2 
However, if the allergy status of the patient is not done properly, warning signs to 
alert the prescriber about an allergy do not necessarily appear as described in the 
following quote.  
Doctor: It’s an absolute pain…because then if you free type them [allergy], 
whereas normally then it will say if you hit penicillin and you try and prescribe 
amoxicillin; no, allergy; so if you prescribe ‘other’ it won’t pick up the potential 
drug interaction. Pharmacist: And they aren't, there isn't like an order as to 
how to find your particular drug (laughter). B2 
The facility to be able to prescribe medication that is not on the system needs 
to be available for situations where unusual medications are required; however the 
system is not able to link potential warnings about the medication prescribed as 
“not on the system”, consequently the system does not alert the prescriber to a 
potential error. Awareness of HCPs regarding the “not on system” situation needs 
to be reinforced to prevent them from using it unless absolutely necessary. This 
would take into account possible interactions that will not be highlighted. 
Pharmacist: Yes the only reason why that (prescribing error) happened was 
cos it had to be prescribed as “not on system” so usually if sodium bicarbonate 
is prescribed as sodium bicarbonate it would flag up saying you are 
duplicating. That doesn’t necessarily mean the doctor will still not prescribe it, 
they will just go yes whatever… A1 
4.4.4.3.1 Summary 
In summary, the theme “Interface - interacting with the prescribing system” 
has considered the sub-themes summarised in Table 4-2. Interacting with the 
prescribing system has changed the logistics of how the HCPs carried out their work 
within the in-patient setting, depending on where the patient, prescription chart 
and medical notes were in relation to each other. Multidisciplinary team scenarios 
such as ward rounds, on call, medication rounds or prescription review, also had to 
adapt in order to interact with the prescribing system and the patient. The clarity of 
the prescription and the prescribing story altered due to the legibility of the 
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prescription and its design. Design features included the number of different 
screens, the view of the prescription, the order in which medications were listed, 
the size of the display, the addition of strength and formulation to the individual 
prescriptions, extra prescription items and gaps of information. Learning how to 
operate the prescribing system was a task in itself and impacted upon how the 
HCPs interacted with the system. Depending on the HCPs’ training, experience, 
computer literacy and whether they were comfortable with their environment or if 
they were new to the ward influenced their abilities to provide safe, timely, 
effective, efficient and patient centred healthcare. Specific difficulties in using the 
EPMA prescribing system were discussed throughout the focus groups; most were 
highlighted within each group due to the impact they may have on patient safety. 
These difficulties included selection errors, antibiotic prescribing and allergy status.  
Table 4-2 Sub- themes of "Interaction with the system" 
Theme Sub-themes 
Logistics “Lost” Prescription, Location of the prescription, 
Remote prescribing. 
Clarity of the prescription Legibility, prescription chart design. 
Operating the system Training, Agency staff, Computer Literacy, Experience 
Using the system Selection errors, Antibiotic prescribing, Allergy status. 
 
4.5 Change in working practices 
The change in prescribing system from paper to electronic led to a 
modification of HCPs’ tasks and roles, causing the system to impact on their 
working practices. 
 Role of the pharmacist and nurse 4.5.1
The role of each health care professional has had to adapt to a new situation, taking 
into consideration what the ePrescribing technology can or cannot facilitate in 
order to provide quality patient care.   
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4.5.1.1 Pharmacist Role 
The use of the EPMA system to prioritise pharmacists’ work was considered 
by all the focus groups. EPMA enabled the pharmacist to prioritise newly prescribed 
medications for review or any changes that were taking place. However, using this 
method to prioritise work can prevent an overall look at a patient’s medication and 
possibly hinder more in-depth or holistic patient reviews. For example, there may 
not be any changes made to a prescription but the patient’s condition could be 
declining requiring necessary advice regarding medications; these situations cannot 
and should not be overlooked. 
Pharmacist: I think it’s really helped us prioritise our work as pharmacists, 
because before we would have had to of looked at every chart to see if there 
was anything new or any, but now we can, we can really use it to prioritise 
and review drugs. But I also think now that if something’s reviewed you don’t 
always go back and revisit it, so say if you’ve missed like an interaction or you 
know it’s very. You’re focusing on things that have changed rather than, 
things that are there and already checked. A2 
Pharmacists deliberated about how the new “technical” part of checking the 
prescription, had distracted from their “clinical” check making the process more 
time consuming as they were “scrutinising” the prescribing system. 
Pharmacist: I just find that because you’re perhaps concentrating on the 
technicalities of, has the right drug been selected and in the right dose you 
always have to take a step back and then review it clinically as well so, 
whereas a glance at the drug chart (paper system) and you can see 
everything. A2 
Pharmacists considered the errors they were looking for, to be human errors 
created by the change in prescribing system and not just clinical mistakes made by 
the doctors. This showed how conscious the pharmacists were that human error 
might have increased with a change in prescribing system. 
Pharmacist: they (errors) are not as apparent as they used to be so you just, 
it’s more time consuming from a pharmacist’s point of view because you have 
got to really, you are scrutinising a system because you know that errors 
happen and it’s because it’s a new system, it’s not necessarily that you are 
looking for the doctors making mistakes, it’s the system errors that you are 
looking for. Like have they prescribed a prn (when required) on a regular 
schedule. A3 
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 As discussed previously in “training” (Section 4.4.3.1) pharmacists have 
become EPMA guardians and are usually the first port of call if any of the HCPs have 
difficulties in using the system. This puts more responsibility on the pharmacists to 
know how the system works. It is therefore important to ensure that pharmacists 
have a good understanding of the EPMA system, not just for themselves but also 
for others, and should be factored into training. This requirement for EPMA support 
means the availability of pharmacists on the wards needs to be ensured in order to 
facilitate MDT and support to all HCPs. 
4.5.1.2 Nurse Role 
Nurses found EPMA more convenient to use compared to a paper 
prescription. By having access to other information, such as blood results on the 
computer as well as the EPMA facilitated the checking by nurses of blood tests 
before administering a medication. This was an improvement, as previously some 
nurses may not have checked. The EPMA system provided a communication tool via 
a “bubble” that enabled HCPs to provide more detailed information about 
medications, than compared to the paper prescription. This information, that would 
previously be hand-endorsed on the paper prescription in a limited space, could 
now be used to discuss information with patients about their medication; such as 
administration details, supply comments, counselling comments and/ or discharge 
letters. 
Nurse: We can also teach the patients as well because if there are instructions 
in the “bubbles”…we then look quite knowledgeable when we tell the patient 
(chuckles and laughs) we don’t know everything...Doctor: You see EP gives you 
a higher IQ Nurse: Well you can advise them at the same time of 
administration, and that’s part of their education ready for discharge isn’t it. 
A3 
 Staff from the hospital with a paper-based system considered how the 
EPMA system could save time by bringing the medications that were due to be 
administered for a particular drug round to the top of the list, therefore making the 
nurses’ medication round more efficient. This provided insight into the possibilities 
that staff perceived EPMA could provide. 
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Nurse: Yeah I think it would save a lot of time. At the moment we go through 
the chart literally start at the front and go through every single page to make 
sure that you've not missed anything off whereas it would be start at the top 
and working your way down wouldn't it I suppose? C1 
The experience of nurses working with the EPMA system counteracted the 
potential benefits of bringing the medications that were due together. Nurses, 
when using the EPMA system, can only see medications that need administering on 
that medication round. The EPMA system hinders foresight for future medications, 
therefore requiring nurses to have more situational awareness regarding future 
medication rounds as explained in the next section. 
 Situational awareness 4.5.2
As noted in previous research (80) and reinforced in the focus groups, having 
EPMA in place can, to different extents, bring the information that a HCP requires 
together in a predictable and standardised way. Yet the EPMA system is detached 
due to design issues such as different screens and the order in which the 
medications appear, therefore hindering awareness of the complete prescribing 
“story”. The amount of information provided for HCPs to review can lead to 
information overload, which may also cloud a HCP’s judgement and ultimately their 
situational awareness as explained below. 
Doctor: That’s the problem with computer systems it always shows that if you 
can collect more data, people tend to try and do it then you can see more of 
what you are doing, but it becomes the fact that you end up with so much 
data you can’t make decisions because there is just too much, too much to 
see… A5 
4.5.2.1 Time of Day 
It is important when prescribing using the EPMA system, to have situational 
awareness of time; this is because the EPMA system is strictly aligned to the time of 
day and specific drug round timings. In order to ensure a patient does not go 24 
hours or more without a medication, the time that a prescriber inputs a new 
prescription must be considered. For example, if a “regular” medication is 
prescribed at 9am in the morning and it needs to be administered at 8am, the 
medication will not show on the nurse’s administration chart until 8am the next 
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day, causing a 23-hour delay. In order for the patient to receive a dose on the day 
of the prescription, an eStat dose must be prescribed. 
Previous research (20) has discussed what solutions or workarounds have 
been employed to prevent this delay in administering medications from occurring. 
Solutions that have been adopted include adjusting the system clock or giving the 
first dose as a eStat dose (20).  
Within both the hospitals using EPMA, the practice of prescribing an eStat 
was in place as the official solution to the timing issue. Therefore, eStat doses are 
now prescribed more frequently to ensure the patient does not endure a delay in 
receiving a necessary medication when using the EPMA system. The doctors and 
nurses explained how they required situational awareness, and how it had proved 
quite problematic. 
Doctor: I suppose in terms of, when you prescribe on EPMA will dictate when 
the first dose is given so if you don’t remember to do Stat doses and certain 
things that might need to be given there and then there may be more less a 
day in medication. Erm so there's a timing issue with when you prescribed on 
EPMA as well, which is really hard to remember because if you've, if it’s not 
before eight o’clock they don’t get their morning medication. B2 
The change in prescribing system had impacted on working practices by requiring 
the prescriber to duplicate prescribing, when needed, but this had resulted in 
frustration and inefficient working practices to overcome a latent failure within the 
EPMA system and avoid patient safety issues. 
Doctor: I’ve got to go back and prescribe a stat so the patient can have their 
dose…uhhh that can get a bit annoying because its time consuming at times 
when your, when you thought you had done a job and you know you haven’t 
and it’s no one’s fault it’s just I learnt that it’s difficult to understand the 
timings of it and to get my head around that. A2 
Prescribers are also able to change the clock on individual prescriptions 
making the EPMA system think the prescription was created at 6am rather than 
11am and therefore creating a dose to be given. This however appears as a missed 
dose on the administration section, through no fault of the nursing staff, creating a 
problem with the audit trail within the system. This is a workaround within the 
EPMA system and not an official solution to the problem, however it shows how 
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workarounds can impact upon patient safety and audit trails in order to facilitate 
timely and efficient clinical workflow. 
Nurses are not able to prescribe or modify prescriptions in the EPMA system, 
whereas before with paper prescribing, amendments could be made to facilitate 
patient care, such as the time medications should be given. Now the nurses 
officially have to contact the prescriber to get eStat doses prescribed before they 
can administer the medication even when the nurses know the patient needs it.  
Nurse: But then when I have asked for it to be prescribed today, it’s not 
actually been prescribed for today it’s actually been prescribed for tomorrow… 
so she (patient) has had a day without it, so it’s a case then of going back and 
saying do you think we could have a Stat dose of that…and she didn’t … A1 
However, at one of the Trusts it materialised that an unofficial workaround had 
been adopted by nursing staff in order to circumvent contacting the prescriber. This 
entailed “borrowing” doses from the following day’s prescription, which then has a 
knock-on effect for the rest of the following day’s administration.  
The fact that eStat doses are now prescribed more frequently than previously 
on a paper prescription was also discussed in the focus groups under the  theme 
“view” of the prescription because ultimately, with every Stat dose that is 
prescribed, the prescribed regular medications get pushed further and further 
down the medication list. This resulted in the HCP having to scroll further and 
further down the screen to view the “regular” medications. In other EPMA systems, 
mentioned in previous research (20) the opposite effect occurred where the Stat 
medications fell off the bottom of the screen as they appeared last in the “list” of 
medications. 
Nurses, when using the EPMA system, can only see medications that need 
administering during that medication round. The EPMA system hinders foresight for 
future medications therefore requiring nurses to have more situational awareness 
regarding future medication rounds. This was explained in the following quote, it 
reinforces how important it is to have HCPs working as a team and communicating 
with each other in order to facilitate every aspect of the healthcare system and 
ultimately the quality of patient care. 
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Nurse: EP very nicely turns the next doses that are due at the next ward round 
time green, people were very heavily focusing in on what was going green 
next and forgetting anything that was in-between… people weren’t looking 
ahead and it was kind of changing the mentality (SA) of the nursing staff to 
always look for things outside of drug round times… Communication was a big 
thing in making sure it got given… Doctor: Yes, if the communication had 
been… if the computers not on or the patients not there no one would notice 
the red flashing… A4 
Regular interactive communication within the MDT is required to a certain 
extent between HCPs to promote and support situational awareness whilst carrying 
out their work in the healthcare setting. With the introduction of EPMA, 
communication within the MDT has changed and with the advent of remote access 
to EPMA may have potentially detached HCPs from each other, affecting 
colleagues’ situational awareness regarding patient care. 
 Communication 4.5.3
The sub-theme of communication reviews and describes the adjustment 
required, once ePrescribing was implemented, and how the multidisciplinary team 
communicated physically, verbally, in writing and during ward rounds. Socio 
technical system theory considers how the workforce social situations can be 
impacted, especially when avenues of communication are altered and how this can 
affect quality of patient care being provided. 
4.5.3.1 Physical communication 
In the hospital with paper prescribing in place, concern was raised over the 
loss of a physical prompt and reminder that the paper chart had in facilitating the 
HCPs’ working practice. With the paper prescribing system HCPs can sometimes see 
a prescription being written, whereas with the electronic system a physical prompt 
is not presented anymore, because the prescriber is generally away from the 
specific patient and might even create a new prescription remotely. 
Nurse1: Oh we just have to wait and see what’s on there (computer) Nurse 2: I 
think it depends some doctors will tell you they’ve prescribed something , if it 
happens all the time you may just go to the screen and there’s a new tablet 
there. B2 
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Newly prescribed medications can appear on the EPMA system and has led to 
different practices being adopted by HCPs. The fact that unless someone is 
constantly checking the “computer” a new entry or change to any medication will 
not be seen unless verbally communicated, this was considered exasperating as it 
had led some HCPs to constantly check the computer. 
Pharmacist: I feel a bit of a slave to a computer whereas I didn’t before. Plus 
we could potentially see every change as well and the times it happens, 
whereas I used to feel more satisfied by seeing the chart once every day, now I 
feel constantly, see if they need anything else… you can feel like you should be 
checking them [Computer] more because they're there and available erm and 
because things do appear, whereas before if the nurse needed something 
they’d ring and if I'm not here they’ll bleep me to go and get it whereas 
because it’s done on the computer… B2 
4.5.3.2 Verbal communication 
More emphasis on verbal communication within the MDT to facilitate 
situational awareness and patient care was now required with the introduction of 
EPMA, especially regarding the “eStat doses“ as discussed (Section 4.5.3.1), to 
ensure patients did not experience a time delay in getting their medications. 
Nurse 1; I think now the once only side of things the doctors are physically 
seeking you out now to say we’ve prescribed this…Nurse 2: They have to tell 
you that otherwise we wouldn’t know that until the next ward round, the next 
medication round… A3 
Expectations of EPMA are high and it is still assumed by some HCPs that its 
use will facilitate communication to the point of needing less verbal 
communication. A surgical consultant had believed from one of the training 
sessions that the EPMA system would be able to physically alarm or flash red by the 
patient’s name if a medication was overlooked or was not dispensed at the 
appropriate time, but then realised that unfortunately this wasn’t the case. The 
Consultant explained how, on a number of occasions, antibiotic Stat doses required 
post-surgery had not been given. The consultant felt this may be due to lack of 
communication between theatre recovery and the ward, however the 
consideration of communication between prescriber and nurse was overlooked. 
The fact that it was still a retrospective review of missed medications, all be it in a 
110 
shorter time frame, and was not considered good enough and that something more 
immediate needed to be done.  
Doctor; I appreciate now that you have got an electronic flagging up of things 
that have been missed in the 24hrs after they have been missed, that’s useful 
but at the time I want the antibiotics given at the time, I’m wondering how 
more immediate that could be. A4  
Acknowledging how important communication is in the healthcare system, 
the EPMA focus groups could not understand that verbal communication still needs 
to take place to inform different HCPs when a TTO is ready. An assumption made by 
HCPs was that with the introduction of EPMA, pharmacy knew electronically about 
TTOs and medication changes; this needed to be clarified across the hospital. 
Pharmacist: Well unless we’re told what's been prescribed because there's 
nothing there's no ring bells or I mean even TTOs people think that 
automatically there's a signal in pharmacy something that shows you what's 
been done. There isn't until someone verbally tells us, so if you prescribe 
something you've not told me then I'm not going to know to order it either… 
Nurse: You can do it a TTO on a computer system and then you have to 
physically verbally tell someone that you've done it so the pharmacist can do 
their bit I find ridiculous, because there's technology and then it sort of breaks 
down and it goes sort of primitive with communication. B1 
In one of the focus groups, the verbal communication between HCPs was 
described as sometimes being difficult when any of the HCPs were actually using 
the computer and that it was “impossible” to talk to colleagues as they were 
concentrating so much on the computer and didn’t want to make a mistake.  
Doctor: Not all the nurses are tremendously computer literate, and that’s 
probably fair to say of half the staff in the hospital…they are impossible to talk 
to because they can’t hear you, because they are so focused on that screen… I 
think communication wise I think typically they are so focused on the 
computer, it’s probably for doctors as well, but I have particularly noticed it 
with nurses doing their medication ward rounds. A5 
Not been able to talk to colleagues whilst on a medication round was also 
touched on in another focus group when a nurse felt that, when using the 
computer on medication rounds, they experienced a lot less interruptions by 
colleagues and likened it to previous research conducted around the use of red 
aprons whilst conducting a medication round. 
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Nurse: It goes back to the red pinny and ‘do not disturb’ whereas if you've got 
that computer it’s up there its more daunting you don’t want to interrupt 
somebody if they're on the computer... People do tend to not disturb you as 
much when you've got a computer as when you have got the red pinny. 
4.5.3.3 Written communication 
One of the hospitals uses electronic notes within the ePrescribing system; the 
notes are completed by all the HCPs. It materialised that the result of all the HCPs 
entering notes into the same section had ended up with an information overload 
situation that could become overwhelming. This required a HCP with experience to 
“suppress” the notes that they felt were no longer relevant to the patient. 
Examples of such were given; this then opened the question up to what information 
was documented, and how important that was for the MDT to know. What seems 
important information to one HCP would not necessarily be seen as such to another 
HCP. The debate about one set of notes for all HCPs versus silo notes for each 
profession continues. 
Pharmacist: So with the notes, someone has got to go in and physically 
suppress them (irrelevant notes)... there's doctors, nurses, pharmacists but it 
needs someone to take the initiative to go through and then suppress it. B3 
The documentation made on ward rounds was considered to be quite 
comprehensive and clear. It was felt that doctors were more likely to say what the 
problem with the patient was, the plan and to explain why they were starting a 
specific medication. The causes for lack of written documentation in the notes were 
considered in the focus groups, with the introduction of remote prescribing being 
cited as one of the reasons. Other explanations for lack of written communication 
were that the patient had been seen at the weekend or in the evening time by a 
busy on-call doctor. The difference in written communication between the hospitals 
was explored in the next phase of work and will hopefully provide more insight into 
the reasons for lack of clear written documentation. 
Pharmacist: They’re (on call medic) running around doing all of the jobs, they 
actually write up the meds that might be needed but the last thing that they 
actually think to do or have time to do is to write in the notes as to why they 
have done something, unless it was obviously a major review. Doctor: Or they 
may of prescribed remotely as we have heard… Pharmacist: Well yes exactly, 
yes, yes so I tend to find that that’s when the documentation isn’t as clear or 
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detailed. Doctor … I rang through to the ward but we didn’t write anything in 
the notes. I mean probably for best practice you should do… A4 
Delays in prescribing were acknowledged by medical staff citing that specialist 
teams are no longer readily prescribing in EPMA for the patient and are instead 
recommending in the notes, causing possible oversight by the responsible team 
leading to an interruption in patient care.  
Doctor: Yeah I think specialist teams prescribe less when they come round 
whereas before they might have been willing to change the drug chart now 
they will just write in the notes to change this, this and this so a lot of people 
will feel like it’s if they write in the notes that’s okay but there is then 
essentially a delay. B2 
Written information within the EPMA system that is needed for the HCP to 
carry out their specific jobs cannot be seen at the same time. This can be linked in 
with the theme “view of the prescription”; it shows how written communication is 
not always accessible when it should be in order for the HCP to carry out their 
work. For example with paper prescribing, the HCP can physically look at the paper 
prescription whilst creating a TTO ensuring that the correct information is on the 
TTO and assisting a double check, along with having the medical records to back up 
the information provided. With the EPMA system it is not possible to view the TTO, 
prescription and HCPs notes all at the same time leading to the HCP having to 
memorise the information whilst navigating through the different screens.  
Doctor: So it’s impossible for me to do a TTO and at the same time look at the 
medications, the verified medications that the patient came in on so it’s 
actually quite fiddly to actually get it completely right and to kind of... a lot of 
it relies on your memory and not been too lazy to not go back in and to see on 
that list and try and try and go back. A1 
Written communication within the MDT used to take place using “post it 
notes” on the paper chart and then put in the jobs tray which, it was agreed by all 
HCPs, was not a very formal means of communication and had a lot of problems 
associated with it as explained: 
Pharmacist: With paper charts we often relied, rightly or wrongly, wrongly I 
think on post it™ notes on drug charts… We had cases were a post it note 
came off and got stuck on different patients chart and the meds were 
prescribed for the wrong patient… but you take that system away and then 
you have to think about another way of communicating jobs whether it be via 
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job books or heaven forbid actually talking to somebody,… but you also want 
the security somewhere of having a job record to write it down in because the 
person that you have spoken to over the phone has a million phone calls about 
different things and will they actually remember to do that … A4 
Alternative ways of communicating were therefore very important in order to 
continue lines of written communication. The differences between medical and 
surgical working practices were discussed showing that diverse circumstances such 
as ward based F1s and team-based F1s called for different ways of communicating.  
Pharmacist: I think the specialities will be very different in the way they handle 
it (written communication) and are able to… A4 
A jobs-book based on the wards had previously been used when paper prescribing 
was in place on the surgical wards. This had enabled non-urgent jobs to be 
communicated whilst the team was not accessible, such as in theatre etc. This form 
of communication via the jobs-book had therefore been adopted on the medical 
wards once EPMA was introduced now those post it™ notes were not possible. A 
jobs-book for the doctor and a separate one for the pharmacist had been adopted 
on one of the wards. However, the use of the jobs-book was questioned and 
highlighted the fact that it wasn’t used that often. Also the possibility of it not being 
used correctly caused patient safety concerns. 
Doctor: a lot of jobs don’t get written in there because the doctors don’t look 
at it and the doctors don’t look in it because not much gets written in it… it’s a 
bit of a self-prophecy and personally I would prefer just to be bleeped … then I 
know about it straight off, I can write it on my jobs list. If it’s something 
urgent, I can deal with it more urgently. That’s my preference and that’s how I 
would prefer to get rid of the jobs books… I think it helps me stay on top of 
things, because I am constantly in contact with everyone.  A4 
Doctor: you would sometimes find things written in them [jobs book] that 
were totally inappropriate.  A1 
 Questioning as to whether it was a legal document was also raised. There 
seemed to be no standard practice within the hospital of using the jobs-book. For 
example, one pharmacist was communicating the same issue in four different ways, 
because it wasn’t clear what should be done. These situations need to be guided by 
management and the organisation to improve communication and prevent any 
patient safety issues or duplicate of work leading to inefficient working practices. 
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Pharmacist: I found myself writing it in the jobs book, in my pharmacy care 
plan and in the notes and bleeping the doctor which is completely ridiculous. 
A4 
The way written, verbal and physical communication takes place in all three 
of the study hospitals is different for a lot of reasons, not just because of the 
prescribing system. What is important to understand is how best to communicate 
when the prescribing system does change. One doctor felt that, whatever the 
prescribing system used, HCPs needed to communicate properly. 
Doctor: I think that’s true of any kind of communication no matter what urmm 
system you have in place to communicate between the nursing staff and 
pharmacy and the doctor. It doesn’t work if the actual people doing it do not 
properly communicate. A1 
4.5.3.4 Ward Rounds 
Ward rounds became a big discussion point in all the focus groups 
deliberating about how they, could or had, altered when the prescribing system 
changed. The importance of the medical ward round to facilitate communication 
between the multidisciplinary team, and quality patient care was prominent within 
the focus groups. Once EPMA is implemented, the need to have full representation 
from each HCP within the multidisciplinary team on the ward rounds becomes 
more apparent. Staff in Hospital C with paper prescribing in place explained how 
the prescription was not always “considered” and reviewed by the team if it was 
not at the end of the bed. The question about if this practice would change once 
EPMA was in place was raised. 
Doctor: The team will come and see the patient and nobody’s asked me for 
the drug chart so they’ve obviously not even considered looking at the drug 
chart when they’ve reviewed the patient, so that whole step’s kind of missed, 
so would an electronic system get reviewed regularly? Would it be …?  C3 
It was perceived by HCPs working in the hospitals with EPMA that the 
prescriptions were not being looked at as much on the ward rounds as they used to 
be and it was a “habit” that had materialised with the introduction of EPMA.  
Pharmacist: Definitely, I think that’s something I have noticed since EP has 
come in, that the prescriptions are looked at a lot less on ward rounds, I think 
it’s a habit thing that’s going to get worse Doctor: potentially it’s a real 
problem… A3 
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Doctor: I've noticed especially comparing it back to when I was a medical 
student was that the drugs don’t get reviewed enough Nurse: Yeah I certainly 
agree, it used to be obs [observation] chart and the kardex [prescription 
chart], you know list of the meds and now it’s obs chart. B1 
Prescribing by consultants was perceived to still happen in Hospital B but mainly on 
the Emergency Medical Unit that still had paper prescriptions in place.  
Doctor: When we do ward rounds seniors never look at the book [laptop], they 
do but not every time, whereas before when you had a drug chart at the end 
of the bed they would get it out, they’d look at it, and they do it in EMU 
[Emergency Medical Unit] as well, the consultants will add medications that 
they want them to be on or cross things off. B2 
The variability in how each consultant carries out the ward round with their 
multidisciplinary team was discussed in the focus groups. The specialities of 
medicine and surgery have to contend with different issues when carrying out a 
ward round as previously discussed under the theme of logistics. This gave insight 
into the hurdles that doctors had to overcome when carrying out the ward round 
and what repercussions this had.  
Doctor 1: With medical ward rounds they tend to take the ward trolley and 
computer and it’s a slow thing, and their willing to check these things. Surgical 
ward rounds whilst generally being a bit quicker they don’t want to be slowed 
down by having to … Doctor 2: If you can get something and just show it as 
soon as they ask for it like you can do with the paper chart… but if you say 
‘hang on I’ll just go and log onto the computer and bring up the EPMA 
system’…They're onto the next patient. B1 
The speed at which senior medical staff conducted ward rounds was raised, leading 
to patient safety issues. Senior staff must consider how much time it takes to access 
and prescribe a medication in the EPMA system, compared to a paper prescription 
in order to ensure quality of care is not compromised. This should be supported and 
reinforced by management and the organisation, to ensure that adequate time is 
allocated to carrying out ward rounds and preventing any patient safety issues. 
Doctor: our consultant does things, does his ward rounds at high speed so you 
have to be able to do things quickly. So it means that things can get forgotten 
if you are not carefully noting things down umm but… he won’t slow down for 
us to do that so (Laughs) that is an inflexible part of the system. A1 
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 Patient Contact 4.5.4
The change to EPMA has taken the HCP physically away from the patient 
due to the location of the computers on the wards, and working remotely to the 
patient, as previously highlighted. Even when every effort has been made by the 
HCP to ensure they still have patient contact, the quality of that contact has also 
changed. The increased concentration required by the HCPs when using the EPMA 
system due to reasons discussed in other themes such as the view of the 
prescription, operating the system, computer literacy, hardware reliability and 
verbal communication, has led to the patient perhaps not having as much time with 
the HCP. Patients may need to discuss specific concerns they may have with the 
HCPs, whilst they are using the EPMA system. However, being distracted when 
interacting with the computer and possibly administering the wrong medications 
was also a cause for concern.  
Nurse 1: You have to concentrate on the screen Nurse 2: The patients don’t 
understand do they? Nurse 1: You do try, you do talk to the patient but you 
can’t talk and look at the screen because otherwise you completely lose track 
of where you are, you know your quite danger… you forget where have I 
clicked on that or which drug have I just put in the pot… A5 
The computer was also foreseen as a physical barrier, sometimes between the HCP 
and patient unlike the previous paper chart system, potentially leading to a less 
personal experience of care. 
Pharmacist: it’s a bit impersonal because you've got that barrier, you know, 
typing away and stuff. B1 
Nurse: I think they [nurses] tend to hide behind them [computers] as well 
because they're at that height, you can tend to do your medicines hidden 
behind it whereas when we have the medicine trolleys and the cards I don’t 
think we could hide quite the same. Not that I'm going to hide but I think we 
can be perceived as hiding behind it… like a barrier between you ware as if you 
had a card you only had a piece of paper that you were fiddling around with. 
B3 
The theme “change in HCPs working practices” has considered the sub-
themes that are summarised in Table 4-3. Communication between the HCPs within 
multidisciplinary teams and the patient had to evolve upon implementation of 
117 
ePrescribing. Situational awareness is required to understand each HCP role as well 
as the multidisciplinary team’s role in providing quality patient care.  
Table 4-3  Sub- themes of "Change in HCPs working practice" 
Theme Sub-theme 
HCPs roles Pharmacists Role, Nurses Role 
Situational Awareness Time of day 
Communication Physical, Verbal, Written, Ward round 
Patient Contact  
 
4.6 External influence 
The theme of external influence encompasses the organisation level of regulation, 
policy and culture that impact upon the HCPs working practices and ultimately what 
is incorporated in the design of the prescribing system. 
 The NHS as an Organisation  4.6.1
 All HCPs using the EPMA system require longer and more detailed training, 
compared to the training provided with a paper prescribing system, as discussed 
previously (Section 4.4.3.1). The knowledge and experience they gain when using 
specific prescribing systems, to be able to prescribe safely, led to questions about 
how prescribers would cope moving between different hospitals and potentially 
different prescribing systems. It was suggested that having the same EPMA system 
across the country would be a good idea.  
 An “ideal” universal situation was discussed within the groups, what would 
be good in theory and considered by the “NHS” or management, was seen as not 
always being possible in reality. The confidence HCPs had in the NHS and the Trusts 
being able to achieve this was exposed when they joked about the fact that the 
NHS couldn’t even decide on a standard observation chart to use, so how could 
they decide on a standard EPMA system.  
Doctor1: A significant portion of your prescribers are people that change 
hospitals, so moving onto new computer systems , is it a bad idea to have a 
118 
variety of different  computer systems? each with their own problems that you 
only start getting fully used to…Whereas at least if everything is written, a lot, 
most of the cards are very similar you get a certain amount of consistency 
with it. Doctor 2: It’s very unlikely that there will be consensus on what system 
to use across the board, especially across the entire NHS but even across one 
general area. Nurse: They can’t even decide on what observation chart to use, 
so you’ve got no chance… (Everybody laughs loudly) A1 
Without the introduction of a national EPMA system, the Royal College’s policy 
Standards for the Design of Hospital In-Patient Charts, that have been published to 
support the design of both paper and ePrescribing systems should be adopted by 
Trusts across England.  
4.6.1.1 Clinical Indication 
Within the focus groups, discussions about the antibiotic policy Start Smart- 
Then Focus set by the NHS regarding antibiotic prescribing came up (47). These 
discussions provided insight into how having a clinical indication on the prescription 
had been accepted, perceived and followed within the HCPs’ working practice and, 
if changing to an EPMA system, had facilitated or hindered the documentation of a 
clinical indication. This then led onto discussions about having an indication on all 
prescriptions, as proposed by the report Standards for the Design of Hospital In-
Patient Charts produced by the Royal Colleges (2). A unanimous agreement across 
all focus groups was that to provide a clinical indication on all prescriptions would 
be far too time consuming, and that it wouldn’t be realistic in practice. Many of the 
focus groups concluded that to have a clinical indication on newly initiated 
medications in the hospital would be beneficial for communication with the patient, 
especially on discharge and between HCPs. The reasons why it would not be 
practical to have a clinical indication on all the prescriptions was explained. 
Doctor 1: That would take you forever wouldn’t it…? I think it would take too 
long Doctor 2; Very cumbersome. Doctor 3: You definitely wouldn’t get to view 
the patient then would you. Doctor 4: I think that that’s very useful for the 
patient and it often; you know I would say it is more useful in primary care 
but, on the eprescription antibiotics it’s very difficult often to find the 
indication that you want from the drop down menu, so having to find it for 
every single medication, the patients on and then having to find a thing to say 
I don’t know (all laugh). A3 
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Discussions exposed how policies were enforced within the system, but that 
enforcement had other repercussions in practice. Every focus group explained how 
when a patient is admitted to hospital they would not necessarily know why the 
patient was on all their medications and, without being able to confirm with the GP, 
they would not want to provide a clinical indication in case it was incorrect. A 
solution to the situation was proposed in one of the groups. 
Doctor: I think there's a case [clinical indication] for new things I don’t think 
you could ask somebody who’s clerking in the patient who’s potentially like 
confused and really unwell to go through all of their medicines and say why 
they're on it, particularly when things have got multiple uses. But I think if 
you're starting something new I think that’s probably quite good practice just 
say why. Nurse: It would be good as well when patients are transferred 
between wards, you know, why …B2 
Pharmacist: I was thinking that it wouldn’t be as time consuming if, when a 
patient came in you could select as a clinical indication, GP continuation. Then 
if you did Rx something new, you could put an indication on, so I thought yes 
that would be a good idea. A1 
 However, a consensus across all focus groups were that it would be feasible 
to provide a clinical indication for newly initiated medication in hospital, and that 
this would facilitate communication with GP surgeries. A comment arose about 
communication being reciprocal and that GP surgeries should provide a clinical 
indication with the list they provide of patient medications. 
Doctor: Can you have it the other way round then; GPs explain why they're 
[patient] on mediations? C2 
 Hospital Management 4.6.2
4.6.2.1 Selecting an EPMA system 
The decisions about which EPMA system is suitable for a specific hospital 
are difficult with several factors having to be taken into consideration; one factor 
would be how considerate and active the EPMA provider is, in improving the 
system in line with the hospital needs.  
The belief by all HCPs that the EPMA system cannot be technically changed or that 
the supplier refuses to change the software in order to facilitate their work-flow 
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and improve patient safety, has actually hindered valuable feedback to the EPMA 
management team. HCPs no longer report difficulties and there is certain apathy 
toward the system as they believe their improvements could not be acted on 
anyway. This strengthens the case for in-house developed EPMA systems that have 
been developed within the NHS system and that can be adapted to improve user 
interface issues. 
Pharmacist: I think with this particular software as well the issues that like 
we've all identified we can’t do anything about to change the system because 
from what I've been told this particular programme is an American based 
company it would cost like one per cent of their customer base compared to 
America and everything has to be done in house by them, we have no control 
as far as like in house modification of this programme so if they don’t do 
anything about it they won’t listen to us if we ask for something because they 
have to change it as a whole for the whole customer group. Nurse: There are 
other systems we used for nursing roster we use electronic there and we can 
suggest things to upgrade it and within weeks improvements are made. 
Pharmacist: I think it’s the same within the programme like we can’t influence 
the future outcome kind of thing to make it better for the Trust we’re just 
stuck with this and it’s never going to change because there’s no changes you 
can make. B1 
This situation was also acknowledged and discussed in a recent document 
produced by the Institute Of Medicine (IOM) entitled ‘Health IT and Patient Safety’ 
(77). It provided insight into the barriers that are encountered by the users in 
ensuring adaptations can be made to the prescribing system. The IOM 
acknowledged how numerous Health IT products can only be maintained by the 
producer of that product, causing users to keep service contracts with that 
producer, regardless of whether that producer addresses patient safety issues 
associated with its product (77). 
External influences on prescribing, such as policies, guidelines, drug databases 
or specific software functionalities, can be put in place and reinforced by the EPMA 
system to try and ensure that the recommendations are followed. However, the 
policies are not always appropriate or relevant to every situation and there is no 
guarantee that staff will follow the policies anyway.  
EPMA teams need to consider the relevance of information provided in the 
EPMA system, and how up to date that information is to ensure quality patient 
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care. The use of specific software and its functionalities to facilitate HCPs working 
practices needs to be considered and tested before it is used. For example the 
“databank” for medication interactions did not always provide relevant interaction 
information to the HCP. This resulted in frustration and less confidence in the data 
provided by the system leading to “warning” information being ignored more 
readily. 
Pharmacist: It’s just not an intelligent system (warnings) I think for someone 
has gotten a text file and given us a programme as a cross reference and then 
that’s it; nobody’s actually looked at it. B1 
In one of the EPMA hospitals, only one person could access a patient’s 
medication at any one time. This restriction had led to many knock-on effects 
causing delays in HCPs’ working practice and patient care, especially as the system 
could become “locked” if the EPMA system went down or a user did not log out 
properly. Once the system was “locked” staff needed to wait 20 minutes for the 
system to unlock a patient profile. Yet, staff had to lie to IT in order to get help in 
completing urgent jobs and continue the work they needed to be done, resulting in 
another workaround. 
Pharmacist: I've rung IT ( about a “locked” patient) and they’ve gone ‘have 
you waited 20 minutes?’ and I'm thinking ‘I haven't got 20 minutes to wait for’ 
and then I go ‘no’ and they go ‘well you have to wait 20 minutes’ and I just 
automatically say yes now because you know it just gets the job done 
quicker… especially when you want to do someone like I say an urgent 
discharge or something it’s just a hindrance. B1 
4.6.2.2 Information Sharing 
Alterations as to how information is accessed or viewed to improve how the 
EPMA system is used, led by each profession, need to be communicated to the 
wider user groups so that they can utilise the improved information sharing. The 
improvements made may not have the desired impact if the wider hospital 
community is not informed or considered. For example the electronic “note” 
system, sometimes referred to as the bubble, provided an electronic means of 
communication between HCPs, and was used in Hospital A by the pharmacists; 
however, other HCPs did not use the electronic note system as much. The need to 
promote teamwork and bring everyone together to ensure people know about 
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changes needs to be done using different communication methods. E-mails are not 
always checked or screen-savers rarely seen if computers are in use all the time. 
Those managing EPMA systems cannot rely on electronic communication alone, to 
deliver important messages.  
Doctor: But actually, when I started you know I knew the note system existed 
but I didn’t know it was so widely used by pharmacists. Pharmacist: Same case 
applies a lot of people aren't aware that it exists. B1 
Important information about EPMA changes and support must be advertised and 
promoted effectively to ensure it is reaching all HCP staff, in order to make them 
aware of what EPMA support is available and how to access it.  Standard cascades 
providing information to inform HCPs need to be decided for each ward and the 
rest of the hospital community to ensure staff get the information they require 
regarding EPMA changes.  
Nurse2: It’s [EPMA support] not made, it’s not notable on the ward anyway, 
there’s nothing to say go to this particular person… Nurse 1: There’s no 
number… A2 
4.6.2.3 Hardware 
Hardware is ultimately the responsibility of the organisation; the computer 
technology has to be available, reliable, and portable in order for HCPs to carry out 
their work. Continual IT support and management are required to ensure that 
hardware issues do not affect patient care.  
Doctor: I think one of the biggest problems is access to computers on the 
ward. None of the laptops seem to work without being plugged into a power 
supply… There's only two desktop computers, one’s permanently got the ward 
clerk on it and one is shared between every other sort of person in the multi-
disciplinary team so...  B1 
A shortage of computers on the wards was cited as one of the reasons for access 
delays, with computer availability becoming worse at peak times in the working day 
when all HCPs required the computers at the same time for their specific job roles. 
The HCPs have to adjust their working practice quite considerably leading to some 
physically leaving the ward and then coming back to review notes.  
Doctor: I think there are some issues with surgical wards because you may 
well have four or five teams visiting all in one go, because they have so many 
different surgeons looking after so many different patients. Nurse: and it’s 
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usually at drug round time in the morning, when 3 of them (computers) are 
already in use for the drug rounds. A4 
Pharmacist 1: On busy wards there can be numerous occasions you cannot get 
on the computer, which means you can’t do any work at all. Pharmacist 2:  
You are completely stuck then… because you have got yourself a computer 
and you’re in the middle of a patient and you don’t want to let that computer 
go”.  A5 
Poor computer battery life and Wi-Fi issues compounded other difficulties with 
accessing the EPMA system. Reporting the issues of faulty equipment took too long, 
which lead to the hardware issues not being fixed, sometimes for weeks. Unreliable 
Wi-Fi connections could interrupt accessibility during a ward round. Good IT 
support is essential to keep the system running smoothly and providing quality 
patient care. 
Pharmacist: There’s not enough computers, especially if the computers are 
broken, the buttons are missing. A4 
Doctor: And I think when there is an issue like a technical issue like say isn't 
working a lap top isn't working you're absolutely got your jobs to do and IT are 
notoriously … Pharmacist: Slow. Doctor: … you're fifth in the queue [over the 
phone] kind of thing you can’t wait around and that the issue just gets ignored 
and its days or weeks, I mean someone has time to report it. B1 
Nurse: It’s also getting the trolleys to work which is stupid and just now it’s 
taken me twenty five minutes to give three people medications. Because you 
walk into the bay and… the Wi-Fi cuts out and you've got to wait for it to load 
back… the same thing happens again and you're literally just constantly 
walking around to get it to connect up to the ward. B3 
This phase shows how important it is to implement the right EPMA system that will 
improve patient care and safety over and above a paper prescription. At the time of 
writing, the EPMA systems design, produced commercially, are maybe not 
adaptable enough to address patient safety needs and therefore are not showing 
much improvement over paper prescribing.  
It is important that the health IT community and researchers are facilitated in 
sharing information about the design of different IT systems without concern over 
non-disclosure clauses (77). Ascertaining if in-house designed EPMA systems 
specific to the NHS compared to commercial systems, produce better quality 
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patient care and are safer because of their consideration of front line staff working 
practices, needs further investigation. The use of information technology in 
healthcare can and will improve HCPs working practices once a system is designed 
and developed taking into account the needs of the HCP. 
 Accountability 4.6.3
Accountability and audit trails are seen as a big advantage to using EPMA and 
enable a lot of information about the prescribing and administration of medicines 
to be monitored by hospital management. All HCPs commented on how it was easy 
to change a prescription on a paper system without having an audit trail. They felt it 
would make a big difference not being able to amend a prescription in the EPMA 
system without knowing who did it. On paper, the prescription can be changed 
under the same signature so the original prescriber would be accountable whereas 
in EPMA this was perceived to be impossible.  
Doctor: People not being able to change a prescription, that’s really 
important, people will change your prescriptions; either they will change it for 
the good or the bad. Change the amount of times, the medication is incorrect 
and you're the one that’s signed for it… C2 
Pharmacist: As a prescriber I feel far more secure and reassured with an 
electronic prescribing system having a complete audit trail of who did what 
and when and knowing that no-one can alter my prescriptions that I’ve 
written without there been a trail of who’s done that... A4 
Administration of medications to the patient had become an ambiguous area for 
accountability using the paper system because of its design and layout. This led to 
confusion about whether a patient had or had not had their medications and 
whether administration had happened at the correct time of day as per the 
prescription.   
Nurse: The clarification of who’s given what. The signatures, the boxes at the 
moment to write the signature in are very small, you know and somebody will 
sign and you’ll think have they given that because they’ve signed across two 
boxes C2 
Nurse: it could be somebody’s missed signing it and then hopefully the system 
would help that… you know, if the nurses have got to put something in that 
box otherwise they can’t actually go to the next drug or something that would 
be a lot better wouldn’t it? C1 
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The ability to check if any medications had not been given to a group of patients 
was now a lot quicker using the ePrescribing system compared to the paper system. 
However, checking an individual’s patient record for missed doses had become a 
more complex process, the administration screen being separate to the prescription 
list, unlike the paper prescription chart. The EPMA system can produce a report 
identifying medication omissions, the reason for the omission and provide a clear 
audit trail of nurse signatures therefore helping nurse managers to prioritise the 
closing of gaps in patient care. It was perceived that the number of omissions had 
“decreased dramatically”. 
Nurse:  On the paper chart if there were blanks which we might not get to see 
visually for 3 or 4 days because we can’t physically go around everyone’s drug 
chart every day, omissions were made, patients didn’t get medications 
whereas now we can view very easily A3M 
When using the paper prescribing system a blank signature box did not necessarily 
mean that a medication had not been given. This needs to be reflected when the 
nurse managers consider the number of omitted medications that were possibly 
happening when using the paper prescribing system. 
Nurse: as part of my job role I check for omissions of medications and I have to 
say since we have being using the EMAR system I think that has decreased 
dramatically, for drugs not being signed for. A4 
Expectations of what the EPMA system could achieve regarding medication 
omissions, over and above the paper chart were still not being met by one of the 
consultants. Questions were raised about the possibility of more immediate action 
being taken if a medication was missed. 
Doctor: I appreciate now that you have got an electronic flagging up of things 
that have been missed in the 24hrs after they have been missed, that’s useful, 
but at the time I want the antibiotics given at the time, I’m wondering how 
more immediate that could be. A4 
4.6.3.1 Limitations of accountability 
However, the focus groups from the EPMA hospitals gave examples of how 
the “audit” trail may not reflect true, real-time practice and that this should always 
be considered when reviewing the data.  
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It materialised, in one of the focus groups, that prescribing pressures were being 
put on junior doctors to prescribe for patients they may not know, possibly going 
against GMC recommendations, and therefore being put in a difficult position. 
Senior doctors need to be as confident in using the EPMA system as their juniors, 
which may require their using it on a regular basis or undergoing further training if 
required. By not keeping up to date with EPMA training, senior staff delegate 
prescribing to junior staff putting them and their patients at risk. Requests to 
prescribe on behalf of another person can happen, but it is up to the hospital 
culture and management to put a stop to it, providing the juniors with confidence 
to decline senior staffs’ requests to prescribe on their behalf. 
Doctor 1: I know a lot of the house officers in surgery get calls from xx saying 
ermm this person needs VT prophylaxis and this, or antibiotic… and you have 
to take it as a given over the phone that, that patient didn’t have any 
allergies. Doctor 2: Well I would say that you shouldn’t be doing that…you 
shouldn’t be prescribing in the absence of any knowledge of the patient that 
GMC would not… that is a risk with ePrescribing that anyone from anywhere 
who has access to prescribing can prescribe without ever getting actually 
physically near the patient, so it’s a benefit but it’s a risk. A4 
Not having access because senior staff do not have or have forgotten passwords 
was another reason given for possible “audit” trail issues.  
Doctor: I know that a lot of the consultants and registrars don’t have them 
[password], because I spoke to one registrar she doesn’t have a password for 
EPMA and was asking about medication and I just think well why, you know, 
for you to even be able to look at that [prescription] you need a password. It’s 
I think it’s dangerous to be honest. A1 
Prescribing under another HCP’s log in was raised as an issue; the HCPs explained 
how their working practice as part of a team lent itself to potential accountability 
issues. From the following quotes, it was felt that staff did not want to be seen as 
obstructing a fellow colleague’s work especially if they were in a rush. 
Doctor: Especially yeah, because when you do have like other teams coming to 
the ward and they ask to check some of the medications while you're on EPMA 
because you're on it. So then it’s… So you might end up getting involved in 
someone else’s medication that you've not had anything to do with. B2 
Doctor: There are an awful lot of prescriptions out there that you think are 
done by Dr Smith but were actually made by Dr Jones and did those stops 
(discontinued a medication) that were made by somebody else. Because you 
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are doing a ward round with 2 or 3 people around it, I’ve done it this 
morning… It’s just another little, it’s another problem that doesn’t exist with a 
pen, its creating another danger, so yes its more accountable and yes you do 
know who prescribed it but that you know, you might know the wrong person 
as opposed to not being able to read the squiggle at all. A4 
The issue of EP users' not acknowledging pop up warnings that frequently appear in 
the EPMA system was discussed in all the focus groups. HCPs were aware of the 
audit trail and speculated how accountable the prescriber would be pressing the 
“enter” button and overlooking warnings. Questions about how liable the 
prescriber would be if ignoring a warning, which led to a patient safety issue, were 
raised and that it needed to be prevented in the future. 
The nurses had also found restrictions to recording accountable information in the 
EPMA system. The HCPs had no knowledge of a facility that would enable them to 
amend an entry after the event regarding the administration of a medication. This 
then raised the question as to how HCPs were able to amend the system if they 
knew they had prescribed or administered something wrong and wanted to rectify 
the entry.   
Nurse: you think they’ve [patient] taken it all and then you discover they 
haven't... it [EPMA] doesn’t give us the facility to go back and say ‘they’ve 
refused it’ so you think they’ve had everything and they haven't always.  B3 
Concern was raised by a doctor that, even if a maximum dose on the EPMA system 
is prescribed, the system itself still allows the nurses to administer more than the 
maximum dose prescribed. This shows an insight into how the HCPs want the 
system to help in preventing patient safety issues over and above what the paper 
prescription could achieve regarding accountability. 
Doctor: And I think the PRNs [as required] kind of erm alarmed me when I first 
found out about you can actually give as many PRNs [as required], it doesn’t 
stop you giving, say the cycle’s [frequency] three times a day, you can still 
actually administer over three times a day. B1 
Changes that HCPs make to the prescription are now audited and therefore what 
was once possible on a paper prescription, such as changing a medication 
preparation, e.g. different inhaler types or insulin pen versus insulin vial, is now 
seen as possibly “writing a prescription” which has steered pharmacists’ reluctance 
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to change a prescription as it may be perceived as prescribing. The fact that the 
medication is now always prescribed as a specific preparation has possibly 
increased the error of a wrong prescription and requires the pharmacist to make 
these changes. 
The theme “External influence and instruction on prescribing” has 
considered the sub-themes that are summarised in Table 4-4. The HCPs considered 
the NHS as a national organisation and also discussed local organisation level. 
Considering the external influences and instruction the organisations can have on 
the prescribing process. A proposed benefit of technology is the ability to audit 
situations, as previously discussed, and therefore important to organisations is the 
use of audit and ultimately accountability.  
 
Table 4-4 Sub-themes of “External influence and instruction on prescribing” 
Theme Sub-theme 
The NHS as an Organisation Clinical Indication 
Hospital Management Selecting a EPMA system, Information Sharing, 
Hardware 
Accountability Limitations of Accountability 
 
4.7 Chapter Summary 
This chapter has described what is happening in practice from the 
viewpoints of HCPs working within a MDT, regarding prescribing systems. The HCPs 
within their MDTs’ in this phase discussed how their existing or previous work 
procedures were or would be affected by the implementation of EPMA in both a 
positive and negative way.  
When considering phase two findings, interaction with the prescribing 
system changed considerably. The need for clarity regarding new communication 
routes, such as the impact on the clarity of the prescription chart, was highlighted. 
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HCPs are distributed across the hospital, which does not facilitate multidisciplinary 
teamwork. The advent of remote prescribing was perceived as disrupting the 
opportunities for MDT working together and patient contact. The focus groups 
provided a greater understanding of situations encountered by HCPs and the MDT 
when using the different prescribing systems. This enabled the researcher to 
consider the findings when carrying out the next phase of the programme of work. 
The focus groups had delivered HCPs’ perceptions, within a team setting, of what 
had changed and the issues they encountered. However, what was actually 
happening in practice needed to be taken into account, as personal perceptions do 
not always reflect reality.  
The next chapter of the thesis gives an account of the retrospective 
documentation analysis conducted in phase three and considers the clarity of 
written communication, in relation to prescribing and how it can influence the 
quality of patient care provided.   
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5 EXPLORING THE CLARITY AND ACCURACY OF PAPER AND 
ELECTRONIC PRESCRIPTION CHARTS 
Chapter 4 described how the three different in-patient prescribing systems 
affected HCPs’ working practices, as part of a multidisciplinary team. This chapter 
focuses on how different prescribing systems affect the quality components, 
through HCPs’ working practices and the clarity of written communication via the 
prescription chart, within the prescribing system and the supporting medical notes. 
Having described in Section 2.2.4 the methodologies and rationale for phase three, 
a more detailed description of the documentation review, including data collection, 
followed by how data analysis occurred is provided. The findings are then 
presented and summarised.  
5.1 Aim and Objectives 
The aim of this study was to explore how different prescribing systems affect 
quality components (STEEEP), through HCPs’ working practices and the clarity of 
the prescription chart and medical records, with a focus on newly initiated 
medication. Its objectives were: 
 To compare the clarity and accuracy of the prescription chart, between 
prescribing systems. 
 To explore the factors that affect the clarity and accuracy of prescription 
charts in Hospitals A, B and C. 
 To consider the clarity and accuracy of documentation in a patient’s medical 
records, once a prescription is newly initiated, as a risk factor for medication 
errors in the in-patient setting 
 To consider the timeliness of prescribing and documentation, in newly 
initiated medications, as an indicator of clinical work-flow and 
communication 
 To deduce how often patients were informed about their newly initiated 
medications and included in the decision making process 
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5.2 Method 
The selection criteria for the three study sites were purposively selected to 
capture the diversity of the prescribing systems across England. The selection of the 
three hospital sites for phase three was explained in Section 2.3.  
 Ethics   5.2.1
Due to restrictions in place for HCPs not directly involved in the patients’ 
care, the research and development department within each of the three hospitals 
must approve access to patient-identifiable information. To gain access to patient 
identifiable data, in the three hospitals, the National Information Governance Board 
(NIGB) was consulted about section “251” approval. During that time, the 
responsibility of the NIGB to provide support relating to section “251” approval 
moved to the Health Research Authority (HRA). Delays were encountered due to 
consideration of the different pathways that should be followed.  
The decision was that two of the hospitals classed the researcher as a “third 
party” and so the use of de-identified patient data was considered. It was 
concluded that this was not possible, as the information included in the study was 
documented in several locations and each patient needed to be identifiable to the 
researcher in order to correlate the data with communications written by HCPs 
about the same patient. Finally, it was decided that patient consent would be 
required to access patient information in two of the hospitals. 
The researcher had to follow different protocols to gain access to patient 
identifiable information within each hospital. This involved a byzantine process as 
each NHS hospital required different information and pathways to be completed. 
Access to patient identifiable information in the three Trusts is provided below; see 
Section 2.3 for more information on each site.  
5.2.1.1 Access to patient identifiable information in Hospital A 
As the researcher was employed by Hospital A, the service evaluation within 
that hospital was classed as a “local” service evaluation that did not involve a third 
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party carrying out the data collection (137). This enabled the researcher to gain 
approval by ensuring that the service evaluation occurred according to clinical 
governance guidelines. Approval from the hospital’s Caldecott guardian was 
obtained, with the Research and Development Department facilitating the process.  
5.2.1.2 Access to patient identifiable information in Hospital B 
In Hospital B the researcher attended an audit meeting and discussed the 
proposed study, answering questions from the audit lead, it was concluded that the 
hospital wanted the researcher to have an honorary contract, rather than approach 
individual patients to gain consent. They acknowledged the NIGB 
recommendations, but stated that this was advisory and that the Trust had the final 
decision. The researcher became an honorary staff member to enable access to 
patient identifiable information. Approval was gained from the Research and 
Development Department facilitating the process. 
5.2.1.3 Access to patient identifiable information in Hospital C 
In hospital C, it was decided by the research and development department 
to follow the recommendations of the NIGB and so patient consent had to be 
obtained to view patient identifiable information. This was done by carrying out a 
prospective patient selection process over a seven-day period, and then 
retrospective record review determined if they had been prescribed new 
medications.  
The following inclusion and exclusion criteria for approaching a patient in Hospital C 
were applied: 
 Inclusion criteria for approach - Patients resident on the chosen wards over 
a 7 day period (identified by the Ward Clark using the hospital Patient 
Administration System (PAS)) and those patients that ward staff considered 
suitable to be approached (owing to their current health or their ability to 
give informed consent). 
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 Exclusion criteria for approach - Patients that ward staff considered 
unsuitable to be approached (owing to their current health or their ability to 
give informed consent). 
 
The researcher asked the ward sister, which patients complied with the inclusion 
criteria in Hospital C. Consent to review healthcare documents, was sought by the 
researcher from those identified patients meeting the approach inclusion criteria. 
Each patient was approached and the study explained to him or her verbally, by the 
researcher. They were given a copy of the Patient information leaflet (Section 
9.3.3). Patients were given a minimum of 30 minutes to consider whether they 
were happy for the researcher to view their healthcare documents. Patients then 
either informed the staff nurse looking after them, or the researcher upon her 
return to the ward to obtain consent using the patient consent form. Once patient 
consent was obtained, the researcher had no further contact with the patient. 
 Data Collection 5.2.2
Once the researcher had access to patient-identifiable data each 
prescription chart along with the medical, nursing and pharmacy notes were 
reviewed for each patient admitted to the study ward over a seven-day period 
following the inclusion and exclusion criteria below. 
The inclusion criteria for patient selection were: 
 Resident on study ward during the specified seven-day period 
 New medication initiated during in-patient admission period  
 Patients whose length of stay on the specified ward is greater than 24 hours 
Exclusion criterion for continued inclusion: 
 Patients whose length of stay on the specified ward is less than 24 hours 
Each patient who was prescribed a new medication during the course of their 
stay on the specified ward was identified and the researcher reviewed their medical 
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records relating to that admission retrospectively. Anonymous data were extracted 
to a data collection form for subsequent manual entry into a database.  
As discussed in Section 2.2.5.5, the recording unit for phase three content 
analysis that was used to produce the medical entry score was defined as: 
All medical note entries made for every newly initiated medication that was 
prescribed during a patient’s admission on the study ward. This was done by 
identifying all the new medication prescribed; medical notes were then 
reviewed and entries copied verbatim if any reference to the newly initiated 
medication was documented. 
5.2.2.1 Medical Entry Score 
A simple rating scale was devised to grade the depth of written 
communication around newly prescribed medications, based on the GMC standards 
(12) and the  implications that poor clarity and accuracy of communication can have 
for the MDT in providing quality patient care. This was carried out using content 
analysis and the recording unit previously defined in Section 2.2.5.5. In this instance 
the recording unit was each medical note entry made about a newly initiated 
medication; this was then rated by the researcher, with a background in Pharmacy, 
using a 5 point scale similar to previous studies (24). The rating scale was named 
the Medical Entry Score (MES) and was created by the researcher to provide 
examples of how medical entries communicate important information about new 
medications in the medical notes. The MES rating scale, rated the clarity and 
accuracy of the written content provided in each recording unit and used a 5-point 
grading scale developed for phase three as shown in Table 5-1 provides examples of 
each situation where a new medication was prescribed and the written 
documentation provided. The scale was not validated, however its use and 
validation may be considered in future work from the results that were discovered. 
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Table 5-1  The Definition, meaning and examples of the Medical Entry Score (MES) 
used in this study. 
Score Standard Meaning Transcription of entry 
1 Clear and 
accurate 
direction 
Standard of clarity 
and accuracy is such 
that the reason for 
initiation is clearly 
provided along with 
the medication 
details (dose and 
frequency) and so 
acted on with 
confidence. 
ATSP re rigors. BG/Admitted xx/xx 
SOB 2 pulm oedema. 
3 x blood cultures –ve  
MSU xx/xx – E.coli, resistant to 
Trimethoprim (was on trimethoprim)  
Susceptible to cefalexin / 
nitrofurantoin. 
Imp. UTI – prev. incorrect abx to 
cultures. 
Plan. Urine dipstick, 
MSSU, Nitrofurantoin 50mg qds 3/7. 
2 Implied 
direction 
Standard of clarity is 
such that there is a 
reason for initiating 
a new medication, 
along with the 
medication name, 
however no specific 
medication details 
provided. 
ATSP re: redness at old venflon site. 
Pt c/o soreness L forearm + hand 
post venflon, otherwise well. 
Imp. Localised cellulitis. 
P po clindamycin (penicillin allergy)  
3 Implied 
but no 
clear 
direction 
Mention of a 
possible indication 
within the entry but 
no specific 
connection made 
between medication 
and indication. 
Imp. Headache NOT ENT related? 
Temporal arthritis. 
Plan – steroid nasal spray 
4 No clear 
direction 
New medication 
documented as a 
“group” of meds, +/- 
indication given 
C/O constipation 
Plan Laxatives 
 
5 No 
direction 
No documentation 
of indication or new 
medication 
No entry 
Key 
ATSP – asked to see patient Re - regarding BG – Background 
SOB – shortness of breath -ve – negative MSU – Mid stream urine 
Imp - impression UTI – Urinary tract infection Abx – antibiotics  
qds – four times a day 3/7 – for 3 days Pt – patient 
c/o – complaining of  L – left P – plan 
Po – oral ENT – ear nose and throat  
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5.3 Results 
The three hospitals and the number of patients admitted to each study ward 
over a seven-day period are shown in Table 5-2. This gives the breakdown and final 
patient numbers for review when following the inclusion criteria. Table 5-2 also 
highlights the number of patients who were approached in Hospital C, and gave 
consent to the researcher accessing their medical documents. 
Table 5-2 Final patient numbers reviewed, showing a breakdown summary of  
number of beds on each ward, number of patients admitted, length of stay, 
number of newly initiated medications and medical note availability across three 
wards (Medical 1, Medical 2 and Surgical) for Hospital A, B and C. 
Hospital A 
Ward speciality Medical 1 Medical 2 Surgical  
No. of beds on ward 28 28 28 
No. of patients admitted in 7 days 25 31 46 
No. of patients length of stay >24 hrs 15 17 24 
No. of patients prescribed new medicine 14 11 21 
Patient notes unavailable 5 2 7 
Total reviewed 9 9 14 
Hospital B 
Ward speciality Medical 1 Medical 2 Surgical  
No. of beds on ward 28 28 28 
No. of patients admitted in 7 days 21 49 42 
No. of patients length of stay >24 hrs 19 33 17 
No. of patients prescribed new medicine 12 14 10 
Patient notes unavailable 3 4 0 
Total reviewed 9 10 10 
Hospital C 
Ward speciality Medical 1 Medical Surgical 
No. of beds 12 18 20 
No. of patients admitted in 7 days 28 37 39 
Length of stay >24 hrs 23 24 28 
Unable to consent 10 11 8 
Declined 2 3 5 
Consented 11 10 15 
No. of patients prescribed new medicine 9 9 11 
Notes unavailable 0 0 1 
Total reviewed 9 9 10 
A total of 89 patients healthcare documents were reviewed with approximately 30 
patients from each of the three hospitals having new medications initiated in the 
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Hospital. The characteristics of each patient whose medical records were reviewed 
provide background and context to the review see Figure 5-1 below.  
Figure 5-1 Percentage of patients in Hospitals A, B and C based on gender, age and 
patients taking less than or more than six pre-admission (PA) medications.  
 
 
From the 89 patients included in the study, Table 5-3 shows 455 new medications 
were specifically reviewed, they consisted of 48 Stat medications, 280 regular 
medications and 127 as required medicines. Table 5-3 shows the number of newly 
initiated medications that the patients were prescribed and subsequently reviewed. 
This is then broken down into Stat prescriptions, “e” Stat medicines (with %), 
regular medicines and as required medicines see list of terms. 
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Table 5-3 Number of patients prescribed new medications, and breakdown by 
administration category, of newly initiated medications, in Hospitals A, B and C. 
Hospital A B C Total 
No. of patients 32 29 28 89 
No. of new medicines prescribed 181 130 144 455 
No. of new Stat medicines  23 10 15 48 
No. of new eStat medicines 17 (18%) 19 (24%) n/a 36 
No. of new regular medicines 96 79 105 280 
No. of new prn medicines 62 41 24 127 
No. of order sets 7 4 n/a 11 
% - represents the percentage of patients prescribed an eStat medication, to facilitate comparison 
between Hospitals A and B. 
 
 Numbers were double-checked for quality assurance purposes prior to any 
analysis-taking place. Although no statistical analysis was applied, a number of 
differences in terms of the clarity and accuracy of the prescription chart and 
medical records was considered. Findings are presented in Sections 5.3.1 and 5.3.2 
to consider the impact that prescribing systems have on the clarity and accuracy of 
written communication by HCPs. Additionally the positive and negative effects of 
the systems were deliberated to provide future recommendations of the ways in 
which EPMA technology can be used effectively and to its full potential.  
 The clarity and accuracy of the prescription 5.3.1
5.3.1.1 The number of associated eStat doses prescribed 
Associated electronic Stat doses (eStat) are prescribed (Sections 2.3.1 and 
2.3.2) due to the time of day that an accompanying regular medication is prescribed 
and the inability of the EPMA system to be flexible. The EPMA software used in 
Hospitals A and B does not provide any kind of reminder or prompts to alert 
prescribers that an associated eStat dose may be required when prescribing a 
regular medication. Prescribers have to consider this option themselves, however 
the situation is emphasised in their EPMA training. There are also no specific 
guidelines in place within the two hospitals regarding the use of associated eStat 
medications. 
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The number of eStat doses prescribed from the data, was similar in both the 
hospitals that had implemented EPMA. As a percentage of the newly initiated 
medication prescribed regularly, 18% (n=17) of the medications also had an eStat 
dosage prescribed in Hospital A and 24% (n=19) in Hospital B (Table 5-3). In order to 
prescribe an associated eStat medication, different steps needed to be taken in 
Hospitals A and B (Sections 2.3.1 and 2.3.2) due to the different software used for 
prescribing electronically. Nevertheless, in both cases, a similar percentage of eStat 
medications were prescribed. Prescribing eStat medications created extra work and 
cognitive load for the prescriber, reinforcing the situational awareness that is 
required in order to prevent a medication administration being delayed or omitted 
and causing increased workload in prescribing the medication a second time. As a 
measurable standard the NPSA (4) suggests for EPMA systems “Where delays of up 
to five hours before scheduled administration will occur following a prescription, 
systems should remind prescribers that an intermediate dose may be required”. The 
researcher reviewed all regular medications to see if any additional associated eStat 
medicines should have been prescribed according to the NPSA statement. It was 
found that in Hospital A, a further 15% (n=14) of regular medications should have 
had an eStat dose prescribed and in Hospital B, a further 13% (n=10) of regular 
medications should have had an eStat dose prescribed. Effectively a total of 33% 
(n=31) of eStat prescriptions should have been prescribed in Hospital A and a total 
of 37% (n= 29) eStat prescriptions should have been prescribed in Hospital B to 
prevent any delays in medication being administered or omitted. The quantitative 
findings show that extra eStat prescriptions were completed, but not all the time 
within the ePrescribing system. EStat prescriptions were needed to ensure patients 
received their medicines on time and that no omissions of medication occurred due 
to the lack of a prescription.  
From a qualitative review of the prescription charts that had eStat 
medicines prescribed, it could be seen how each extra eStat medication 
compromised the clarity of the prescription chart. For example, in Hospital A the 
view of the prescription chart, listing patients’ medications, can only display a 
maximum of eleven medications at a time on the screen. Medications appear in the 
140 
list order of Stat, as required, regular and then discontinued (in a blue colour); 
within each category, they are displayed in alphabetical order. 
In Hospital A when a patient required several medications, the initial display 
of medications was not always relevant for administration or review by a HCP. This 
was because some prescriptions remained on the active screen, even if they had 
been administered, so that HCPs could also see what had previously been given. 
Extra eStat doses therefore pushed other prescribed medications further down the 
list on the initial screen, thereby reducing the clarity of the prescription chart. The 
way the medications are presented in a list order leads to the different types of 
prescription category, such as Stat, as required or regular medications impact upon 
the display of each other. This reinforced previous comments made in the focus 
groups (Section 4.4.2.2) about the initial EPMA view of the medication had to be 
scrolled through before relevant medications, that needed review, could be seen. 
Consequently, the design and arrangement of medications affect the clarity of the 
prescription, workload, and efficiency of HCPs’ working practice. It materialised that 
HCPs, usually the pharmacist, had to discontinue the medications in order to make 
the prescription clearer but that sometimes this could also lead to patient safety 
issues (Section 4.4.2.2). 
In Hospital B (Section 2.3.2), the regular and Stat medications appear 
together under the title of regular medications with the “as required” medications 
being displayed separately below the regular medications. Because the regular and 
Stat medications appear together in the electronic display, the regular medication 
and its associated eStat medication appear together, because each category can 
appear in alphabetical order or BNF order depending on how the user arranges 
them. Discontinued medications can be seen on a separate screen. This meant 
however that as required medications, when reviewing medications via the 
prescribers screen, got pushed further down the electronic prescription screen and 
needed scrolling down to be seen.  
The use of separate sections for each medication, as with a paper chart may 
provide a clearer picture than is currently the case with the list view in the EPMA 
141 
systems. The administration information, due to the design and layout of the EPMA 
system is not visible in the prescriber’s viewing screen. This provides understanding 
about the lack of clarity and accuracy on the medication “story” at a glance. 
The fact that prescribers, still need to inform the HCP looking after the 
patient that a Stat medication had been prescribed and needed administering was 
discussed in the focus groups (Section 4.5.3.2). Nevertheless, both EPMA systems 
prompt the prescribers to administer the Stat medication themselves or to inform a 
nurse that the dose needs to be given. It was perceived in the focus groups that 
technology could somehow inform HCPs when a new prescription was created in 
the system. However, this was not the case and instead some HCPs were 
continuously checking the electronic prescription chart to look for changes that 
could occur at any time, instead of getting on with their work (Section 4.5.3.1). This 
practice was also advocated in the NPSA document (4) stating that staff should be 
encouraged to interrogate systems for Stat doses.  
Communicating the fact that an eStat medicine had been prescribed and 
required administration was never documented in the medical notes; this message 
would usually take place in the form of verbal communication, as the nurse would 
generally need to know instantly about Stat medications requiring administration. 
5.3.1.2 Prescription Order Sets 
An order set is a collection of clinically related medication orders grouped by 
purpose (5). Documentation review enabled the exploration of order sets that were 
utilised within the EPMA system, in relation to surgical specialities, see Figure 5-2 
and Figure 5-3 for examples of prescription order sets in Hospitals A and B. The 
exploration highlighted patient safety issues with unclear and inaccurate written 
documentation of the order sets in the medical notes (Table 5-4). As well as the 
order set becoming a convenience (5) to facilitate efficiency, there were 
consequently patient safety issues: these included the possible duplication of 
medication or a failure to act on or highlight allergies or contra-indications to the 
medication within the pre-defined order sets. 
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Figure 5-2 Example of a prescription order set in Hospital A 
 
The image originally presented here cannot be made freely available via 
LJMU Digital Collections because of copyright. The image was sourced 
from Hospital A, EPMA system. 
 
The use of order sets facilitated the prescribing of several drugs all at the 
same time, advocating an increased efficiency for HCPs, especially in the speciality 
of surgery (5). Conversely, the use of order sets contributed to unnecessary 
prescribing of medications, leading to the prescribing of excessive medications and 
reducing the clarity of the prescription as discussed below.  
 
Figure 5-3 Example of a prescription order set in Hospital B 
 
The image originally presented here cannot be made freely available via 
LJMU Digital Collections because of copyright. The image was sourced 
from Hospital B, EPMA system. 
 
Within Hospitals A and B, the number of as required medications newly 
prescribed in the surgical specialities appeared to increase compared to the district 
general Hospital C with paper prescribing in place. On further examination, this 
appeared to be, to some extent, due to the utilisation of order sets within the 
EPMA system. The actual number of newly prescribed as required medications 
143 
exceeded the number of regular medications prescribed in the same period; see 
Table 5-4 below. 
Table 5-4 Prescribing of new medications on the surgical wards in Hospitals A, B 
and C with specific focus on order sets. 
Hospital A B C 
No. of surgical patients 14 10 10 
No. of new medications 90 51 65 
No. of Stat medications 9  6  8 
No. of Regular medications 38 22 44 
No. of prn medications 43 23 13 
No. of prn in order set 27 11 n/a 
No. of order sets used  7 in 6 pts 4 in 3 pts n/a 
 
In Hospitals A and B, two similar patient case studies showed that each 
patient was prescribed an order set twice during their admission to the ward. On 
review of the two cases, each HCP prescribed a second order set that contained 
very similar medications to the first and then proceeded to cancel numerous 
prescriptions, rather than to prescribe individual medications that were required in 
the first place.  
The use of order sets and whether they are effective or if they contribute to 
patient safety issues requires consideration. Specific protocols about the use of 
order sets are required to make HCPs aware of the risks of their use and to promote 
patient safety. The use of order sets may also de-skill the prescriber from creating 
individual prescriptions that they believe to be complicated. For example, the order 
sets prescribed for the patients at Hospital A included one for a naloxone infusion 
and a morphine infusion within the sets, see Figure 5-4. 
Figure 5-4 View of a surgical prescription order set in Hospital A 
 
The image originally presented here cannot be made freely available via 
LJMU Digital Collections because of copyright. The image was sourced 
from Hospital A, EPMA system. 
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In Hospital, B a morphine sulphate prescription was changed 14 times in 
total; a mixture of 4 Stat prescriptions and 10 “as required” or prn prescriptions 
were created. During review, it was realised that when the morphine Stat doses 
were prescribed, the nurses already had the option of administering as required 
morphine, and then because the “as required” prescription would have shown as 
duplication within the system it was discontinued. The other prescription changes 
occurred due to the wrong route of administration being selected and then further 
duplication of a morphine sulphate prescription occurred due to the prescribing of 
two separate order sets. 
Again, the clarity of the prescription was further reduced by the use of order 
sets that include many as required medications. Thus, when a lot of as required 
medications are prescribed for a surgical patient and the prescriber uses order sets, 
the regular medications that are important, were pushed even further down the 
screen due to the way in which the regular medications were displayed. 
5.3.1.3 Clinical indication on the prescription  
Having a clinical indication on as required or antibiotic prescriptions adds to 
the purpose and clarity of that prescription. However, the quality of the 
prescription can be disputed if the clinical indication on the prescription is wrong or 
not completed. 
All three hospitals within the study have policies in place, that state antibiotic 
therapy and as required medications must have a clinical indication specified on the 
prescription. The hospitals recorded the clinical Indication in different ways: 
 In Hospital A, the EPMA system used mandatory fields to force the 
prescriber to document the clinical indication of the stipulated medications, 
by not allowing them to continue with the prescribing process unless the 
information was completed.  
 In Hospital B, the clinical indication of stipulated medications was done by 
completing a “note” within the electronic prescription, this was not 
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compulsory and therefore the system did not enforce the prescriber to 
provide this information. 
 In Hospital C, on the paper drug chart there was a specific box requiring the 
clinical indication to be completed, like the rest of the prescription, 
manually. 
Because the three hospitals each had different ways of attaining the clinical 
indication of an as required medication or antibiotic on the prescription, it had led 
to different completion rates, see Table 5-5.  
Table 5-5 Number and percentage of new prescriptions with a completed Clinical 
indication on the prescription. 
Hospital A B C 
No. of Patients 32 29 28 
No. of new antibiotic prescriptions 19 19 35 
No. of new antibiotic prescriptions with a clinical 
indication 
19 
(100%) 
8 
(42%) 
20 
(57%) 
No. of new antibiotic prescriptions with a MES of 1 or 
2, to confirm accuracy of the clinical indication 
9  
(47%) 
6 
(75%) 
7 
(35%) 
No. of new “as required” prescriptions 62 41 24 
No. of new “as required” prescriptions with a clinical 
indication 
62 
(100%) 
22 
(54%) 
16 
(67%) 
 
In Hospital A, 100% completion of the clinical indication was achieved 
because of the mandatory field within the EPMA system. However, the accuracy of 
the clinical indications on the prescription was reviewed, in order to see if 
mandatory fields could achieve an accurate entry. Approximately half of the 
antibiotic prescriptions, 47 % (n = 9/19) had clinical indication entries that 
correlated with written documentation in the notes (MES of 1 or 2). The remaining 
10 did not have a detailed enough entry in the medical notes (MES 3, 4 or 5) to 
confirm accuracy.  
Interestingly, the completion rate of the clinical indication in (paper drug 
chart) Hospital C was superior to that of Hospital B where the EPMA system did not 
force the prescriber into completing the information. However, the accuracy of the 
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clinical indication was also explored, showing that the clinical indication may be 
completed but that it is not necessarily accurate.  
In Hospital B, where eight antibiotics had a clinical indication completed on 
the prescription, six (75%) had corresponding detailed entries in the medical notes 
to confirm that the clinical indication on the prescription was accurate, as it 
corresponded with the medical note entry (MES of 1 or 2). Of the 22 as required 
medications that had a clinical indication on the prescription, not one had a 
corresponding clinical indication documented in the notes (MES of 3, 4, or 5). The 
clinical indication in some as required cases was already populated within the 
electronic prescription, as it was part of an order set; this is discussed in the next 
section 5.3.2 when considering the medical entries within the notes. 
In Hospital C, of the 20 antibiotics that had a clinical indication on the 
prescription, only seven (35%) had a detailed corresponding medical entry (MES 1 
or 2) to confirm the accuracy of the clinical indication. The remaining 13 antibiotics 
had a MES of 3, 4 or 5. The general term “antibiotics prescribed” was used within 
the medical note entries on a number of occasions. Of the 16 as required 
medications that had a clinical indication on the prescription, only two had a MES of 
2 confirming its accuracy. The remaining 14 as required medications had a MES of 4 
or 5. 
The limitations of this study, exploring the accuracy of the clinical 
indications, are apparent due to the lack of detailed medical entries in the medical 
notes. It does not mean that the clinical indication was conclusively wrong or 
inaccurate, if there is no corresponding medical entry. However, the researcher 
cannot decisively say if the clinical indication was 100% accurate, this also reflects a 
“real” world scenario. 
 The clarity and accuracy of medical note entry 5.3.2
Where the clarity of a prescription is impaired, it may cause 
misunderstanding for healthcare practitioners such as other doctors, nurses or 
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pharmacists, possibly to the point that the prescription cannot be acted on without 
first seeking clarification from the prescriber.  
Medical entries are a contemporaneous log of information that may not 
clearly connect the required data. Decision-making is inferred or implied rather 
than implicit when connecting diagnosis and treatment. These entries were 
reviewed in order to explore the impact written communication can have on the 
quality of in-patient prescribing. 
A total of 89 patients healthcare documents were reviewed with 
approximately 30 patients from each of the three hospitals. The medical note 
entries for newly initiated medications (effective prescribing) were explored. This 
involved confirming that the prescriber had made a clear connection between 
diagnosis and treatment, by documenting within the same note entry their 
intentions, showing consideration of relevant clinical findings and diagnosis of the 
patient and stating the plan of action including the medication to be prescribed 
(12). The correlation of information was also explored, by looking at the 
information that was documented in the HCPs’ notes about a new medication and 
seeing if it matched the information provided on the prescription chart. 
Using the rating scale (Section 5.2.2.1) based on the GMC standards (12), 
the documentation within the notes did not always fulfil the criteria for clear 
documentation and led to difficulties in exploring possible medication errors.  
In all three hospitals, the MES of “1” was reached less than 30% of the time. 
This evidence suggests and reinforces previous research (38) that a direct 
connection of diagnosis and treatment, with a complete record of the new 
medication’s name, dose and frequency in the medical notes rarely happens 
leading to patient safety issues and inefficiency for HCPs.  
Medication errors occurring within the EPMA system are now possibly more 
convincing and harder to pick up compared to the paper prescribing system 
(Section 4.4.2). Therefore, written documentation in the medical notes is essential 
to confirm or pick up if a prescription error has occurred. 
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Documentation of new medications that took place on the medical wards 
was clearer, than notes made on the surgical wards; this can be seen in Figure 5-5 
and 5-6. Medications that are prescribed for in-patients in the area of medicine, 
rather than surgery, tend to be more complex and involve a higher number of 
patients needing newly initiated medications on discharge from the hospital. This 
provides some understanding as to the quality of written communication that takes 
place between the specialities of medicine and surgery. 
Figure 5-5 Medical Entry Scores for medical ward in-patients 
 
Refer to Table 5-1 for definitions of medical entry scores 
Documentation of the new medications of surgical patients had no clear 
direction or connection to the diagnosis in at least 65% of the patients, with 80% of 
surgical patients having no mention whatsoever of the new medication in Hospital 
B. In Hospital B, whenever the order sets were used in surgery they were not 
documented within the notes; this raises concerns about the use of order sets and 
their clarification within the medical notes.  
In Hospital A, if the surgical patients new medications within an order set 
were mentioned, not all the medications within the order set were documented, 
rather notes such as “pain relief” or “antiemetic”. The lack of clarity in written 
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documentation regarding order sets may be because not all of the medications 
within the “order set” were to be continued once the patient was discharged. 
However, this treatment was being provided to the patient whilst in hospital and 
therefore all HCPs involved in their care should know about the patient’s 
medications and the reasons why they were required in order for quality patient 
care to be provided by the multidisciplinary team. Documenting the order set name 
would define the medications that were prescribed and the reason why: for 
example, ANMINOR see Figure 5-2. 
Figure 5-6 Medical Entry Score for surgical ward in-patients 
 
Refer to Table 5-1 for definitions of medical entry scores 
 
 Timely documentation 5.3.3
The length of time it took to prescribe on the prescription chart and 
document in the medical notes was quantified. This was achieved by recording the 
time interval between making an entry in the medical notes and generating a 
prescription on the prescription chart. The working practices of HCPs were also 
taken into account, so whether the entry in the notes occurred before or after the 
prescription was created. The efficiency of HCPs is important to consider, as it 
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informs how quality care is being provided, possibly highlighting further delays in 
treating patients with a change in prescribing system. Therefore, the time it takes to 
create a prescription and how efficient HCPs are when new technology is 
implemented could expose further delays in treating patients. 
The time a prescription is created and the time interval between entering 
the intended plan of action in the medical notes and prescribing was explored in 
Hospital A and B. The problems that HCPs now perceive with efficiency included 
remote prescribing, delayed access to the prescribing system and the ability to 
prescribe on ward rounds; these were discussed in the focus groups and considered 
during documentation review. 
Unfortunately, because a time is only documented in the medical notes for 
each entry and not on the paper prescription chart, it was not possible to compare 
the data from Hospitals A and B with Hospital C and consider the impact on working 
practice between paper and ePrescribing. Further quantitative research within this 
area would be warranted. 
A total of 88 out of 181 (49%) newly initiated medications in Hospital A had 
a time of documentation in the medical notes, as per the GMC standards, enabling 
the researcher to deduce the time taken to prescribe a medication on the 
prescription chart before or after it was documented in the medical notes. A total 
of 49 out of 130 (38%) newly initiated medications in Hospital B, also had a time of 
documentation in the medical notes.  
Figure 5-7 and Figure 5-8 show the time interval between documenting in 
the medical notes and prescribing the medication on the prescription chart. The 
figures also depict whether the prescription, on the prescription chart, was created 
before or after an entry was made in the medical notes. The red bars show the 
percentage of prescriptions prescribed on the drug chart before an entry was made 
in the medical notes. 
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Figure 5-7 Distribution graph showing the time interval between documenting in 
the notes and prescribing in Hospital A. 
 
Figure 5-8 Distribution graph showing the time interval between documenting in 
the notes and prescribing in Hospital B. 
 
Only 2% of the prescriptions were created before the medical note entry 
was made in Hospital A, showing that 98% of the time the medical note entry was 
completed first. Figure 5-7 informs how the HCPs carry out their work in Hospital A 
and provides insight into HCPs clinical workflow when using an EPMA system. In 
Hospital B, the majority (88%) of medical note entries were made before a 
prescription was created. 
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Prescribing the new medication did not always immediately happen after the 
intended plan of action had been entered in the medical notes (12). In the district 
general hospital A (Figure 5-7), 25% of the medications documented in the medical 
notes were prescribed within ten minutes of the documentation taking place; this 
occurred (Figure 5-8) 22% of the time at Hospital B. The longer time intervals may 
suggest that access to the EPMA system could have hindered the prescribing 
process from taking place promptly. The percentage of medications prescribed 
increased as the time interval increased, with the majority of medications (75% in 
Hospital A and 65% in Hospital B) being documented and prescribed within an hour 
of each other. 
This interval of time between documenting in the medical notes and then 
creating a prescription has highlighted additional delays in the prescribing process. 
Previous research (4) has focused on delays by other HCPs in supplying and 
administering a medication, yet the periods involved in making an active clinical 
decision and actually prescribing the medication could be adding further efficiency 
concerns to the prescribing and administration process. This illustrates part of the 
clinical workflow processes that occur in practice. Yet it can only consider when the 
MDT or individual prescriber documented a clinical decision and not specifically 
when the clinical decision was made. It would not be unreasonable to assume that 
the speed at which ward rounds occur, as discussed in the focus groups, may have 
led to junior doctors documenting a prescribing decision in the notes and then 
prescribing after the ward round has ended. This raises questions about the clinical 
workflow of ward rounds and its timeliness and efficiency from a quality healthcare 
perspective. 
 Information given to patients (patient contact) 5.3.4
This Section explored HCPs’ entries in the notes for confirmation that the 
HCP had discussed and provided information to patients or their carers about the 
new medications that they had been prescribed. The information documented in 
the HCPs’ notes about discussing the new medications with the patient and 
providing them with advice was explored in order to deduce how often patients 
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were informed about their medications and included in the decision making 
process. Within all the hospitals, a similar number of verbal communications (Table 
5-6) with the in-patient were documented during their stay. 
Table 5-6 Information documented in the medical notes by HCPs, about 
discussions they have had with patients about their newly initiated medication. 
Hospital A B C 
No. of patients 32 29 28 
No. of medicines 181 130 144 
No. of medicines discussed 13 14 13 
% of medicines discussed 7% 11% 9% 
Where written documentation was recorded in the notes, the communication 
lacked detail about the information given to the patient. At all three Hospitals A, B 
and C, each with a different prescribing system, the results show similar levels of 
documentation about new medications being discussed with the patient. Whether 
a patient received information about their newly initiated medications was 
independent of the prescribing system used.  
5.4 Chapter Summary 
This chapter has given an indication of what is happening in practice using a 
documentation review approach of prescribing systems. Documentation review 
was chosen to evaluate (138) the changes in clarity and accuracy of the prescription 
chart and medical records making comparisons between Hospitals A, B and C. 
Documentation review was considered important as it enabled the direct 
comparison, without bias, of equivalent documents that already existed, that were 
not created for the purpose of research.  
Phase three indicated that changes in clarity occur with the prescription chart 
and medical entries in the notes, when moving from paper to ePrescribing systems. 
Documentation in the medical notes must improve, now that prescribing errors 
have become more convincing with the advent of ePrescribing. A clinically 
meaningful prescribing error can also occur, when the timely treatment of a patient 
is hindered. Documentation review has also shown how other quality components 
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such as efficiency and patient centred care can be influenced by a change in 
prescribing system. 
The following chapter brings together all three phases of the programme of 
work to discuss the findings and consider their implications for practice when 
providing quality care to patients. The limitations of the programme of work are 
also deliberated, along with future research aspirations. 
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6 DISCUSSION AND IMPLICATIONS FOR PRACTICE 
This chapter will discuss the data presented in Chapters 3-5 along with 
recommendations for practice, demonstrating that the impact prescribing systems 
have on healthcare quality is very complex. The data highlighted areas for critical 
consideration that are original or have previously been emphasised in research studies, 
providing more in depth detail as to why difficulties by frontline staff are encountered 
when using paper or EPMA systems and therefore the implications for practice.  
As Lucian Leape explained  
“Human beings make mistakes because the systems, tasks, and processes they work in 
are poorly designed” 
This was acknowledged in the NHS document Building a Safer NHS for Patients: 
Improving Medication Safety (84), where it was explained that errors which occur 
when both human and system factors interact, in a chain of often complex events, 
result in an undesirable outcome. The need to review systems in order to minimise the 
risk of latent conditions is therefore essential. 
While this programme of work was designed to explore the impact that different 
in-patient prescribing systems can have on healthcare quality, and how the change in 
prescribing system can impact on HCPs working practices, it did not seek to make 
statistical generalisations. Traditional statistical generalisations are based on sampling 
theory, where the ability to make extrapolations about a population is based on the 
representativeness of the sample selection. Within the programme of work analytical 
generalisation was used, whereby findings are generalised to theory, as proposed by 
Yin (139). The theory of STS (98) framework guided the final triangulation of the results 
to consider the prescribing systems as a whole. Understanding the issues where social 
and technical aspects interact in the prescribing system, emphasise where healthcare 
quality is impacted by a change in prescribing system.  
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6.1 Key Findings and Themes 
 When comparing paper and ePrescribing systems, the difference in the clarity 
of the prescription changes quite considerably, a factor that relates to the ease 
with which the correct meaning of the prescription is interpreted. The clarity of 
the prescribing “story” has deteriorated with the introduction of ePrescribing, 
impacting on HCPs ability to provide quality healthcare. 
 The accuracy of an electronic prescription is difficult to deduce, due to new 
types of prescribing error created by the design of the ePrescribing system and 
lack of detailed documentation in the notes of a prescribing decision. 
 The use of a clinical indication within the ePrescribing system could provide a 
way of detecting the inherent risk of selection error. 
 Further work reviewing EPMA design, is essential to progress the “standards for 
the design of hospital in-patient prescription charts” in relation to ePrescribing, 
along with optimising socio technical interaction and quality patient care. 
 The variation in training between individual training sessions and between 
hospitals was significant.  
 The change in clinical workflow and practices included very complex issues, 
such as eSTAT doses. 
 Quantifying prescribing errors based on quality indicators born out of paper 
prescribing deficiencies, will always show that ePrescribing has improved 
patient safety. Newly created prescribing errors due to the ePrescribing system 
need to be robustly identified, to enable a fair comparison between the safety 
of paper and electronic prescribing systems. The harm caused by newly created 
ePrescribing errors needs further consideration. 
6.1.1.1 Themes 
How technology can impact upon the individual: 
 Clarity of the prescription chart – Safe, Timely and Efficient 
 Accuracy – Safety and Errors (new error types) 
 Clinical Indication 
 Regulation 
 Accessibility and Reliability of the system 
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Social impact on technology 
 Training and Education 
 Clinical Workflow 
 Location of the prescription chart – Patient Centred 
 Change in HCPs’ Working Practices 
6.2 How technology can impact upon the individual 
 Clarity of the prescription chart – Safe, Timely and Efficient 6.2.1
A central focus of this programme of work, investigating the quality of care, is 
the clarity and accuracy of the prescription chart. Prescribing medicines is a key part of 
healthcare and so it is important that the prescription chart conveys clear and practical 
instructions to those reading them (12) . The General Medical Council  prescribing 
standards stated that doctors should “keep clear, accurate and legible records” (12), 
reinforcing the need for good communication amongst HCPs. 
The legibility of the electronic prescription is no longer a specific concern as 
information is text rather than handwritten. It is acknowledged that typed text is 
readable (140), yet how the prescription is designed and easily “viewed” and 
interpreted is still open to human error (see Section 4.4.2). Members of the MDTs 
perceived this, as an improvement now that the prescription was “legible” using 
results from the focus groups (Section 4.4.2.1). However, the HCPs felt their ability to 
identify medication risks was reduced, as illegible handwriting could indicate 
prescriber uncertainty and would lead to more caution when reviewing and 
administering medicines, prompting HCPs to double check the information in the 
notes. With the move to ePrescribing, HCPs in the focus groups reflected that there 
were no subtle clues (as with paper prescribing) and the prescription was “quite 
convincing" (see Section 4.4.2.1), leading to greater, possibly false, confidence in the 
accuracy of the information than would have been the case with some hand-written 
prescriptions.  
A number of design aspects influence the factors that limit the clarity and 
accuracy of EPMA prescriptions. The design aspects deliberated within the 
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multidisciplinary team focus groups (see Section 4.4.2.2), and reinforced with 
documentation review (Chapter 5). The design of the prescription chart (Section 
4.4.2.2) affected the HCPs’ working practices, changing their clinical workflow and their 
ability to provide quality care to their patients. The “prescribing story” and clarity of 
what medications a patient took were obtainable by a “glance” at the paper 
prescription chart. However, such an efficient, clear picture was perceived to be 
absent due to the layout and intricacies of the ePrescribing system.  
The design of the ePrescribing system had affected the “prescribing story” and 
clarity because HCPs now needed to view different screens to get the information they 
require, as well as scroll through the screen: this made the “prescribing story” of what 
medications a patient had received, or would receive, harder to comprehend (Section 
4.4.2.2) and detached. 
In ePrescribing systems, HCPs are required to navigate different screens to see 
all medication details, and must remember to do so during busy periods. 
Consequently, the HCP may not obtain a comprehensive view of the currently 
prescribed medication leading to increased patient risk. Not being able to view 
different screens at the same time, had led to inefficiencies compared to the paper 
prescribing system. For example, it was impossible to view the patient’s medications at 
the same time as creating the discharge letter. Cognitive load had also increased, as 
HCPs now have to remember information between screens leading to additional 
implications to patient safety and effective patient care (Section 4.5.3.3). The issue of 
navigating different screens leading to fragmentation of information concurs with 
previous studies (141). 
The design of the ePrescribing system had affected the “prescribing story” and 
clarity because of different “views”, depending on the HCPs’ working practice and 
priorities. The EPMA systems provided a view of prescription items, without any 
administration details available with it, generally for prescribers and pharmacists. 
Alternatively, a separate administration view, called the Electronic Medication 
Administration Record (eMAR), is available for nurses or any other HCP administering 
medications on a drug round using the EPMA system. The ability to gain information 
about a patient’s medication, and what they have taken becomes detached and the 
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prescribing “story” is impacted upon by having these separate views. Patient-centred 
care is hindered to a point, as specific patient administration details are disconnected 
and unclear. 
The design of the ePrescribing system had affected the “prescribing story” and 
clarity because the individual prescription items in Hospital A and B appeared in a list. 
The prescription items were presented using one “line” within the EPMA system 
(Sections 2.3.1 and 2.3.2 ), unlike the paper prescription chart in Hospital C that had six 
lines for each regular and as required individual prescription, along with the 
administration details (Section 2.3.3). The use of only one line to display a prescription 
item on a prescription chart compared to six lines brings the display of medications 
closer together and forms a list perspective. The individual medications become less 
defined and harder to distinguish, especially when the HCP has to scroll up and down 
the list, navigating past Stat medications in Hospital A to review the regular 
medications. Scrolling through the list to view all the medications could be time 
consuming and inefficient. 
The design of the ePrescribing system has affected the “prescribing story” and 
clarity because the ePrescribing system has different size displays depending on the 
electronic device used to view the prescription chart, compared to the paper 
prescription chart that has a large set viewing size that does not change. Small displays 
of text that never filled the computer’s visual display unit were a common occurrence 
on the desktop computers; it was like trying to “run a hospital through a letter box” 
(Section 4.4.2.2). The change in size and display can cause inefficiencies trying to 
decipher the prescription, possibly leading to patient safety risks. The lack of clarity 
and size of the prescription chart, whilst carrying out drug rounds, had led to HCPs 
having to concentrate a lot more on the computer screen rather than conversing with 
the patients. 
The order in which individual prescription items appear within the EPMA list is 
dictated by the EPMA technology. The systems in both Hospitals A and B displayed the 
prescription items alphabetically or by BNF category, rather than chronologically as on 
a paper prescription chart. Not having the medicines chronologically arranged can 
make deciding when a medication started or stopped difficult to comprehend, leading 
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to greater patient safety risks, for example, the length of course of an antibiotic, or the 
monitoring of a patient’s new medication. Whether a medication was taken before 
admission to hospital or newly initiated in the hospital setting was no longer as 
apparent in the EPMA system compared to the paper prescribing system. Previous 
studies have shown that the majority of prescribing errors occur early in the in-patient 
stay (1)(142). Knowing if a patient was taking a medication prior to coming into 
hospital (pre-admission medication) or that the medication started in hospital is 
important information. For example, being able to distinguish newly initiated 
medication facilitates communication with primary care, such as the GP, when the 
patient is ready for discharge from the hospital. When carrying out documentation 
review, the researcher had to document prescribed medications chronologically to 
understand what had happened retrospectively. The difference between a pre-
admission medication and a medication newly initiated in the hospital was not clear 
within the EPMA system (Sections 4.6.1.1 and 5.3.1.3). This highlighted the change 
from reviewing medicines chronologically on a paper prescription chart to 
alphabetically within the EPMA system.  
Each prescription item displayed in the EPMA system requires the addition of 
strength and formulation of the medication. This extra information of strength and 
formulation, is now required compared to the paper prescription, because the EPMA 
system may be linked into the pharmacy dispensing system. Therefore, the strength 
and formulation of the medication product needs selecting in order for the pharmacy 
department to be able to dispense the medication. However, the addition of strength 
and formulation data brought clarity issues. Some HCPs explained how easy it was to 
mix up the strength of the medication with the dose of the medication, and that when 
prescribing the medication it was “not how prescribers think about medications”. The 
change in working practice (Section 6.3.4) had therefore influenced selection issues 
and had increased the chance of prescribing errors due to choosing the wrong 
formulation. This was discussed in the telephone interviews (Section 3.3.2.3) and the 
focus group discussions (Section 4.4.4.1)  
Additional prescription items, compared to a paper prescription chart, are 
required with the use of electronic prescription charts; these include eStat medications 
and order sets. The focus groups and documentation review highlighted how the 
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additional prescription items had caused further issues with prescription clarity. Even 
though supplementary paper prescription charts were, still in use for certain 
medications, the addition of eStat doses, and/or the use of order sets (Sections 5.3.1.1 
and 5.3.1.2) to the prescription chart had thwarted the clarity of on-going medications 
for patients. Extra “as required” medications were being prescribed due to the use of 
order sets.  
6.2.1.1 Recommendations for clarity 
Issues encountered regarding the clarity of the prescription chart and its 
implications for practice are considered. To minimise the impact these issues have on 
working practices of HCPs, the following recommendations are proposed: 
 Re-configure EPMA software to reduce the navigation of different screens in 
order to obtain important information. Alternatively, the use of two visual 
display units for one computer would avoid HCPs having to recall information 
between screens, so for example HCPs can view the prescription chart at the 
same time as creating the discharge letter. 
 EPMA systems need to be re-configured to present the medications in 
chronological order, to enhance the prescribing story visually.  
 A distinction between pre-admission medication and newly initiated 
medication would facilitate communication between primary and secondary 
care, along with enabling the use of a clinical indication on the prescription. 
 A minimum viewing size for an electronic prescription chart, using any 
electronic device, needs stipulating in the “standards for the design of hospital 
in-patient prescription charts”(2). The use of smartphones to view a 
prescription should not be encouraged. 
 A tick box incorporated within the EPMA system, as a prompt to prescribe an 
associated eStat medicine if the medication is not due within the next five 
hours. The prescriber would still make the final decision. 
 An associated eStat medicine should not take up a completely new line on the 
prescription display, an asterisk would be sufficient. 
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 A different tab for each category of medicine so that they can be navigated 
easily and regular medicines viewed straight away without scrolling through 
Stat or as required medicines.  
 Administration status displayed with the prescription to highlight omitted 
medicines to HCPs that do not view the administration screen. 
 The use of order sets, for convenience, must be discouraged to ensure a 
specific protocol is followed. 
 Accuracy – Safety and Errors (new error types) 6.2.2
Due to the change in clarity of the prescription, the accuracy of the prescription 
and prescribing errors were difficult to deduce by the HCPs without using their clinical 
experience or referring to the medical notes. Previous research has shown that the 
design of the EPMA system could contribute to the creation of new errors 
(69)(136)(143). 
The lack of documentation in the notes of a prescribing decision or of an 
indication for a new medication was noted in all three phases of this study. The issue 
of prescribing documentation in the hospital medical record, has been a matter of 
concern for some time, being cited as a specific reason for prescribing errors (38). The 
prominent error type identified from the telephone interviews with Chief Pharmacists, 
whose hospitals had implemented and were using ePrescribing and the focus groups 
with HCPs, was the introduction of selection errors within the prescribing system. 
Doctor: It’s not safer for me because I prescribe the majority of medications so….I 
don’t write the wrong thing but I can click on the wrong thing and if I’ve written 
the wrong thing it’s because I’m stupid, if I click on the wrong thing it’s because I 
have made a mistake. A5 
Selection error has been identified in previous studies (64–70)(64,144). The technology 
used in Hospital A to order microbiology services experienced (Section 4.4.4.1) similar 
selection error issues. This led the researcher to consider how these selection errors 
could be robustly identified within the ePrescribing system. As discussed previously in 
the “clarity of the prescription” (Section 4.4.2) identifying this new error type had 
proved difficult for HCPs and was putting greater demand on their time. In addition, 
perception of less patient contact and discussion about their medications was taking 
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place, due to the change in location of the prescription chart, decreasing the HCPs’ 
chances of picking up the potential new types of selection error. However, written 
documentation of patient contact and discussions about medications was very similar 
between all three Trusts. The use of a clinical indication on the EPMA prescription 
could provide a solution, by requiring the prescriber to confirm the prescription with 
an indication; however, this would require further research. 
The clarity and accuracy of the medical note entries were queried by the HCPs 
in phases one and two of this study and, therefore, reviewed in phase three. With the 
clarity of ePrescribing being affected by various design changes, the medical note 
entries were important for HCPs to be able to check that the prescription was correct. 
Entries in the medical record were legible but, like the prescription chart, the medical 
plan was not clear (Section 5.3.2) and therefore the accuracy of the electronic 
prescription chart could not be deduced in many cases (Section 5.3.1.3). However, this 
reflects the issues that HCPs face in everyday practice of not being able to confirm if a 
prescription is appropriate for the patient. The reasons why doctors do not write 
clinical decisions in the medical notes regarding patients’ medications have also been 
studied: reasons included lack of time and colleagues’ clinical judgement to fill in the 
gaps being cited (135). Such issues forcibly demonstrate that awareness of the new 
selection errors within computerised systems should be stressed within training and 
the need for a quality entry in the medical notes to be able to detect the error.  
There is a conflict between providing efficient or safe healthcare, in order to 
identify new error types (10). The safety of the patient is paramount, so the time taken 
to try to identify the errors was perceived by pharmacy staff to have increased. 
Efficiency slowed due to the HCPs scrutinising the system and questioning its 
information, because human error was still a factor in providing the correct data 
(Section 4.4). Unclear medical note entries, as evidenced in Chapter 5, can also hinder 
HCPs’ efficiency in detecting prescription errors. 
The NPSA rapid response document (4), ”Reducing Harm from Omitted and 
Delayed Medicines in Hospital”, recognised the risks that e-prescribing brings to the 
administration of medicines and also how it can magnify existing problems already 
seen with a paper prescription chart. The need for doctors to have an awareness of 
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what time of day it is, when prescribing within the EPMA system and ultimately 
situational awareness (Section 4.5.2) about new prescriptions arose in the focus 
groups. HCPs felt it had resulted in quite a change to their working practices, requiring 
extra work, responsibility, and that it was difficult to comprehend. Documentation 
review therefore reviewed the use of eStat doses and the time delay between 
documenting a prescribing decision and creating a prescription as this could contribute 
to medication delays (Section 5.3.3). 
Hospital policies for the use of eStat medications need clarifying and reinforcing 
with HCPs. The use of eStat doses was included in training sessions provided by 
Hospitals A and B; nonetheless, the EPMA systems did not provide a reminder to the 
HCPS that an intermediate dose might be required, as proposed by the NPSA. It is not 
efficient for HCPs to check the EPMA system continually for any changes to 
prescribing, even though the NPSA proposed this as a solution. HCPS within the focus 
groups mentioned that they were constantly reviewing the information presented in 
the ePrescribing system, which had affected their clinical workflow in a negative way 
(Sections 4.4.1.1, 4.5.1.1 and 4.5.3.1). The extra task of prescribing the medication 
twice (eStat and a regular medication) had led to workarounds by staff, such as 
changing the system clock or borrowing doses from the next day. However, these 
solutions, although quicker for the HCP involved, had consequences for patient safety 
and were not officially documented within quality assurance protocols that should 
reflect actual practice within Hospitals A and B. 
6.2.2.1 Recommendations for accuracy 
Issues encountered regarding the accuracy of the prescription chart and its 
implications for practice were presented in the previous section. Proposed 
recommendations to try to minimise the impact these accuracy issues have on the 
working practice of HCPs include: 
 To make HCPs fully aware in training that the EPMA system does not 
completely take away human variability and that human error can occur, 
resulting in errors being harder to pick up. 
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 To provide HCPs with common errors encountered, with each specific EPMA 
system, using errors reported within the Trust in relation to the EPMA system 
used. 
 To make HCPs aware of selection errors within computerised systems and 
reinforce within training. 
 To make HCPS aware that a quality entry in the medical notes could enable 
them to detect errors within computerised systems and confirm accuracy.  
 To complete a clinical indication on the prescription chart, in order to confirm 
the appropriateness and accuracy of the prescription. This could be a possible 
solution but would require further research. 
 To remind prescribers via the EPMA system, that an intermediate dose (eStat) 
may be required, as proposed by the NPSA guidelines. 
 Clinical Indication 6.2.3
One of the recommendations by the Royal Colleges (2) that had not previously 
been a routine design standard on in-patient prescription charts, was to include a 
space for clinical indication on all regular and as required medications. The addition of 
a clinical indication to the design of the prescription chart was examined throughout 
the programme of work, as it facilitated a comparison between the use of a paper and 
electronic prescription charts.  
The use of an indication on the prescription varied across England with a 
variety of medications having an indication included (Section 3.3.1.2), the main group 
of medications being antimicrobial therapies followed by warfarin and as required 
medications. Very few hospitals required an indication on all of the prescribed 
medications. The overall response during the telephone interviews with chief 
pharmacists to the theory of including an indication on the prescription was positive; 
however, practical issues were raised as a reason for it not being routinely used. Staff 
at both paper and ePrescribing hospitals acknowledged that the inclusion of an 
indication on the prescription would make it clearer as to why the prescription was 
needed, facilitating HCPs’ working practices and communication with patients, 
assuming the clinical indication was correct. The use of an indication on the 
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prescription was reinforced during the focus groups, when communication between 
prescribers was thought to be facilitated by the inclusion of a correct indication.  
Chief pharmacists and frontline HCPs however all had reservations about the 
ability to include an indication on all regular and as required prescriptions. Concerns 
over completion rates and accuracy of the indication were discussed, and were the 
main driver for caution when using an indication on the prescription. The difference 
between a pre-admission medication and a newly initiated medication was defined 
and how the different medication categories influenced HCPs’ abilities to complete the 
indication for the medication. Where an indication was included on a prescription in 
phase three, the indication was studied to see how accurate it was when included on 
the prescription. Confirmation of accuracy had its limitations, however, the accuracy of 
the non-mandatory field entries in the EPMA system were confirmed to be higher, 
compared to the accuracy of the mandatory field entries.  
If we are moving towards electronically based systems, a clinical indication 
would be fundamental to resolving the issue of selection errors. This is important to 
ePrescribing systems, as ePrescribing is rolled out the use of a clinical indication needs 
to be part of standard workflow. This should not just be enforced, but actually become 
part of the medical, nursing and pharmacy education that people receive early on to 
understand the value of this piece of information in terms of identifying and 
minimising selection errors inherent in the ePrescribing system. 
6.2.3.1 Recommendations for clinical indication 
 Incorporating a clinical indication on the prescription would facilitate 
discussions with patients about their medications, before discharge from 
hospital. 
 Incorporated on all electronic prescriptions to identify and minimise selection 
errors inherent in the ePrescribing system. 
 GP surgeries need to supply the clinical indication of all patients’ medications 
upon admission to hospital, enabling continuity of care and the ability to 
provide a clinical indication on pre-admission medications. 
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 The use of a clinical indication on the prescription for newly initiated 
medications within the hospital and not pre-admission medications could 
increase the probability of a complete and accurate clinical indication.  
 Hospital Trusts must promote and reward good quality written documentation 
in the medical notes. The use of a clinical indication on the prescription chart 
could facilitate HCPs in providing efficient care as documentation of an 
indication in the medical notes is rarely clear. 
 Regulation 6.2.4
Regulation, control, feedback, and audit are important factors to monitor and 
improve quality healthcare, with the advent of new error types occurring with the 
EPMA system (65)(66)(64)(144). These were emphasised in all three phases of this 
study, noting the change a different prescribing system can bring to the area of 
regulation.  
Leaving gaps on a paper prescription chart, which could be considered a 
workaround, leads to issues of clarity and accuracy and from an audit point of view 
considered detrimental to quality patient care. The introduction of Mandatory fields 
within the EPMA system, as deliberated in phase one (Section 3.3.2.1) has enabled 
“regulators” to track and reinforce policies and guidelines. Conversely, mandatory 
fields have potentially provoked the ingenuity of hard-pressed staff, to create further 
workarounds to avoid being slowed down by the system (Section 4.4.4.2). The 
accuracy of the information provided is then questionable. For example, the EPMA 
system in Hospital A provides prescribers with a list of possible entries for mandatory 
fields, when prescribing. Therefore, if uncertain about specific information that is 
required, there could be a greater tendency to guess or complete the mandatory field 
with the wrong information (Sections 3.3.2.3 and 4.4.2.1) leading to administration 
errors and ultimately harm to the patient. 
Mandatory fields are appropriate for core prescribing information, but the 
expansion of their use needs consideration, taking into account the length of time it 
may add to a HCP’s clinical workflow, and the possible safety compromises the use of 
such fields could precipitate. As mentioned in Chapter 3, it is a balance between audit, 
workflow, and safety data (Section 3.3.2.2).  
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Obtaining specific information available in the ePrescribing system compared 
to the paper prescribing system had become a lot quicker and more efficient (Section 
3.3.2.2). This was a very positive aspect of the technology in phase one when chief 
pharmacists thought of the advantages of EPMA systems (Section 3.3.2.1). The 
ePrescribing system had enabled them to view a lot of information remotely and could 
now be utilised by the Pharmacy Department to improve care. For example, pharmacy 
staffs were able to locate patients on a specific medication that had been recalled and 
action the response quickly. 
The issue of being able to change a paper prescription, with no audit trail back 
to the HCP who had changed the prescription, raised concern with the HCPs (Section 
4.6.3). With the introduction of ePrescribing, the ability to audit prescription changes 
back to the HCP, that made the change, was an area that had improved. Although 
explanations, in the focus groups, of how audit and accountability in the EPMA system 
still had limitations, the ability to deceive the electronic audit system had become a lot 
tougher, minimising the occurrence of accountability weaknesses. 
6.2.4.1 Recommendations for regulation 
Considering what can be done, to minimise the negative aspects that regulations 
can have on the working practice of HCPs, the following recommendations are 
proposed: 
 The use of mandatory fields should be limited to essential prescription 
information.  
 The accuracy of mandatory field information needs auditing once in place to 
review the overall effectiveness of mandatory fields.  
 Further research to explore the use of mandatory fields and their impact on 
quality prescribing is warranted. 
 Accessibility and Reliability of the system 6.2.5
Without an accessible and reliable prescribing system, HCPs cannot provide 
quality care to their patients. Information stored within the system must be available 
at all times, quickly and efficiently to support HCPs clinical workflow. 
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The main issues noted in the focus groups with the paper prescription chart 
was that it could go missing, as it could be easily moved from the patient bedside on 
the ward and was an integral part of many processes, thereby making it susceptible to 
loss (Section 4.4.1.1). Other reliability issues with the paper prescription chart 
included; the prescription chart could fall apart after being in use for some time, due 
to high usage, and that it required re-writing as it could only hold a limited amount of 
prescription data (Section 4.4.1.1).  
The electronic prescription chart, on the other hand, had very different issues 
to contend-with, such as lack of available computers (Section 4.6.2.3). This was further 
compromised by hardware problems like broken keyboards, flat batteries, and Wi-Fi 
interruptions affecting drug and ward rounds. The response time and lack of IT 
efficiency in attending to these issues was apparent in both Hospitals A and B with 
queuing systems via the phone to report issues and then poor response times once an 
issue had been reported (Sections 4.4.1.1 and 4.6.2.3). Downtime (when the complete 
ePrescribing system is not available) was not explicitly discussed in the focus groups; 
however, downtime was mentioned as a potential worry by all focus groups. The 
advent of more electronic based documentation, such as electronic medical notes, was 
a concern, as computers would become integral to the HCPs’ clinical workflow and 
therefore the availability and reliability of the system would become crucial in 
providing quality care.  
Disruption of computer access and ultimately the electronic prescription chart, 
due to lack of computer availability caused by hardware issues needs correcting 
quickly and efficiently by the organisation. Delays in patient care due to hindered 
prescribing or missed doses all impact on the quality of care that is provided. These 
situations are due to technical issues that are beyond the HCP’s control. Nevertheless, 
hindrance of HCP’s clinical workflow occurs and an extra task of trying to find a 
solution follows. The HCP at the frontline is seen as the person not providing a quality 
service to patients and so these obstructions to providing care can cause frustration 
amongst HCPs. 
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 Recommendations for accessibility and reliability of the system 6.2.6
 Mapping the peak times of computer use and carrying out a clinical workflow 
review of all staff using the computers at peak times is required to see if more 
computers would solve the accessibility issues. 
 Provide a competent, designated IT staff member on the wards to take 
responsibility for keeping hardware functional and operational in all locations 
of the hospital, providing HCPs with easy access to the IT team if required. 
6.3 Social impact on technology 
From a social perspective, the staff involved in managing the different 
prescribing systems have taken on a more complex and time-consuming project that 
requires more effort and input to facilitate its use and ensure quality care is not 
compromised. Key HCPs, who have to learn and know how to operate and use the 
prescribing system, have had to change how they carry out their work (clinical 
workflow) in order to incorporate the new technology into their everyday working lives 
(Sections 3.3.2.2 , 4.4 , and 5.3). 
During the telephone interviews, from a social perspective, a chief pharmacist 
explained how the implementation of ePrescribing within the hospital had been a good 
quality initiative in itself (Section 3.3.2.2). This initiative brought together 
representatives of all the professional groups that would be using the system and 
gaining their viewpoints, along with specific training. The chief pharmacist believed 
that if the same process was used when implementing a paper prescribing system, 
with the same “buy in”, the quality of prescribing using the paper prescription chart 
might also have been better as HCPs may have complied a little more.  
 Training and Education  6.3.1
The training of staff to use any prescribing system is very important to provide 
quality patient care (Section 4.4.3.1). HCPs perceived that the paper prescription chart 
was self-explanatory and therefore minimal training was required compared to the 
ePrescribing system and that they could figure out what needed to be done in order to 
create a prescription (Section 4.4.3.1). The paper system did not require computer-
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literate staff and enabled agency staff to carry out their work without affecting other 
colleagues. However, it is confounded by the EQUIP study that looked at the 
prescribing error rate, with paper prescribing, in hospitals and recommended the need 
for a standardised paper prescription chart to facilitate prescriber training, in an 
attempt to improve the quality of prescribing (145)(45) on a paper chart. The theories 
for a standardised prescription chart anecdotally make a lot of sense, but the 
possibilities of a standardised EPMA system across England are not realistic when 
taking into account all the influential factors such as politics, Trust finances, existing 
software interfaces within the hospital etc. that influence the choice of system by Trust 
Management.  
A major finding from the focus groups was the variation in training provided 
between each individual training session and between Hospitals A and B. This wide 
variation in training was unexpected due to all the policies and procedures in place 
within such a complex, high risk, healthcare system. This variation might be due to the 
inexperience of the hospitals implementing the new prescribing system or the cost of 
employing staff competent enough to provide quality training on the systems. Having 
HCPs teaching other staff members is beneficial as they will be aware of the pitfalls, 
however HCPs do not necessarily have any teaching qualifications in order to provide 
an engaging and productive teaching session. How training was delivered was 
discussed at length in the focus groups, with improvements to training being 
suggested. HCPs agreed that a productive training session was essential but having an 
intuitive ePrescribing system was also important (Section 4.4.2.2); HCPs described how 
a more user-friendly system would enable them to work more efficiently. However, 
they acknowledged the dangers of trying to use any electronic system without the 
appropriate training (Section 4.4.3.1) or having not used the system on a regular basis. 
Documentation review in phase three (Chapter 5) revealed an “out of hours” 
doctor user guide in Hospital B, that provided a username and password for a limited 
amount of time. This showed that doctors were permitted to use the ePrescribing 
system without any detailed training and would be self-certified. It also enabled 
generic access to doctors, possibly affecting the audit trail for a short time within the 
Trust.  
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Different training packages were provided for nurses, doctors, and pharmacists 
(Section 4.4.3.1). The ePrescribing team trained some HCPs themselves; others 
received training from fellow colleagues on the job, potentially passing on 
workarounds or bad habits between staff. The diversity in training and time permitted 
would potentially create different standards of users and ultimately have an impact on 
the quality of patient care. Some HCPs felt that training was “painful” and rushed or 
did not focus on the important points. 
Each profession had its own specific training within each Trust that focused on 
parts of the system they used the most. It was debated within the focus groups that 
each profession should know and understand the whole system in order to have an 
awareness of how their actions can affect the whole system and fellow colleagues 
within the multidisciplinary team. Pharmacists in Hospital B explained how they did 
not have a training “package” yet the doctors and nurses did. Pharmacists felt they use 
the system most of the time, yet their training was a combination of the training 
received by doctors and nurses. The fact that pharmacists had also become unofficial 
IT support on the wards reinforced the need for thorough training and an overall view 
of the system (Section 4.4.3.1).  
The use of different functionalities within the ePrescribing system, such as 
clinical decision support, mandatory fields etc. requires standardisation and a lot of 
consideration from management to facilitate training. What may seem like a good 
patient safety initiative could also backfire if not used properly. This again reinforces 
the need for good training and that experienced staff is essential to providing quality 
patient care. It is important that training be provided by a competent ePrescribing 
team made up from each profession (MDT) who have an understanding of the issues 
that arise when using the system in relation to each professional’s job. 
6.3.1.1 Recommendations for training 
 Further research in the area of education and training on the EPMA system is 
required in order to provide the best training for new HCPs in the time 
allocated by each hospital Trust.  
 Follow up training should be available to all staff members, at any time, if they 
feel they are not confident in using the system to the best of their ability.  
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 Extra training and/or support should be readily available for staff that are not 
computer literate or do not use the system on a daily basis. 
 A compulsory review or mini-test, for example every two years put in place by 
the Trust to ensure the quality of their EPMA users.  
 An EPMA “users group” with HCPs actively using the prescribing system on a 
regular basis would be beneficial to highlight workarounds and general EPMA 
system issues. 
 Explanations about situational awareness and the functionalities in use within 
the system, such as automatic stops for antibiotics, must be discussed in 
training and routinely emphasised based on a patient safety perspective.  
 A multidisciplinary team approach to training could provide opportunity for 
situational awareness of using the system and enhance inter-professional 
learning. 
 Clinical Workflow - Timeliness 6.3.2
The time taken to prescribe an individual prescription item using the electronic 
system compared to the paper system was perceived to take much longer (Section 
3.3.2.2). This was noted by chief pharmacists during the telephone interviews and 
frontline staff in the focus groups (Section 4.4.4.2), who were using the ePrescribing 
system on a regular basis.  
A chief pharmacist explained how you “could make it half an hour to prescribe 
something” (one prescription item) in the ePrescribing system. This provided insight 
into how important it was to consider the balance between getting accurate audit 
information, safeguarding patients by using mandatory fields and warnings but not 
slowing clinical workflow down to the extent that it could have a rebound effect on the 
original quest for quality patient care. For example, having too many mandatory fields, 
and the number of safety warnings that appear, in the end could have a negative effect 
on the HCPs’ ultimate goal of providing patient care as the time taken to complete a 
prescription could take so long that they do not have time to see physically the patient. 
The increase in time taken to prescribe medication using the ePrescribing 
system can be a driver for HCPs to create workarounds. For example, the ingenuity of 
staff to avoid completing the mandatory fields, by putting a “full stop” rather than the 
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required information (for example a clinical indication) as an entry in the mandatory 
field. Each individual item prescribed within the electronic system requires the 
strength and formulation of medications unlike the paper system (Section 2.3). This 
ultimately leads to the prescription becoming more time consuming to create and 
requires the prescriber to have knowledge about specific formulations. 
The lack of computer availability in both Hospitals A and B were slowing HCPs’ 
clinical workflow (Sections 4.4.1.1 and 4.6.2.3). Even when the HCPs had obtained a 
computer they still had to log onto the system: an even harder task was to keep access 
to that computer. Some HCPs had resorted to carrying the computer with them “not 
wanting to let it go”, possibly leading to a shortage of available computers. Lack of 
computer availability on the wards was also resulting in the promotion of remote 
review and prescribing. HCPs described how they had to leave the ward to obtain 
access to a computer and then go back to the ward in order to check the patients’ 
notes and discuss things with the patient. 
The time difference between, documenting the decision to prescribe a new 
medication in the medical notes and then creating a prescription in the prescribing 
system was reviewed in phase three (Section 5.3.3). This provided an understanding of 
the prescribing HCPs’ clinical workflow and the time it takes to create a prescription 
once it is decided to prescribe a new medication. It was deduced in phase three that 
90% of new medications are documented in the notes before being prescribed. 
6.3.2.1 Recommendations for clinical workflow 
 Hospital Trust management responsible for EPMA must ensure a balance 
between audit information, safeguarding patients and clinical workflow is 
achieved. Further research to consider the optimal balance is required. 
 Management need to facilitate feedback about inefficiencies in the system and 
provide a prompt action plan to minimise wherever possible the use of 
“unofficial” workarounds. 
 Management must ensure that a prompt connection to the EPMA system is 
possible and computer facilitates are available at the patient bedside and 
remotely to facilitate clinical workflow. 
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 The EPMA system should have the facility to log out automatically on one 
computer terminal, if a HCP tried to log onto the system at a different 
computer terminal. 
 Any changes to the prescription will require a password or fingerprint to 
provide an audit trail, but this process must also be efficient and rapid. 
 Consultants need to consider their juniors when ward rounds are taking place, 
providing sufficient time to prescribe before moving to the next patient. 
Training should reinforce how important the balance of efficiency and safety is 
within the complex healthcare environment. 
  Location of the prescription chart – Patient centred  6.3.3
With the recommendations of the Francis and Berwick reports (8)(146) to 
ensure patients are central to their own care, the change in location of the prescription 
chart, away from the patient bedside, becomes a concern. The adjustment in 
prescribing system has had a considerable impact on HCP’s working practices and the 
amount of patient contact they have. In phases one (Section 3.3.2.2) and two (Section 
4.4.1.2) it was acknowledged by chief pharmacists and HCPs that the change from 
paper to ePrescribing systems had promoted less patient contact due to the advent of 
remote prescribing or remote access. This issue has also been raised in other EPMA 
implementation studies (20)(114), yet the best solution is not straight forward. The use 
of handheld devices (i.e. tablets) at the patient bedside has been suggested (20), to 
bring the HCP closer to the patient, but the size of the prescription chart is then 
compromised. 
Characteristically in a hospital with paper prescribing, the prescription chart is 
kept at the bedside, with the patients’ observation charts; this was standard practice in 
Hospital C (Section 2.3.3). Having the paper prescription chart at the bedside provides 
opportunity for the HCP to discuss medications with the patient and clarify any 
queries. It also provides a physical prompt as to when a new medication is prescribed 
for a specific patient. EPrescribing has enabled HCPs to access, review, and prescribe 
from anywhere, on or off the ward that the patient is staying on; this has taken the 
action of prescribing away from the patient. Hospitals, when implementing 
ePrescribing as in Hospitals A and B, have computers on wheels that can be pushed to 
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the patient bedside or laptops available for the HCPs to use. In reality, as discussed in 
the Focus groups (Section 4.4.1.2), the physical effort to take the computer to the 
patient bedside tends to hinder patient contact from occurring. The use of computers 
on wheels does not always facilitate HCPs’ working practices, especially during surgical 
ward rounds, when patients are distributed across numerous wards. 
When HCPs were “On Call” remote access to the prescribing system enabled 
efficiency and timeliness, by facilitating review of more than one patient’s prescription 
chart, from a single location. All HCPs were able to check advice was followed and 
carried out as instructed, therefore aiding a double check and helping patient safety 
aspects. On the other hand, if a prescription is created remotely to the patient (Section 
4.4.1.3), the HCPs need to ensure that they have examined the patient and that they 
are happy that the prescription is appropriate. The GMC advises only prescribe when 
you have adequate knowledge of the patient’s health; this becomes difficult to comply 
with when working remotely to the patients and their medical notes (12). 
Documentation in the medical notes becomes a concern, as the medical notes are not 
routinely available when remote access to create a prescription or review a 
prescription takes place. This may change with the introduction of electronic patient 
records (EPR). However, the patient may become even more detached from the 
prescribing process, with more documentation going electronic, resulting in less 
patient-centred care. With no immediate access to supplementary prescription charts 
or medical notes, the complete patient “story” is not available to the prescriber. In 
addition, the actions taken by the HCP to prescribe or review a patient’s medication 
cannot be documented in the notes at the same time.  
Considering the changes in potential patient contact, discussed in the focus 
groups, the situation was explored during documentation review (Section 5.3.4). 
Documentation of patient discussions about their new medications only occurred 
approximately 10% of the time in all three hospitals (Table 5-6). These results were 
independent of the prescribing system, though limitations due to lack of written 
documentation rather than communication with the patient could be deduced. Such a 
low percentage, even with documentation issues, highlights the fact that patients may 
not be involved in the decision making process as much as they should. Patients need 
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to be informed about new medications whilst taking them as an in-patient in hospital, 
even if the medications are not going to continue once the patient is discharged. 
The review in phase three explored the quality of documentation in the 
medical notes and the time difference between documenting in the notes and creating 
a prescription. As discussed in phase three the lack of detailed written communication 
in the notes was worse than previously suspected, with 80% of new medications on 
the surgical ward in Hospital B not being documented (see Figure 5-6). The 
prescriptions not documented may have been created remotely to the patient and 
medical notes. However, further quantitative work in this area is required to deduce 
how often remote prescribing is taking place and how patient safety is fairing.  
Doctors also felt that more junior prescribers may find themselves being put 
under pressure by other staff members to prescribe remotely for a patient without 
examining them first (Section 4.6.3.1). Therefore, prescribers must safeguard against 
remote prescribing. Some HCPs commented on how examination of the patient had 
changed their mind. HCPs must consider the balance between safety, saving time and 
working more efficiently. As Reason (10) explained the balance in any system between 
output and safety must be considered. 
6.3.3.1 Recommendations for patient-centred care 
 A computer with a minimal size visual display unit that will provide a full view 
of the electronic prescription chart at every patient’s bedside is required. 
 The position of the visual display unit must be unobtrusive and adjustable, to 
facilitate patient discussion with the HCP and ensure its position is user 
friendly. 
 A checklist should be implemented to facilitate documentation of patient 
counselling regarding new medications and any concerns raised by the patient. 
 Management must promote a patient safety culture, safeguarding against 
remote prescribing “pressures” from staff to prescribe without examining the 
patient first. 
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 Change in HCPs’ Working Practices 6.3.4
One of the main changes in working practices for all HCPs was how they now 
communicated with each other and the patient. The use of physical prompts, such as 
seeing the prescriber physically write a prescription at the patient’s bedside, was no 
longer possible. Alternative means of communication were required, such as “jobs 
books” rather than “post it notes” for written communication. The amount of verbal 
communication was perceived to have increased after implementation of EPMA 
(Section 4.5.3). This was also concluded in another study that looked specifically at the 
experiences and perceptions of hospital pharmacists (114). In Hospitals A and B there 
was an awareness by all HCPs in the focus groups that changes in communication had 
occurred but that no one was really quite sure what official process should be used 
between the multidisciplinary members (Section 4.5.3.3). Specific communication 
changes were discussed within the focus groups, but exact solutions and official ways 
of communicating, since the implementation of EPMA, were not clear to the HCPs. For 
example pharmacists, on some occasions, were documenting important queries they 
had for prescribers in the pharmacy care plan, jobs book and medical notes along with 
bleeping the prescriber to inform them verbally (Section 4.5.3.3) leading to duplication 
of work and inefficiencies. 
The most time consuming practice that has been adopted into clinical workflow 
is the need for HCPs, specifically nurses and pharmacists, to constantly check the 
EPMA system for newly prescribed, changed or discontinued medications (Section 
4.5.3.1) which is not a two way process of communication. The practice of constantly 
checking the system was adopted as a check for lack of verbal or written 
communication from the prescriber because, unless someone is checking the 
computer, new prescriptions may not be picked up in time. 
It is not clear which HCP is responsible for delays in treatment when a change 
in medication occurs and is not actioned. Therefore, lack of guidance has led to HCPs 
becoming obsessed with checking the EPMA system. Until prescribers take 
responsibility for informing their fellow HCPs verbally of any necessary changes in 
prescribing, the practice of checking every patient’s prescription chart, just in case a 
change is made, will remain and add to HCPs’ inefficiency and workload. Continuous 
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access to the system and the need to check “constantly” may distract from other 
clinical practices leading to some HCPs feeling “a bit of a slave to the computer”. The 
NPSA (4) suggested the need for HCPs to check the system as a way of picking up 
potentially delayed doses. However, a more robust two-way communication solution is 
required to enable HCPs to work more efficiently. This prompts the question whether 
there is a greater need for verbal communication between HCPs now, compared to the 
paper prescribing system. However, from the data obtained, this increase in verbal 
communication cannot be quantified by the methods used.  
Nurses can no longer modify prescriptions, as previously done with the paper 
prescribing system, to facilitate the doctors’ working practices, such as altering 
administration times or formulations. Therefore, the ePrescribing system had enabled 
a more robust audit trail, yet it had increased prescribers’ workload forcing them to 
consider new situations, leading to a change in working practice (Section 4.5.2). For 
example, prescribers now have to consider the time of day they create a prescription 
(situational awareness) and what exact formulation they require of a medication, that 
with a paper prescribing system would not be routinely considered. 
The pharmacists’ review of the prescription chart, and therefore their clinical 
working practice, has changed becoming more time consuming due to the alteration in 
clarity of the prescription chart and the items prescribed. Pharmacists’ review now 
includes a more “technical” check, as well as a “clinical check” scrutinising the system 
to ensure the “new” potential prescribing errors are not missed (Section 4.5.1.1). 
However, pharmacists could now prioritise any changes made to the prescription from 
one location, making them more efficient. Nevertheless focusing on changes to the 
prescription chart may lead to overlooking patients whose condition has declined and 
require Pharmacy intervention. The way to prioritise patients for pharmacy review 
needs discussion within the MDT and a procedure put in place within the pharmacy 
department so that pharmacists have a framework to prioritise.  
The natural inclination of HCPs to ask their pharmacy colleagues about how the 
EPMA system worked and how to navigate difficulties was happening (Section 4.4.3.1). 
Pharmacists are more accessible than the IT department, and they tend to have 
experience that is more practical with the EPMA system. Either way within the focus 
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groups, most HCPs would ask their pharmacist about an issue with EPMA first before 
contacting the IT department. This has highlighted a potential change in practice for 
pharmacists, trying to support their colleagues when using the EPMA system even 
when HCPs have all had the same training.  
6.3.4.1 Recommendations for HCPs’ working practices 
 Hospital management need to ensure there are clear and official avenues of 
communication between HCPs, with the implementation of EPMA. Taking into 
consideration how HCPs work as part of a MDT and that inter-professional 
communication is essential to facilitate quality patient care. Without clear 
routes of communication, responsibility is ambiguous which can lead to miss-
communication and ultimately patient harm.  
 The EPMA technology could inform all HCPs of changes made to their patient 
prescriptions, in order to minimise HCPs constantly checking the computer 
system for any changes.  
It is likely that the findings presented in this chapter after theoretical abstractions from 
the data were not due to the researcher, or participants that were recruited from a 
typical case sample, but the fact that they were uncovered was due to the three 
methods used and triangulation of the data and methods.  
 Reflexivity  6.3.5
Working as a Pharmacist in the NHS hospital sector prior to undertaking the PhD 
was an area that needed consideration. The researcher had experience of working 
with different electronic and paper systems, which may have brought with it 
preconceptions. However, the researcher had not specifically worked with an EPMA 
system. This enabled the researcher to take advantage of the “insider” knowledge and 
experience for example in gaining access to research sights and designing the study 
whilst remaining an outsider in terms of exposure to EPMA systems, therefore 
reducing the risk of pre-conceptions.  
Being reflexive is a massive challenge when you have a clinical focus. It is difficult 
to separate roles between researcher and clinical pharmacist. The researcher’s identity 
as a pharmacist was made explicit to the participants in all hospitals. Reasons for this 
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were that the researcher was known in one of the study hospitals, as well as previous 
hospitals they had worked in. Therefore, it was felt likely that if not revealed at the 
outset, the fact that the researcher was a pharmacist would emerge. Furthermore, the 
researchers inside knowledge would become apparent to participants over time due to 
the terminology or phrases used. Although the researcher’s background as a clinical 
pharmacist was revealed, their role as a student and researcher was highlighted. To 
help establish this, the researcher during casual conversation with chief pharmacists or 
employees within the study hospitals would freely discuss information relating to her 
experiences both as a researcher and as a pharmacist. It is important to build a good 
rapport with participants in the study and other individuals within the setting in order 
to help individuals to feel comfortable with the researcher and enhance the depth and 
quality of data collected. 
During the telephone-interviews with chief pharmacists answers to some open 
questions were lengthy and included terminology used specifically in pharmacy to 
explain the intricacies of the prescribing systems. Having worked within the subject 
area the researcher did not have to interrupt the flow of conversation to clarify too 
many issues. However, the term “you know what I mean” was used by chief 
pharmacists during the telephone interviews, if the researcher did not know what they 
meant, it was clarified at the time.  
When facilitating the focus groups with the MDTs in each of the three hospitals, it 
was essential to remain impartial. However, as the members of the MDTs were aware 
of the researcher’s background as a clinical pharmacist, they were able to use medical 
terminology and phrases that would only be understood by someone whom had 
previously worked within the subject area.  
When carrying out documentation analysis, the researcher’s background initially 
slowed the process when reviewing notes for clarity and accuracy, as clinical context 
was distracting. However, piloting the documentation analysis process and 
constructing a simple guide to gain the correct information kept the researcher on 
track and facilitated the process. On the other hand, having “insider” knowledge of 
navigating different sections of the patient’s notes and familiarity of documentation 
construction in healthcare improved the process. 
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This chapter has discussed the implications for quality healthcare practice from 
across all three phases of the programme of work and provided recommendations. 
Reflexivity of the methods has also been taken into account. The final chapter will 
conclude the programme of work by, providing limitations and key recommendations 
for the future along with further research aspirations.   
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7 CONCLUSIONS 
The final Chapter of this thesis focuses upon the significant areas from the 
previous chapters. In Chapter 1, the background literature regarding prescribing 
systems was presented, with an overview of the programme of work specified in 
Chapter 2. The findings from the three phases of the programme of work are described 
in Chapters 3, 4, and 5. Chapter 6 has discussed and highlighted the implications for 
practice that different prescribing systems can have on quality healthcare. This chapter 
presents limitations, personal reflections and finally the conclusions that explain what 
is required in future development of the EPMA system in order to facilitate quality 
healthcare and further research. 
7.1 Methodological Limitations for the programme of work 
During the telephone interviews in phase one; it became apparent that 
personal assistants were, to different extents, answering the phones for the Chief 
Pharmacist and trying to make decisions, in some cases, on their behalf. The 
researcher explained to the personal assistants that it was NHS research being carried 
out. To overcome this scenario the researcher reassured the personal assistants about 
the research and offered to e-mail them a copy of the research information directly 
and then ring back. Explaining the research and taking the time to build a rapport with 
the personal assistant facilitated further interviews taking place. The time of year, just 
after Christmas, meant that some potential participants were on annual leave initially; 
therefore, to overcome this, the data collection period was extended from 4 weeks to 
6 weeks. Different regional responses to the telephone interviews were noted; 
however, the purposive stratified sampling used enabled the researcher to take into 
account the region and size of hospital across England. 
Whilst conducting focus groups within phase two the researcher was aware of 
potential scenarios that could arise during each focus group session, such as group 
dynamics including dominant participants or quieter individuals. Having researched 
known limitations of focus group methodology and carrying out a pilot study the 
researcher was able to pre-empt possible situations and facilitate the group ensuring 
each participant spoke within the discussion. It is important to be aware that focus 
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group discussions provided multidisciplinary team perceptions, and not necessarily 
reality. Considering the perceptions gained from phase two, phase three minimised 
the use of perceptions by reviewing actual written documentation created by the same 
multidisciplinary team members. 
The availability and retrieval of the medical notes / documents in phase three 
to review written documentation created by the multidisciplinary teams presented a 
limitation that informed “real” world research. The researcher within each study 
hospital had to rely, to a point, upon administrative staff to obtain the relevant 
medical documentation for the study. The researcher, wherever possible, facilitated 
the process; any notes that could not be located due to different scenarios were 
documented and the researcher followed up to see if any of the patients had passed 
away. This was not the case for any of the unavailable notes. The number of 
unavailable notes was higher within the hospitals that had EPMA in place, compared to 
the hospital with paper prescribing.  
The researcher did not review any completely illegible entries in the medical 
notes, the researcher used their clinical experience to decipher difficult to read 
passages but did not have to disregard any entries due to illegibility. 
Having to obtain patient consent in phase three at one hospital, limited 
diversity of the patient notes accessed. The impact of a patient’s condition or 
treatment, when considering the change in prescribing system, may affect the 
structure of content within the written documentation and therefore could influence 
the results. 
The range of prescribing systems included in the programme of work 
attempted to capture the diversity of in-patient prescribing systems in use across 
England and gain peoples’ experiences. Therefore, the three hospitals (A, B, and C) in 
phases two and three were selected as each had their own prescribing systems in 
place. However, specific issues in relation to prescribing systems not represented 
within this programme of work have not been identified. Whilst this is a limitation to 
the programme of work, the inclusion of more hospitals with different prescribing 
systems would not have been possible with the available resources. 
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Phase three documentation analyses of the medical notes, exposed medical 
entries did not constantly comply with documentation standards. Consequently, 
medical notes did not always have times documented for entries or mention new 
medications being initiated, and therefore could not be associated with the new 
prescription. In order to deduce how often the newly initiated medication prescribed 
was warranted, the new medication needed to be documented in the notes. This 
proved to be very difficult as the extent of clear written communication within the 
medical notes was limited. Therefore, it was not possible to determine if the correct 
medication, dose, and frequency was prescribed or whether a prescribing error had 
taken place. The situation reflects clinical practice and highlights an area for concern 
regarding patient safety.  
Phase three begun the development of the “medical entry score” tool used in 
documentation analysis to deduce whether the entry in the medical notes made by the 
prescriber was specifically linked with the initiation of a new medication. Judgement 
on clinical content was required to deduce the Medical Entry Score (MES) from entries 
in the medical notes; subjective decision-making was a limitation inherent in the 
analysis. However, the data were purely descriptive and no attempt was made to 
assess the clinical significance of the data. The use of the MES rating scale would be a 
valuable asset to medical note audit in the future; this area of research requires much 
needed investigation. 
The programme of work-entailed exploration of how different prescribing systems 
affected HCPs’ working practices and so included doctors, nurses, and pharmacists. 
Additional groups, for example patients, pharmacy technicians, and IT specialists might 
have given different perspectives on the topic; however, their opinions fell outside the 
remit of the PhD. The value of other groups’ opinions is acknowledged, providing an 
opportunity for future research. 
7.2 Personal reflections 
Deciding to take on a PhD in pharmacy practice was influenced by my experience 
as a hospital pharmacist, specialising in Oncology and a constant need to learn. Central 
tasks as a clinical pharmacist in Oncology would involve using my initiative and thinking 
 186 | P a g e  
 
of novel solutions to a problem. I found this stimulating and exciting, once the desired 
outcome was achieved; discovering this is where my potential lay.  
Organising the work involved for a PhD takes good time management and 
requires organisation with a lot of attention to detail; I have certainly learnt that 
planning, determination, endurance, and motivation are all essential in order to 
complete a PhD to the best of your ability. However, too much planning can 
sometimes hinder the process, for example the moments where I procrastinated about 
the process so much, that it hindered me actually progressing with the work. Being 
able to discuss the research with my peers and family encouraged my thoughts on the 
topic and facilitated the whole PhD process. I have learnt that in order for me to 
consolidate thoughts and connect ideas it requires conversations with friends or a 
relaxed thinking environment with no interruptions. 
Recruiting Chief Pharmacists for the telephone interviews and gaining a rapport 
with them was a task at first, but it did provide countless inter-personal skills. It helped 
me consider all the different personalities that we encounter in life and how to adapt 
my approach depending on their mood. Recruiting three hospitals to take part in my 
research also enhanced my networking skills and demonstrated my ability to develop 
and maintain connections with external providers.  
The PhD has been rewarding seeing the outcomes of all the hard work along the 
way, but also challenging at times, providing me with diverse skills in order to achieve 
a high standard of research in the area of pharmacy practice. Because of undertaking a 
PhD, I have gained skills in submitting ethics applications, using different research 
methodologies, qualitative data analysis, preparing abstracts and posters and 
presenting research findings orally at conferences. The determination required and 
self-motivation to continue the PhD has come from my passion for the research 
subject and how this research can inform and improve prescribing systems and 
ultimately patient care in the future. I hope to continue research in the field of 
electronic prescribing and develop both the evidence base and my own expertise. 
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7.3 Conclusion 
This programme of work has successfully explored and provided a greater 
understanding of the effect different prescribing systems can have on healthcare 
quality and how the changes from paper to ePrescribing systems influences HCPs’ 
working practices. When comparing paper and ePrescribing systems, the difference in 
the clarity of the prescription changes quite considerably, a factor that relates to the 
ease with which the correct meaning of the prescription is interpreted. This research 
has established that the change from paper to ePrescribing systems does not 
necessarily improve the ease with which the prescription information is 
communicated. Instead, the clarity of the prescription varies in different ways. It has 
been acknowledged that ePrescribing has created new types of prescribing errors 
(38)(144). This programme of work has confirmed that ePrescribing has new types of 
clarity and accuracy issues compared to the paper prescribing system. 
The clarity of a prescription with paper prescribing systems may be influenced by a 
number of aspects such as legibility, the use of unapproved abbreviations, the 
omission of essential medication details and prescriber identification. These aspects 
have been used as indicators of prescribing quality, all of which have been actioned to 
some extent by the implementation of EPMA. As such, the quality indicators have been 
used to review the quality of ePrescribing, highlighting and showing how ePrescribing 
has improved these quality indicators and quality care. However, these indicators, 
derived from paper prescription issues, are no longer as relevant. The perceived 
improvements of an EPMA system are that it can provide a complete and legible 
prescription. Yet with the introduction of ePrescribing systems, new comparisons and 
considerations arise when looking at the ease with which the correct meaning of a 
prescription is interpreted. The legibility of a prescription is no longer a specific 
concern, yet how the prescription is viewed and interpreted is still open to human 
error or individual opinion. 
When comparing the two prescribing systems (paper vs electronic), using the 
standards that paper prescribing has not met, of course, the electronic system is going 
to achieve a higher standard as was seen in Reducing prescribing errors: can a well-
designed electronic system help? (28). However, the programme of work has shown 
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that with ePrescribing systems, other aspects compared to paper prescribing influence 
the clarity of a prescription. These include the number of screens needed to navigate, 
the ability to follow the prescribing “story” as the data is not presented 
chronologically, distinguishing pre-admission or initiated in-hospital medications, 
active and inactive prescriptions, eStat medications, order sets, staff training and the 
accuracy of the data presented in the system i.e. formulations or selection errors. 
Therefore, new impediments with electronic systems to the clarity of the prescription 
have replaced the old impediments experienced with paper prescription charts.  
Further work reviewing EPMA design, is essential to progress the “standards for 
the design of hospital in-patient prescription charts” in relation to ePrescribing, along 
with optimising socio technical interaction and quality patient care. The published 
standards for the design of hospital in-patient prescription charts did not specifically 
review ePrescribing systems, when reviewing the design of prescription charts, limiting 
their relevance to EPMA design, yet were indicated as being applicable to ePrescribing 
systems. These standards must be revisited to ensure they truly reflect the standards 
required for ePrescribing systems. Regular review of the standards would be pertinent, 
in order to keep up with the ever changing advances of technology and updates that 
are required.  
The aim of the “standards” was to produce a national prescription chart across 
England, with the backing of the Royal Colleges, therefore supporting a standard 
training package for all HCP students. However, the introduction of so many different 
EPMA systems has delayed the plan. With different designs and functionalities 
incorporated into EPMA systems, a set training package would not be possible. 
Standards for topics for inclusion within the training for all HCPs would provide 
structure to training that is essential for HCPs to use the system properly and provide 
quality care. A national EPMA system could enhance the quality of care in the future, 
connecting primary and secondary care. This would require initially a pilot study of a 
small initiative, connecting one hospital with its primary care counterparts such as GP 
surgeries and community Pharmacies, allowing development prior to any role out 
across the country. Unfortunately, some HCPs have lost faith in the ability to enhance 
quality of care in the future due to the current issues they already face (Section 4.6.1) 
and experiences from the failure of National Programme for IT (NPfIT)(147). However, 
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numerous factors such as implementation periods, structure etc. led to the failure of 
the NPfIT, that should not detract from the benefits of IT in the NHS.  
The use of a clinical indication on the prescription chart was proposed by the 
Standards for the design of hospital in-patient prescription charts (2). The research has 
raised the question as to whether the use of a clinical indication on the paper 
prescription chart is of benefit. However, the use of a clinical indication within the 
ePrescribing system could provide a way of detecting the inherent risk of selection 
error. Further research is required to appreciate if a clinical indication should only be 
provided in the hospital setting for newly initiated medication, due to the opinion 
provided by HCPs during the programme of work. The proposed requirement for a 
clinical indication on the prescription chart was addressed in all three phases of the 
programme of work and uncovered different perspectives and working practices. It 
would therefore be beneficial to investigate further the use of a clinical indication on 
the prescription chart as well as in the medical notes. 
Overall, written communication via medical entries within the notes for newly 
initiated medications did not clearly connect diagnosis and treatment. Clear and 
accurate written communication is even more essential now that possible prescribing 
errors are “quite convincing” and harder to pick up. Without clear and accurate 
documentation in the medical notes connecting diagnosis and treatment, new types of 
prescribing errors may not be discovered in time for the patient. 
The findings of this programme of work have raised further research questions. 
Existing research has focused on the implementation of ePrescribing systems and the 
difficulties encountered (20)(32)(80). This research has considered how different 
perspectives regarding the impact that a prescribing system design, whether paper or 
electronic, changes the clarity and accuracy of the prescription chart and the HCPs 
ability to provide quality healthcare. The design of EPMA systems still needs 
development, to maximise clarity and therefore facilitate HCPs’ working practices to 
provide quality healthcare to the patient. 
Due to the aim of the NHS to go “paperless” by 2018, paper prescription charts 
cannot be the future in the long term; however, we must not forget how paper 
prescription charts have stood the test of time, facilitating communication amongst its 
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users. Paper prescription charts have provided a good starting point for designing 
electronic prescription charts, some aspects that have let the quality of prescribing 
down on the paper prescription chart have been addressed when designing EPMA 
technology. Nevertheless, the good design features of paper prescribing need 
integrating into the next generation of ePrescribing prescription chart design, in order 
to facilitate HCPs’ working practices, quality patient care, and safety in terms of future 
development. 
Some think that the cultural change required to ensure effective implementation 
of ePrescribing is a much greater challenge than finding the right system (148). This 
programme of work has showed that the design of the system and therefore the right 
system would enable HCPs and MDTs to embrace the technology and support effective 
implementation in order to provide quality healthcare. 
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9 APPENDIX 
9.1 Telephone Interview 
 Ethics approval 9.1.1
By email 
Dear Katherine, 
With reference to your application for Ethical approval: 
A telephone based interview to explore prescribing and reporting systems in secondary care 
across England and Wales 
Liverpool John Moores University Research Ethics Committee (REC) has reviewed the above application at the 
meeting held on 1st December 2011. I am happy to inform you that the Committee are content to give a favourable 
ethical opinion and recruitment to the study can now commence. 
Approval is given on the understanding that: 
 any adverse reactions/events which take place during the course of the project will be reported to the 
Committee immediately; 
 any unforeseen ethical issues arising during the course of the project will be reported to the Committee 
immediately; 
 any substantive amendments to the protocol will be reported to the Committee immediately. 
 The LJMU logo is used for all documentation relating to participant recruitment and participation e.g. 
poster, information sheets, consent forms, questionnaires. The JMU logo can be accessed at 
http://www.ljmu.ac.uk/corporatecommunications/60486.htm  
                                                                
For details on how to report adverse events or amendments please refer to the information provided at 
http://www.ljmu.ac.uk/RGSO/RGSO_Docs/EC8Adverse.pdf 
Please note that ethical approval is given for a period of five years from the date granted and therefore the expiry 
date for this project will be 1st December 2016. An application for extension of approval must be submitted if the 
project continues after this date. 
Yours sincerely 
PP: 
 
Professor Andrew Young 
Chair of the LJMU REC 
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 Invitation letter for telephone interview 9.1.2
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 Participant information sheet for telephone interview 9.1.3
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 Interview schedule for telephone interview (1-4) 9.1.4
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9.2 Focus Group Discussion 
 Ethics approval  9.2.1
Dear Katherine, 
With reference to your application for Ethical approval: 
Minute No.: 12.75.14 
Project: 12/PBS/002, Katherine Shemilt, P/G Research, An exploration of health care quality surrounding 
prescribing systems in secondary care (Dr Charles Morecroft).   
Decision: Application approved without further information being required following submission of 
application of signature sheet. 
 
Liverpool John Moores University Research Ethics Committee (REC) has reviewed the above application at the 
meeting held on Thursday 12th July 2012. I am pleased to inform you that ethical approval has been granted and 
the study can now commence. 
Approval is given on the understanding that: 
 any adverse reactions/events which take place during the course of the project are reported to the 
Committee immediately; 
 any unforeseen ethical issues arising during the course of the project will be reported to the Committee 
immediately; 
 the LJMU logo is used for all documentation relating to participant recruitment and participation eg poster, 
information sheets, consent forms, questionnaires. The LJMU logo can be accessed at 
http://www.ljmu.ac.uk/corporatecommunications/60486.htm  
                                                                 
Where any substantive amendments are proposed to the protocol or study procedures further ethical approval must 
be sought.  
Applicants should note that where relevant appropriate gatekeeper / management permission must be obtained 
prior to the study commencing at the study site concerned. 
For details on how to report adverse events or request ethical approval of major amendments please refer to the 
information provided at http://www.ljmu.ac.uk/RGSO/RGSO_Docs/EC8Adverse.pdf 
Please note that ethical approval is given for a period of five years from the date granted and therefore the expiry 
date for this project will be 12th July 2017.  An application for extension of approval must be submitted if the project 
continues after this date. 
Yours sincerely PP:  
 
Professor Andrew Young 
Chair of the LJMU REC 
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 Trust gatekeeper invitation letter/e-mail for focus group discussion 9.2.2
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 Trust gatekeeper information sheet for focus group discussion 9.2.3
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 Trust gatekeeper consent form for focus group discussion 9.2.4
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 Ward gatekeeper information sheet for focus group discussion 9.2.5
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 Ward gatekeeper consent form for focus group discussion 9.2.6
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 Health care professional invitation letter to focus group discussion 9.2.7
 
 217 | P a g e  
 
 Participant information sheet for focus group discussion 9.2.8
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 Participant consent form for focus group discussion 9.2.9
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 Participant expression of interest for focus group discussion 9.2.10
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  Focus group script/schedule (1 -2) 9.2.11
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9.3 Documentation review 
  Service Evaluation Approval 9.3.1
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  Ethics Approval 9.3.2
Dear Katherine, 
Proportionate Review – Full Ethical Approval:  Application for Ethical Approval No.: 13/PBS/003 - 
Exploring written communication around prescribing 
Dr Sue Spiers & Dr Chris Wall have considered the application on behalf of Liverpool John Moores University 
Research Ethics Committee (REC).  I am pleased to inform you that ethical approval has been granted and the 
study can now commence. 
Approval is given on the understanding that: 
 any adverse reactions/events which take place during the course of the project are reported to the 
Committee immediately; 
 any unforeseen ethical issues arising during the course of the project will be reported to the Committee 
immediately; 
 the LJMU logo is used for all documentation relating to participant recruitment and participation eg poster, 
information sheets, consent forms, questionnaires. The LJMU logo can be accessed at 
http://www.ljmu.ac.uk/corporatecommunications/60486.htm  
                                                                 
Where any substantive amendments are proposed to the protocol or study procedures further ethical approval 
must be sought.  
Applicants should note that where relevant appropriate gatekeeper / management permission must be obtained 
prior to the study commencing at the study site concerned. 
For details on how to report adverse events or request ethical approval of major amendments please refer to the 
information provided at http://www.ljmu.ac.uk/RGSO/RGSO_Docs/EC8Adverse.pdf 
Please note that ethical approval is given for a period of five years from the date granted and therefore the expiry 
date for this project will be 7th May 2018.  An application for extension of approval must be submitted if the project 
continues after this date. 
Yours sincerely 
PP: 
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 Patient information sheet for review of medical records 9.3.3
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9.4 Dissemination of thesis 
 Conferences Attended 9.4.1
Patient Safety Congress - International Conference Centre, Birmingham, July 2011. 
Health Service Research and Pharmacy Practice (HSRPP) Conference, University College 
Cork (UCC), Ireland, Apr. 2012. 
United Kingdom Clinical Pharmacist Association (UKCPA) Autumn Symposium, Crowne 
Plaza, Chester, Nov. 2012. 
United Kingdom Clinical Pharmacist Association (UKCPA) Autumn Symposium, Crowne 
Plaza, Chester, Nov. 2013. 
Royal Pharmaceutical Society (RPS) Annual Conference – International Conference 
Centre, Birmingham, Sept. 2014. 
 
9.4.1.1 Poster Presentations 
Shemilt K, Morecroft C, Green C, Mackridge A, Ford J. Chief Pharmacists’ perceptions 
of using clinical indication on in-patient prescription charts. United Kingdom Clinical 
Pharmacist Association (UKCPA) Autumn Symposium. Crowne Plaza, Chester. 2012. 
Shemilt K, Morecroft C, Green C, Mackridge A, Ford J. The impact of prescribing 
systems on health care professionals’ working practices. United Kingdom Clinical 
Pharmacist Association (UKCPA) Autumn Symposium. Crowne Plaza, Chester. 2013. 
 
9.4.1.2 Oral Presentations 
Shemilt K, Morecroft C, Green C, Mackridge A, Ford J. Improving prescribing quality; is 
electronic prescribing the answer? Health Services Research and Pharmacy Practice 
(HSRPP). University of Central Lancashire (UCLAN), Preston. May 2013. 
Shemilt K. The impact of prescribing systems on health care professionals’ working 
practices. Research Café. Liverpool John Moores University. May 2014. 
Shemilt K, Morecroft C, Green C, Mackridge A, Ford J. Is clarity and accuracy being 
compromised by the way electronic prescriptions are designed?. Royal Pharmaceutical 
Society Annual Conference, ICC Birmingham. Sept 2014. 
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 Publications  9.4.2
Shemilt K, Morecroft C, Green C, Mackridge A, Ford J. Chief Pharmacists’ perceptions 
of using clinical indication on inpatient prescription charts, Conference abstract for UK 
Clinical Pharmacy Association Conference: 2012 Nov. [Online] Available from: 
http://www.pharmaceutical-journal.com/files/rps-pjonline/UKCPA_Jan_Feb_2013.pdf 
[Accessed 7th Jan 2015]. 
Shemilt K, Morecroft C, Green C, Mackridge A, Ford J. The impact of prescribing 
systems on health care professionals’ working practices, Conference abstract for UK 
Clinical Pharmacy Association Conference: 2013 Nov. [Online] Available from:  
http://www.ukcpa.net/wp-content/uploads/2010/11/Autumn-Symposium-Handbook-
2013-v9.pdf [Accessed 7th Jan 2015]. 
Shemilt K, Morecroft C, Green C, Mackridge A, Ford J, Oral Session 3. Improving 
prescribing quality; is electronic prescribing the answer. Int J Pharm Pract. 2013, 21:17-
18. 
Shemilt K, Morecroft C, Green C, Mackridg A, Ford J. Research Session 2: Improving 
patient safety through innovation. Is clarity and accuracy being compromised by the 
way electronic prescriptions are designed? Int J Pharm Pract. 2014; 22:13–4. 
 
 
